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Abstract 
Abstract of a thesis submitted in partial fulfilment of the  
requirements for the Degree of Doctor of Philosophy in Finance.  
Reliability of Listed Companies’ Value Estimates and Target Prices: Evidence 
from Industry-Based Combined Valuation Models 
by 
Yanfu Li 
 
The low reliability of listed companies’ target prices is a major issue globally. As the foundation 
of the target price, the value estimate is important in the determination of target price reliability. 
The value estimate is the estimated intrinsic value of a company produced by the company 
valuation model. However, there is no individual valuation model capable of fully disclosing the 
intrinsic value, and the use of more than one valuation model simultaneously is a common 
practice. In addition, it is important for the valuation model to be consistent with the 
characteristics of the company. However, the existing literature offers little guidance on this 
valuation issue, especially on how to appropriately construct a combined valuation model based 
on the characteristics of the company.  
This study investigates the underlying reasons for the low reliability of listed companies’ value 
estimates and target prices, and attempts to improve their reliability via the enhanced company 
valuation method. In particular, the study focuses on the industry based combined valuation 
models and their application to the valuations of listed companies from different industries. The 
study begins with the estimation of discount rate for each selected firm, and then applies the 
industry based individual and combined models to generate value estimates for each firm, 
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followed by the target price setting process to determine the most reasonable target price. The 
improved reliability test techniques will be used to measure the performance of value estimates, 
target prices and the financial analysts’ target prices, so that the best individual and combined 
valuation models for different industries can be identified. 
This study has produced several important findings. The results show that the reliability of the 
target price is determined by the value estimate and the target price setting process. The 
reliability of the value estimate is influenced by the data and valuation method. The results also 
show that absolute valuation models have significant advantages in emerging industries such as 
biotechnology. The relative valuation models exhibit good performance in the traditional 
industries such as technology hardware. The forward valuation models are suitable for stable 
industries such as insurance with accurate forecasts. The trailing valuation models have apparent 
advantages in unstable industries such as securities with great uncertainty. The results also show 
that the combined valuation models have significant advantages over the individual valuation 
models. The mixed combined valuation models are preferred in practice.  
Keywords: industry characteristics, company valuation model, reliability 
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Chapter 1 
                                          Introduction 
1.1  Introduction    
In general, listed companies’ target prices are supposed to assist stock market investors to judge 
the best time to exit their existing positions in order to realize the maximum profit potential. 
However, the target prices do not always produce the appropriate trading signals and most of 
them tend to be over-bullish. A number of studies show that the target prices often significantly 
deviate from the market prices. Brav and Lehavy (2003) and Asquith et al. (2005) showed that, 
for the period 1997 to 1999, the average return implied by target prices was 32.9%. Bradshaw et 
al. (2013) found the target prices between the years 2000 and 2009 implied a return of 24.0%. In 
fact, there was only an actual market return of 8.1% from the years 1997 to 2009 (Bradshaw et 
al., 2014). Recently, there have been increasingly doubts about the target prices because of their 
low reliability, especially the assigned target prices for the technology stocks which are often too 
high to be achieved. Bonini et al. (2010) discovered that the target price reliabilities are very 
limited, their prediction errors are consistent, auto-correlated, non-mean reverting and large. In 
fact, the low reliability of target prices is a wide spread issue worldwide. Asquith et al. (2005) 
found that about 54.3% of target prices in the US reach their targets within 12 months. Kerl 
(2011) revealed that approximately 56.5% of target prices are achieved in Germany, and Bonini 
et al. (2010) found that only 33.1% of target prices are achieved in Italy.  
The low reliability of listed companies’ target prices is indeed a serious issue. This chapter 
provides a general discussion of the value estimates and target prices of listed companies to 
enable us to understand the improvement of value estimate and target price reliability. The rest of 
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the chapter is organized as follows: Section 1.2 describes the basic concepts of some company 
valuation related terms. Section 1.3 presents the research problem statement. The research 
objectives are illustrated in Section 1.4. Section 1.5 discusses the research significance, followed 
by the thesis structure outline in the last section. 
1.2  Definitions of Terms 
1.2.1  Company Valuation 
Company valuation is a widely used financial technique and process to estimate the economic 
value of a company. Depending on the status of the company (whether it continues to operate or 
is bankrupt), the premises of valuation can be under going-concern or liquidation, respectively. 
According to the different objectives in performing valuations, Pinto et al. (2010) classified 
company valuation into three categories: transaction-related, compliance-related and litigation-
related valuation. Specifically, the transaction-related valuations contain the private equity 
financing, IPO, acquisition, etc. The compliance-related valuations include the compliance 
encompassing actions required by laws such as financial and tax reporting. The litigation-related 
valuations consist of the legal proceedings including those related to lost profits, shareholder 
disputes, etc.  
1.2.2   Value Estimate 
The economic value of a company can be defined as the intrinsic value, fair value or investment 
value, etc. With regard to the intrinsic value, Dong (2008) revealed that the intrinsic value is 
frequently used in the transaction-related valuation and it is the actual value of a company. 
However, what a company is actually worth is difficult to quantify. The company valuation 
technique attempts to estimate the intrinsic value based on the underlying perception, which 
includes all aspects of the company, both tangible and intangible factors. Therefore, many 
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studies conclude that the company valuation is actually an art rather than an exact science (e.g. 
Frankel, 2005, King, 2012). In addition, the estimated intrinsic value produced by company 
valuation is known as the value estimate. The value estimate reflects the financial analyst’s 
estimation of how much the company is worth at the valuation date. Depending on the different 
objectives in performing valuations, the “semi-finished product” value estimate needs to be 
adjusted according to a series of non-quantitative factors. Kerl (2011) concluded that the 
financial analysts do not take the outcome of valuation at face value, but adjust the results 
qualitatively to satisfy the specific valuation needs. By doing so, the value estimate can turn into 
several “final products” such as IPO price, the acquisition price paid to purchase a company or 
the target price of a listed company’s stock.  
1.2.3   Target Price 
The listed company’s target price is often a specific number used in the stock market investment. 
As a direct indicator of the future intrinsic value per share of a company, the target price reflects 
the financial analyst’s expectation of the future price level that a listed company’s stock is most 
likely to reach within a certain time horizon (Huang et al., 2009). The time horizon is usually 
half or one year following the initial target price announcement date. In general, the target price, 
together with the investment recommendation and earnings forecast are the three most important 
quantitative outputs of a financial analyst’s report (Feldman et al., 2012). Brav and Lehavy 
(2003) suggested that the target prices are the financial analyst’s most informative statement of 
the listed companies’ future intrinsic values. The stock market often reacts significantly and 
immediately to the initial and revision announcements of target price.  
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1.2.4   Relationship between the Value Estimate and the Target Price 
In general, the value estimate is the foundation of the target price. The target price is often based 
on the estimated future intrinsic value, where the future intrinsic value is predicted by using the 
value estimate. The value estimate is the estimated intrinsic value of a company at the current 
valuation date. Since the intrinsic value of a company is subject to change for all time, the value 
estimate cannot adequately reflect the future intrinsic value of a company. Therefore, the 
financial analysts predict the future intrinsic value based on the value estimate. In addition, the 
financial analysts prefer to subjectively set the target prices around rather than equal to the 
estimated future intrinsic values. The distance between the target price and the estimated future 
intrinsic value is known as the “safety margin”. It is often used as an allowance for factors such 
as valuation error or the financial analysts’ confidence towards their estimated future intrinsic 
values. Hence, it is often said that the value estimate is the product of objective valuation, and 
the target price is the product of subjective pricing. Brav and Lehavy (2003) revealed that the 
value estimate is basically the estimated intrinsic value of a company at the current valuation 
date. The value estimate needs to be adjusted to allow the intrinsic value to change over time, 
and better reflect the expected future price level.  
1.2.5   Influential Factors of Target Prices 
The low reliability of listed companies’ target prices is becoming a wide spread issue. There are 
increasing researches investigating the underlying reasons and a number of influential factors 
have been identified. Bradshaw et al. (2013) found evidence that the target price accuracy is 
largely related to the overall market condition, where the target price forecasts are more accurate 
in the up rather than the down market. This is usually true as the financial analysts tend to issue 
“bullish” target prices, which are easier to achieve in a bull market. Asquith et al. (2005) 
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suggested that the high target prices actually are the products of the financial analyst’s optimism. 
Bradshaw et al. (2013) discovered that the target prices issued by the financial analysts employed 
by pure brokers are more optimistic due to the incentives to generate trading. Financial analysts 
who are employed by the brokers with business ties with the target firms tend to provide more 
optimistic recommendations (Michaely and Womack, 1999; Krigman, et al. 2001). Bradshaw et 
al. (2013) further concluded that the financial analyst’s optimism is exacerbated by the conflicts 
of interest and investment banking pressures. Cowen et al. (2006) revealed that the sales and 
trading activities used to fund research create strong incentives for the financial analyst's 
optimism. The authors also found evidence that the financial analysts who work in prestigious 
investment banks are prone to produce more optimistic reports to attract new clients and increase 
brokerage services income. In fact, the financial analyst’s optimism is harmful to the reliability 
of the target price, and often causes the target price to become too high to achieve. Bonini and 
Kerl (2012) found that target price performance decreases with the financial analyst’s optimism.  
In addition, other studies have identified a series of other factors that have influence on the 
performance of listed companies’ target prices. For example, Bonini and Kerl (2012) found that 
financial analysts’ access to privately available information affected their ability to produce 
reliable valuation implications. The authors also revealed that the increased accuracy can be 
attributed to the additional information that financial analysts use to adjust the target prices. 
Gleason et al. (2013) discovered that the financial analysts who demonstrated superior 
concurrent earnings forecasting accuracy usually set target prices more accurately over the 
ensuing 12 months. Kerl (2011) highlighted that the size, reputation and research intensity of the 
investment bank had positive influence on the target price accuracy. Bradshaw et al. (2013) 
discovered that the target price performance is worse when the target company’s stock price 
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volatility is high, and the target price is more likely to be achieved during the company-specific 
positive price momentum. Bradshaw et al. (2013) and Bilinski et al. (2013) concluded that 
country-specialized financial analysts with better past target price forecast records, higher 
forecasting experience, and employed by a large broker often issued more accurate target prices. 
Bilinski et al. (2013) emphasized that country-specific institutional and regulatory factors such as 
accounting disclosure quality, cultural traits and financial reporting standards explained the 
difference in target price reliability across borders.  Ali and Hwang (2000), Ball et al. (2000) and 
Imam et al. (2013) also discovered that the value relevance of accounting numbers varied 
significantly between countries due to the different legal systems, and the level of alignment of 
financial and tax accounting. 
1.2.6   Influential Factors of the Value Estimate    
In addition to the above factors which have indirect influences on the listed company’s target 
price reliability, the target price is directly affected by the quality of the value estimate. Financial 
analysts determine the target price on the basis of estimated future intrinsic value, where the 
future intrinsic value is often predicted based on the value estimate. Recent studies have shown 
that the quality of historical accounting data, the accuracy of company performance forecast data, 
the discount rate estimation method and the valuation model have significant effects on the 
quality of value estimates. For example, Gleason et al. (2013) found evidence that the accuracy 
of a value estimate is strongly associated with the accuracy of the earnings forecast. Cassia and 
Vismara (2009) suggested that the equity reports that adopt the steady state earnings growth rate 
to determine the terminal value always produce more reliable value estimates. Gleason et al. 
(2013) underscored the importance of both forecasting ability and the valuation model. The 
authors further revealed that the potential benefits of superior earnings forecasts can be lost if 
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those forecasts are used as inputs in a flawed valuation model. Demirakos et al. (2010) showed 
that the valuation model affects value estimate accuracy. In the valuation of small, unstable and 
high-risk companies with volatile earnings and a limited number of comparable companies, the 
discount cash flow models often outperform the price multiples. For the companies with negative 
future cash flows, Pinto et al. (2010) emphasized that the residual income model is the most 
appropriate valuation model. Liu et al. (2002) found that the forward price to earnings multiples 
tend to produce the most accurate value estimates for high growth or profitable companies. The 
market condition also influences the valuation model choice. Demirakos et al. (2010) suggested 
that the value estimate quality is more likely to improve when the financial analyst applies the 
price to earnings model in a bull market and the discount cash flow model in a bear market.  
1.2.7   Valuation Methods 
The reliability of the value estimate is not only directly influenced by data, but also by the 
valuation method. The target price is further affected by the target price setting method. Sections 
1.2.7.1 to 1.2.7.3 discuss the valuation methods such as the discount rate estimation method, 
company valuation model and target price setting method. The commonly used techniques to test 
the reliability of both value estimate and target price are presented in Section 1.2.7.4. 
1.2.7.1   Discount Rate Estimation Methods   
As the first step in company valuation, the estimation of an accurate discount rate is essential. 
The discount rate has been widely used in company valuation to estimate the intrinsic value of a 
company. It has direct and significant influence on the reliability of both value estimate and 
target price. Pratt (2002) revealed that the cost of capital for a company has often been used as a 
discount rate that equates the expected economic income to the present value. Although the 
capital structure and source vary significantly across different companies, the equity and debt are 
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two major sources of financing. Therefore, the cost of capital may refer to the required return on 
a company’s equity capital or debt capital, or both (the weighted average cost of capital-WACC). 
However, the estimation of an accurate discount rate is one of the most challenging parts of 
valuation practice. The discount rate should fully reflect both the time value of money and the 
uncertainty of future cash flows (Pratt, 2002).  
1.2.7.1.1   Cost of Equity    
The cost of equity, also known as the required return on equity is an important component of the 
WACC. The WACC is determined by the cost of equity, after-tax cost of debt and capital 
structure. The cost of equity can be estimated by using the following methods. 
The build-up model is a traditional but widely used model to estimate the cost of equity for 
small-cap listed companies. Pratt (2002) revealed that the build-up method estimates the cost of 
equity as the sum of the risk free rate and a series of risk premiums, which include the equity 
market, size and company-specific risk premiums. The country-specific premium should be 
considered but it is not often required for the developed markets. In addition, there is a simple 
and convenient form of a build-up model known as the bond yield plus risk premium model 
(BYPRP). Pinto et al. (2010) recommend the BYPRP for the companies with publicly traded 
debts, which estimates the cost of equity as the sum of the yield to maturity on the company’s 
long term debt and a risk premium.  
The capital asset pricing model (CAPM) is also a popular model to estimate the cost of equity for  
medium and large-cap listed companies. The CAPM was developed 30 years ago by Sharpe 
(1964) and Lintner (1965) with a strong theoretical foundation and ease of application. In the 
earlier survey conducted by Graham and Harvey (2001), three out of four chief finance officers 
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said that they use the CAPM to calculate the cost of equity. Based on the recent survey 
conducted by the Association for Financial Professionals (AFP) with more than 300 top financial 
practitioners, Jacobs and Shivdasani (2012) concluded that about 90% of respondents preferred 
the CAPM in their estimations of cost of equity. Koller et al. (2010) revealed that the CAPM 
estimates the cost of equity by using three factors: risk free rate, market wide risk premium, and 
risk adjustment (beta) that reflects each company’s riskiness relative to the market. However, 
there are increasing doubts about the effectiveness of CAPM, as many studies argue that the beta 
does not describe the risk adequately. Pinto et al. (2010) showed that the coefficients of 
determination for stocks’ beta regression range from 2 percent to 40 percent, with many under 10 
percent. This implies that the CAPM cannot fully capture the risk faced by the company. 
Because of the drawbacks of the CAPM, the empirical evidence based models such as the 
multiple-factor Fama-French model (FFM) and the Pastor-Stambaugh model (PSM) have been 
developed. The FFM model was introduced by Fama and French (1992) and (1993), which 
defines the risk as a stock’s sensitivity to three portfolios: market, size and value. The PSM adds 
to a liquidity factor to represent the excess returns to a portfolio that invests the proceeds from 
shorting high-liquidity stocks in a portfolio of low-liquidity stocks (Pinto et al., 2010).  
There is also a simple and direct cost of equity estimation method known as the Gordon growth 
method (GGM). There are two types of GGM: single-stage and multiple-stage (Pinto et al., 
2010). Specifically, the single-stage GGM estimates the cost of equity as the sum of forward 
dividend yield and consensus long-term earnings growth rate. The multiple-stage GGM estimates 
the cost of equity that equates the sum of present values of the expected cash flows from several 
future stages to the current market price. 
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1.2.7.1.2   Cost of Debt 
The cost of debt, or the required return on debt (after marginal or effective tax) is another 
component of the WACC. The yield to maturity (YTM) on a company’s long term public debt 
(option-free and non-convertible) has often been selected as a proxy of cost of debt. A 
company’s publicly traded debts often contain certain degrees of default risk, especially for the 
companies below investment grade. Hence, the YTM has three major components: real interest 
rate, expected inflation premium and default risk premium. Pinto et al. (2010) revealed the 
default risk premium reflects a series of factors such as leverage, profitability and sensitivity of 
profitability to systemic risk.  
In terms of YTM estimation, Koller et al. (2010) suggested that for the companies with public 
traded long term debts calculate the YTM directly from the bond’s price and promised cash 
flows. Alternatively, the YTM on publicly traded debts is also available from many financial 
databases. For the companies with short-term public debts, public debt trades infrequently or 
even no publicly traded corporate bonds, the company’s long term credit rating can be used to 
estimate the YTM indirectly. For the companies without credit ratings, the estimation of long 
term credit rating is required. The financial ratio comparison approach is the most commonly 
used method to determine the credit rating.  
Jacobs and Shivdasani (2012) found that only 34% of the respondents in the survey of the 
Association for Financial Professionals selected the forecasted YTM rate on the new debt 
issuance. In addition, 37% of the respondents adopted the current average rate on outstanding 
debt to estimate the YTM. In order to produce an appropriate discount rate for the future cash 
flow, the authors argued that the YTM should be based on the forecasted rate on the newly 
issued bonds rather than “old” bonds.  
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1.2.7.2   Company Valuation Models   
Following the discount rate estimation, the valuation model selection and application is the 
second step in company valuation. In today’s valuation practice of listed companies, there is a 
range of absolute and relative valuation models available. Specifically, the absolute valuation 
models estimate the intrinsic value based on the present value of all the future cash flows 
generated by a company. On the other hand, the relative valuation models apply the law of one 
price to disclose the intrinsic value of a company.     
In order to produce a reliable value estimate and target price, the valuation model needs to be 
consistent with the characteristics of the company. Rees (1999) discovered that the valuation 
model’s performance is very sensitive to the company’s characteristics. A group of companies, 
classified as either an industry or a sector often share many similar features and they can be 
valued by certain types of valuation models. Demirakos et al. (2004) conducted a content 
analysis on the equity reports from three industries and discovered that the relative models are 
frequently used in the valuations of stable and traditional industries, where accrual accounting 
can better reflect the intrinsic value of the companies. The authors also revealed that the absolute 
models such as discounted free cash flow model is more suitable for those companies in fast 
growing industries with higher risk. Imam et al. (2008) conducted interviews with 42 sell-side 
financial analysts, and concluded that the absolute model of discounted free cash flow is the first 
choice to value the fast growing technology and media companies. The authors also ranked the 
relative model of price to book value as the primary model for financial companies, since 
financial companies mainly consist of highly liquid assets and their book values approximate 
their market prices. For a cyclical industry which is heavily subject to the business cycle effect, 
Imam et al. (2008) recommended the relative model of enterprise value to earnings before 
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interest, tax, depreciation and amortization (EBITDA) as a reliable model to deal with the 
volatile earnings. For those cyclical companies whose earnings are often negative during the 
down part of a business cycle, Geddes (2003) discovered that dividing the enterprise value of a 
company by its sales is an effective way of comparing companies in cyclical industries.  
In recent valuation practice, the time value of money based absolute models such as the 
discounted cash flow model (DCF) becomes the financial analyst’s dominant valuation model 
(Giamouridis and Montagu, 2014, Lundholm and O’Keefe, 2001). Glaum and Friedrich (2006) 
discovered that the financial analysts started to rely more on the fundamental based absolute 
models after the 2001 dot.com bubble. The financial analysts became more risk averse after the 
crisis, and changed their focus from single period-oriented measures towards an assessment of 
profitability and cash flow generation. However, the absolute models are often over-sensitive to 
the changes in their key inputs, and they also face greater uncertainty in the company’s 
performance forecasting and difficulty in estimating the discount rate. Pinto et al. (2010) argued 
that absolute models react significantly to the changes in the estimated inputs and this may 
potentially reduce their reliability. Goedhart et al. (2005) revealed that absolute models heavily 
rely on the estimation of a number of key components and if they turn out to be wrong this can 
lead to big mistakes. Francis et al. (2000) tested the performance of a series of absolute models 
by measuring the accuracy and explanatory power of the value estimates derived from these 
models. The authors found that in terms of explanatory power, the value estimates produced by 
the absolute models only explained a maximum of 51% variation in the current price. Their 
accuracy test also showed an average percentage valuation error as high as 69.1%. Francis et al. 
(2000) concluded that the major reason for the underperformance of absolute models is the over-
reliance on the estimated terminal values. Steiger (2008) revealed that the terminal value 
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accounts for a large portion of the company’s total estimated intrinsic value and for the high 
growing companies, the terminal value often accounts for 80-90% of the estimated intrinsic 
value (Gode and Ohlson, 2006).  
On the other hand, the law of one price based relative models are easy to apply and provide a fast 
estimation of the intrinsic value of a company. The relative models are often easy to understand 
and simple to present to clients and customers (DeAngelo, 1990), they are particularly useful 
when a company’s intrinsic value cannot be directly observed (LeClair, 1990). The relative 
models were very popular in valuation practice, especially before the 2001 dot.com crisis. Earlier 
studies before the dot.com crisis such as Block (1999) who indicated that half of the financial 
analysts in his survey did not use the absolute models, they considered the relative models such 
as price to earnings as the basis for the valuation. The survey conducted by Carter and Auken 
(1990) also indicated that using the price to earnings model is the most valuable technique for the 
valuation practice conducted by investment managers. However, the relative models have one 
big problem and that is whether the chosen benchmark is fairly priced (Pinto et al., 2010). In fact, 
the effectiveness of the chosen benchmark is difficult to justify. Companies with similar 
operating and financial characteristics are the most common choice of benchmark (Palepu et al., 
2000). Bhojraj and Lee (2002) found that the peer group benchmark based relative models often 
produced more reliable valuation results than the industry and market benchmark. Perhaps the 
most cost efficient way to identify the comparable companies for the peer group is to start by 
examining the target company’s competitors or industry (Koller et al., 2005). Alford (1992) 
recommended the combination of risk (beta) and earnings growth rate as an effective criterion 
for selecting comparable companies. Although the ‘best’ benchmark is similar, it is not exactly 
the same as the company being valued. The valuation results would be misleading when the 
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benchmarks are difficult to identify, especially for a company that operates in several industries 
(Palepu et al., 2000).  
1.2.7.3   Target Price Setting Methods 
Following the company valuation, the third step is that financial analysts need to set a reasonable 
target price on the basis of the estimated future intrinsic value. The future intrinsic value is often 
predicted by using the value estimate. In general, the target price should fully reflect the financial 
analyst’s expectation of the price level a listed company’s stock is likely to reach within the next 
12 months.  
In practice, there is no standard way to set the target price for a listed company. For the technical 
investors, they rely mostly on the technical trading rules such as support and resistance, moving 
averages and Fibonacci extensions to predict what the price level is likely to be in the future. On 
the other hand, value investors tend to focus on the fundamentals of a company, and apply 
several valuation models and financial ratios to estimate the intrinsic value and then set the target 
price. Imam et al. (2008) presented the value investors’ three major approaches in setting target 
price. The commonly used approach sets the target price based on a combination of valuation 
models after adjusting for the financial analyst’s subjective judgments. The second approach 
relies on the comparable transaction or company, which applies the relative valuation models to 
arrive at the target price. The third approach uses the subjectively determined premium or 
discount on the current market price to set the target price. Apparently, the three pricing methods 
involve the financial analyst’s subjective assessments of a company. Bonini and Kerl (2012) 
highlighted the importance of a setting process, whereby the increased reliability of the target 
price can be attributed to the additional information that financial analysts used to adjust the 
value estimate. 
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An immediate question is: how to combine several value estimates when more than one 
valuation model is used at the same time? Imam et al. (2008) found that the financial analysts 
tended to use qualitative judgments to directly combine various value estimates into one. 
However, this over-subjective process may introduce additional pricing error and result in an 
unreliable target price. Unfortunately, the extant literatures offer little guidance on this issue. 
Patena (2011) provided a comprehensive overview of the relevant literatures, and discovered that 
the weighted average methods are the dominant methods to combine several value estimates. 
Specifically, the Delaware Block method is the most prominent weighted average method. It is 
the industry standard approach in the financial legal proceedings and IRS tax-related valuation 
disputes (Beatty et al., 1999). In general, the weighted average method assigns weights manually 
to the value estimates produced by the different valuation models, according to their importance 
and relevance to the company being valued. The weighted average methods are based on the rule 
of thumb and the estimated weights often vary greatly between different financial analysts and 
thus are subject to serious criticisms. Yee (2008) argued that although the current research on the 
techniques to combine value estimates is not adequate, there are many studies exploring how to 
combine different forecasts as a result of applying differing forecasting models. Yee (2004) 
revealed that after appropriate adjustments, these methods can be adapted to determine the 
weights for various value estimates.   
1.2.7.4   Reliability Testing Techniques of Value Estimate and Target Price  
Following the target price setting, financial analysts may wish to test the reliability of the target 
price. Since the target price is based on the value estimate, the test of value estimate is also 
important. Until recently, there were a range of reliability testing techniques for listed company’s 
value estimate being developed. In general, the value estimate is the estimated intrinsic value of 
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a company at the valuation date. The reliability of a value estimate depends on how well it 
discloses the intrinsic value of a company (accuracy), and whether it exhibits a similar trend to 
the fluctuation of intrinsic value over time (explanatory power). Kaplan and Ruback (1995) 
revealed it is possible that one value estimate could successfully estimate the intrinsic value on 
average, but perform poorly in explaining the variation in intrinsic value, and the converse is also 
possible. Francis et al. (2000) focused on accuracy and explanatory power, and used market price 
as a proxy for intrinsic value per share. The authors tested the accuracy of value estimate by 
calculating the price scaled difference between value estimate and market price, and measured 
the explanatory power by regressing between market prices and value estimates.  
Instead of testing the “semi-finished product” of value estimate, investors prefer to focus directly 
on the “final product” of target price. In recent years, a variety of advanced techniques have been 
developed to test the reliability of the target price. Apparently, the easiest way to measure the 
reliability is to judge whether the predetermined target has been achieved by the market price 
within the time period identified by the financial analyst. Demirakos et al. (2010) presented three 
straightforward reliability metrics to test whether the target has been achieved during, on the last 
day or beyond the 12-month horizon. In contrast, the four metrics suggested by Bradshaw et al. 
(2013) are more technical. The first criterion is the ranked correlation between the realized and 
forecasted returns implicit in the financial analyst’s target prices. The second criterion is the 
target price forecast error computed as the actual 12-month-ahead closing stock price minus the 
target price scaled by the beginning market price. The third criterion is a dummy variable equal 
to one if the actual 12-month-ahead closing price is at or above the target price. The last criterion 
is a dummy variable coded as one if the target price is met at any time during the 12-month 
horizon. In addition, it has been found that the financial analyst’s over-optimistic target price 
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setting also has strong influence on the reliability. Therefore, Bonini and Kerl (2012) consider 
the financial analyst-specific ‘boldness’ as an indirect reliability measurement. It is computed as 
the absolute difference between the target price and the market price, scaled by the latter. 
However, very few studies take into account the direction of target prices (targets set above, 
below or equal to the current market prices). Asquith et al. (2005) adopted a measurement ratio 
which is the maximum price achieved within 12 months divided by the target price if it is set 
above the current price. If the price target is below the current price, the measurement ratio is the 
target price divided by the minimum price achieved within 12 months. Imam et al. (2013) further 
distinguished the target prices according to three types of investment recommendation (buy, sell 
and hold), and then tested their reliability separately by different metrics.  
1.3   Research Problem Statement   
The low reliability of listed companies’ target prices is indeed a wide spread issue, Bonini et al. 
(2010) found that the target price reliability is worse in the emerging markets with lower levels 
of market efficiency. In general, the target price performance is directly affected by the quality of 
the value estimate and the target price setting method. Specifically, the value estimate is largely 
influenced by a range of factors including the accounting report quality, earnings forecast 
reasonableness, discount rate accuracy, and especially the valuation model suitability. The 
valuation model is the core element of company valuation, how to appropriately select and apply 
the valuation model is one of the key points to produce a reliable value estimate.  
However, there is no valuation model capable of fully estimating the intrinsic value of a 
company. The multi-period absolute model such as discounted cash flow becomes the financial 
analysts’ dominant valuation model. This is especially true when the information on historical 
accounting items such as actual earnings is insufficient to assess the value of companies, and the 
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demand for forecasted data based absolute models increases (DeFond and Hung, 2003). However, 
the absolute models often face great uncertainty in terms of specific forecast and difficulty in 
estimating the discount rate. Call et al. (2009) suggested that performance forecasting is highly 
sophisticated as it involves the use of various financial statement numbers. Block (1999) argued 
that the difficulty in creating multi-period forecasts in an uncertain corporate environment and 
estimating the appropriate discount rate, makes the multi-period absolute models unattractive to 
financial analysts. In contrast, the single period relative models such as the price to earnings 
model has been widely used in valuation practice. It provides a straightforward estimation of 
intrinsic value, and takes less time and requires fewer assumptions and less information than the 
application of a fully-fledged fundamental analysis with the absolute valuation models 
(Damodaran, 2009). However, its biggest problem is whether the chosen benchmark is fairly 
priced. Thus, every valuation model has its own limitations. Yee (2004) revealed that every 
value estimate is just an incremental piece of information and relying on only one value estimate 
or valuation model may ignore valuable information.  
In fact, the use of more than one individual valuation model at the same time is already a 
common practice. According to the Institutional Factor Survey by Merrill Lynch in 2006, 
institutional investors use an average of nine individual valuation models and financial ratios 
together in company valuation. Vardavaki and Mylonakis (2007) argued that the combined 
valuation models outperform the individual valuation models in general. Jenkins (2006) 
concluded that the strength of the combined models is derived from their abilities to 
simultaneously capture the multiple dimensions of the valuation information contained. Courteau 
et al. (2006) revealed that the potential valuation benefits can be gained from combining several 
valuation models in practice, and there is the possibility of using one model as a check on others. 
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The current study highlights the importance of the combined valuation model. The performance 
of combined valuation model can be further improved by including the complementary absolute 
and relative valuation models. By doing so, the drawbacks of absolute and relative models can be 
minimized while their advantages can be maximized, the synergy can be fully generated. Jenkins 
(2006) revealed that an effective combination of absolute and relative models is able to focus 
both on the long-term forecasts as well as short-term forecasts. Imam et al. (2013) discovered 
that the use of an accrual based relative model alongside a cash flow based absolute model 
reduces valuation error, as accruals add value relevant information to cash flows (Burgstahler, 
1998). The cash flows are also useful in validating the information in accruals, since cash flows 
have incremental value relevance to accruals (Akbar et al. 2011). 
In addition, it is also important for the combined valuation model to be consistent with the 
characteristics of the company to better estimate the intrinsic value. The “apples to apples” 
comparison offers a more defensible way to reflect how much a company is worth. Tasker (1998) 
discovered that the systematic use of an industry-based valuation model is more appropriate in 
different industries. The current study emphasizes that it is important to concentrate on the 
general features of the companies in an industry, and use different combined valuation models in 
differing industries (industry-based combined valuation model). 
The current study aims to improve the reliability of listed companies’ value estimates and target 
prices. The current study highlights the importance of the valuation method and introduces a 
valuation concept of industry-based combined valuation model. The industry-based combined 
model benefits from the combination of both absolute and relative valuation models, which 
further improves the valuation performance by considering the industry-specific characteristics. 
However, there may be more than one suitable combined valuation model for a particular 
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industry. The current study develops an improved suitability test method to identify the best 
industry-based combined valuation models. In order to further improve the value estimate and 
target price reliability, the current study also attempts to improve the cost of capital estimation 
technique and the target price setting method.  
1.4   Research Objectives    
1.  Identify the factors which influence the reliability of listed companies’ target prices and value 
estimates. 
2. Improve the discount rate estimation method for listed companies, which includes cost of    
equity, after-tax cost of debt and capital structure estimation technique. 
3. Identify the best industry-based individual and combined valuation models for the financial, 
information technology and health care industries. 
4. Improve the target price setting method to produce reliable listed companies’ target prices. 
5. Improve the reliability test method for listed companies’ value estimates and target prices. 
1.5   Significance of the Research    
This is the first study to introduce an important concept of industry-based combined valuation 
model to improve the performance of company valuation. The current study contributes 
significantly to the literature on company valuation methods. The industry-based combined 
valuation model takes advantage of both combined model and industry-based model. The 
industry-based combined valuation model has excellent practical relevance in company valuation. 
It provides an effective guidance for the construction of combined valuation models, and 
significantly improves the reliability of valuation results. Second, this is also the first study to 
introduce the important valuation concepts of multi-valuation periods and multi-value indictors. 
The two valuation concepts provide effective practical guidance in the construction of combined 
valuation models. The superior performance of an industry-based combined valuation model is 
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only guaranteed when it fully complies with the multi-valuation periods and multi-value 
indictors. A good industry-based combined valuation model should not only cover all the 
important life stages of a company, but also fully disclose the intrinsic value generated in each 
important life stage. Third, the current study also contributes to the discount rate estimation 
literature by improving the cost of equity, cost of debt and capital structure estimation techniques.  
More accurate discount rates can be estimated and applied to company valuation practice. Fourth, 
the current study provides great insight into the widely-used methods to set target price, and 
presents an enhanced target price setting approach to assist financial analysts to produce more 
reasonable target prices. Lastly, the reliability test method introduced in the current study is 
capable of measuring the performances of both value estimates and target prices. The reliability 
test method can be used to judge the quality of company valuation results. 
1.6   Thesis Outline    
The rest of thesis is structured as follows: Chapter 2 reviews the relevant literature on industry 
characteristics and industry-based valuation models. Chapter 3 presents the research design, 
research method and data. Chapters 4, 5 and 6 discuss the empirical research results. Chapter 7 
applies the out-of-sample test to verify the robustness of the research results. Chapter 8 presents 
the conclusions, implications, limitations and recommendations for future research. In addition, 
Figure 1.1 presents the conceptual framework of the thesis. The conceptual framework clearly 
explains how different research objectives of the thesis are connected with each other, and what 
are relationship between the different terms (e.g. target price, value estimate and actual market 
price) mentioned in the thesis. 
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Figure 1.1   Thesis Conceptual Framework  
 
Source:  Examiners’ comments 
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Chapter 2 
                                      Literature Review  
2.1   Introduction     
This chapter reviews the relevant literature on the industry characteristics and the industry-based 
valuation models. The rest of the chapter is organized as follows: Section 2.2 reviews the related 
studies on the characteristics of financial, information technology and health care industries, 
followed by the discussion of industry-based valuation models. Section 2.3 concludes the 
chapter. 
2.2   Industry Characteristics and Industry-based Valuation Models     
In company valuation practice, the selected valuation model needs to be consistent with the 
features of the company, so that the intrinsic value can be better estimated. Rees (1999) 
discovered that the performance of a valuation model is very sensitive to the characteristics of 
the target company. In addition, a group of companies in the same industry or sector share many 
similar features and thus can be valued by the same type of valuation model. Recently, financial 
analysts have tended to concentrate on the general features of the companies from an industry, 
and use different valuation models in differing industries to improve the quality of valuation 
results. Barker (1999) confirmed that the financial analysts prefer different valuation models in 
different industries, the preferences for valuation models vary systematically according to 
industry. Tasker (1998) discovered that the systematic use of industry-based valuation model is 
more appropriate in different industries. However, many practical problems still remain unsolved 
in company valuation. For example: how to select suitable valuation model based on the 
observed industry characteristics? How can one verify whether the selected valuation model is 
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suitable for a specific industry? How can the degree of suitability for the selected valuation 
model in a specific industry be accurately measured? In fact, the financial analysts use their own 
standards to judge and select industry-based valuation models. This often caused that for the 
same industry, the financial analysts have different valuation model preferences and choices. 
Apparently, the different industry-based valuation model selection standards will cause different 
and even inconsistent valuation results, which will reduce the reliability of value estimates.  
In the existing literature, there are many studies comparing the different valuation models’ 
suitability at the company level without considering the industry characteristics, and they even 
contain strong arguments on the valuation model suitability. For example, Asquith et al. (2005) 
contrasted the performance of a series of valuation models at the company level, which included 
sales, earnings, cash flow and book value based valuation models. The authors concluded that 
the sales based valuation model outperforms other models in general. Sales may be the major 
value driver because the growth of future payoffs depends on sales growth if profit margin and 
asset turnover are stable (Nissim and Penman, 2001). However, the accounting item of sales may 
not be a reliable value indicator, especially as the sales figure can fluctuate erratically for the 
cyclical companies. Other accounting items may be able to better estimate the intrinsic value. 
Kim and Ritter (1999) argued that the price to book value model is better than the price to sales 
and price to earning models. The authors revealed that the accounting figures of sales and 
earnings are often volatile and subject to management manipulation. Although the book value is 
indeed an ideal value indicator under certain circumstances, the valuation method should pay 
more attention to the value creation rather than anything else. In fact, only few financial analysts 
view book value as a starting point in valuation, and the majority tend to focus on earnings and 
earnings growth (Ohlson, 2002). Cheng and McNamara (2000) emphasized that earnings is the 
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most important driver of intrinsic value, other models such as the price to book value model 
cannot be used as the primary valuation model. Bernard (1995) further revealed that earnings is a 
more accurate value indicator than others such as dividend, where the price to earnings model 
outperforms the dividend yield model in general. In fact, the dividend based valuation models 
can generate accurate valuation results, especially when the company being valued is a mature 
company with a stable dividend payout policy. However, financial analysts often encounter 
companies without dividends or dividend payout ratios that are not consistent with their 
profitability. Gleason et al. (2013) discovered that in the valuation of companies without 
dividend or positive cash flow, the residual income model have significant valuation advantage 
over other valuation models. 
In recent years, the application of different valuation models in different industries has gradually 
become a common practice in company valuation. More and more literatures has begun to 
simultaneously study the overall characteristics of an industry and the suitability of valuation 
models at the industry level. However, most studies are based on qualitative analysis, they judge 
the suitability of a valuation model in a specific industry from a purely theoretical point of view. 
For example, Imam et al. (2008) revealed that as the discounted cash flow model concentrates on 
the future, it is able to better reflect the risk and growth opportunities faced by the high-
technology industries in the future. In addition, the authors found that the financial industry 
mostly consists of marketable assets with high degree of liquidity, the book value of the 
marketable assets are approximately the same as their market prices. Thus the authors regard the 
price to book value model as the primary valuation model for the financial industry. Pinto et al. 
(2010) discovered that for the manufacturing industry with large amounts of fixed assets and 
depreciation, EBITDA is able to effectively overcome the influence of depreciation on the 
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valuation result. The authors concluded that the enterprise value to EBITDA model is an 
important valuation model for the manufacturing industry. Demirakos et al. (2004) found that for 
the traditional industries such as restaurant, food and beverage, they often have slow future 
earnings growth but their accounting data tend to be stable. The authors concluded that the 
historical or current accounting data based relative valuation models are able to better estimate 
the intrinsic values for such traditional industries. Banerjee (2003) revealed that the value 
creation process of the biotechnology industry is similar to the real options. Since most of the 
intrinsic values for the biotechnology industry are embedded in the R&Ds which are still in 
progress, these intrinsic values are expected to be released in the marketing stage after the 
lengthy R&D process. Thus the real options model has significant valuation advantage for the 
biotechnology industry.  
In addition, some studies also attempt to judge the suitability of a valuation model in a specific 
industry via the observation of the financial analysts. In general, the valuation reports and 
interviews with the financial analysts are the major research data resources. For example, Imam 
et al. (2008) interviewed a list of financial analysts, and completed an equity report based content 
analysis. They concluded that the financial analysts often have different valuation model 
preferences for the same industry. A similar equity report based content analysis has been carried 
out by Demirakos et al. (2004) across three different industries. The authors found that the 
earnings and sales based valuation model has been frequently used in the equity reports of the 
beverage, electronic and pharmaceutical industries. In addition, based on the observed financial 
analysts’ preferences in different industries, Imam et al. (2008) and Demirakos et al. (2004) 
further ranked the suitability of a series of valuation models in different industries. Imam et al. 
(2013) updated their ranking method and ranked the valuation models based on the target prices 
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generated by the valuation models. Specifically, their study focused on the valuation models and 
the target prices in the equity report, and then ranked the suitability of valuation models in 
different industries based on the performance of their target prices.  
In the existing literature, there are very few studies that have accurately measured the degree of 
suitability of a valuation model in a specific industry via quantitative analysis. Kaplan & Ruback 
(1995) produced a good representation of the quantitative analysis, which provided a strong 
theoretical foundation for the quantitative test on the suitability of valuation model. The authors 
emphasized that the test on a valuation model should be based on the value estimate generated by 
the valuation model. The authors also highlighted that the suitability of a valuation model/value 
estimate depends on two equally important features, which are accuracy and explanatory power. 
It is possible that one value estimate could successfully estimate the intrinsic value on average 
(accuracy), yet perform poorly in explaining the variation in intrinsic value (explanatory power) 
and the converse is also possible. Francis et al. (2000) highlighted the equal importance of 
accuracy and explanatory power, and then provided detailed definitions of both terms. 
Specifically, the authors defined accuracy as the price scaled difference between value estimate 
and market price, and explanatory power as the adjusted R2 of the regression between market 
prices and value estimates. The authors assumed the market is efficient, where the market price 
is used as a proxy for the intrinsic value per share. The latter studies provide a series of 
improvements on the quantitative suitability test for valuation models. 
The existing literature lacks relevant studies on the industry-based valuation models, especially 
the quantitative test on the suitability of industry-based valuation models. The current study 
concentrates on the industry-based valuation models from both qualitative and quantitative sides. 
The next section explores in detail why the valuation model is suitable for the specific industry 
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from the theoretical point of view. The current study chooses the financial, information 
technology and health care industries as the sample industries. The three selected industries have 
apparent distinguishing features, which play important roles in a country’s economic 
development. Section 2.2.1 to Section 2.2.3 review the relevant literature on the characteristics of 
the three sample industries, and then discuss the suitability of the industry-based valuation 
models based on qualitative analysis. 
2.2.1   Financial Industry    
2.2.1.1   Commercial Bank Sector     
The commercial bank is one of the major players in the financial industry. As an important 
financial intermediary in the economy, the commercial bank takes in deposits, offers loans and 
investment products to both personal and institutional customers. Dong (2008) revealed that the 
major source of profit for commercial banks is the spread between the interest it pays and the 
interest it charges. In addition, monopolization is one of the most significant characteristics of a 
commercial bank. The barrier to entry is high and commercial banks are often under strict 
government control in many countries. Compared to the companies in other industries such as 
the manufacturing industry, the fixed assets of commercial banks only account for a significantly 
low percentage of their total assets. In addition, the small capital base (low equity and high debt 
level in its capital structure) often causes the commercial bank to be highly sensitive to negative 
earnings. Although the commercial bank uses the loan loss reserves to absorb the expected losses 
on loans, the unexpected losses must be charged against the equity capital (Zhang et al., 2010). 
Therefore, the adequacy of equity is important and has been regarded as the last protection for 
depositors in an extreme situation. Commercial banks are often required by the regulators to 
maintain reasonable capital ratio.  
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As the unique role of debt in the commercial bank’s capital structure, it is not appropriate to 
consider the total asset or enterprise value in valuation. Damodaran (2013) argues that the debt 
should be viewed as the raw material for a commercial bank to generate income. Therefore, the 
enterprise value based valuation models, such as the enterprise value to earnings before interest, 
tax, depreciation and amortization model, and the enterprise value to book value model have 
been ranked as the most unsuitable valuation models for commercial banks by Imam et al. (2008) 
and Demirakos et al. (2004).  
The book value based valuation models focus directly on the important equity capital of 
commercial banks. Fink (2012) regards the book value of equity as a reliable value indictor, and 
recommends the price to book value model as the primary valuation model. For the companies in 
the non-financial industry, the book value often reflects the original invested cost. However, the 
book values of most of the commercial banks’ assets may approximate their current market 
values (except certain fixed assets such as properties). Wild et al. (2001) disclosed that, as a 
measure of net asset value per share, the book value per share is appropriate for valuing a 
commercial bank, which is composed chiefly of marketable financial assets. Damodaran (2013) 
revealed that the accounting rules of commercial banks have historically been very different 
from the accounting rules for companies in other industries. Commercial banks have the “mark-
to-market” accounting standard and the book value is often a surprisingly reliable value indicator 
of intrinsic value (Fink, 2012). In addition, the stable book value is more meaningful when the 
revenue is abnormally high or low, especially for the commercial bank without adequate 
business diversification and sensitive to changes in macroeconomic conditions. 
Imam et al. (2008) ranked the price to earnings model as the second valuation model choice for 
commercial banks. However, as the performance of commercial banks is often over-sensitive to 
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interest rate changes, other studies argue that the price to earnings is not a suitable valuation 
model for commercial banks. For example, Dong (2008) found significant earnings fluctuation in 
commercial banks. The author argued that volatile earnings is not a reliable indicator for the 
performance of a commercial bank, and this may reduce the effectiveness of the price to earnings 
model. In addition, the loan loss reserve is an important protection measure for commercial 
banks against expected loan losses. The loss reserve has been recognized as an expense in the 
commercial bank’s income statement, and thus the amount of the reserve is negatively related to 
the earnings of the commercial bank. Different commercial banks have different attitudes toward 
credit risk. The more conservative the commercial bank, the higher the level of reserves, and the 
lower the earnings (Zhang et al., 2010). Therefore, the earnings is sensitive to the level of loan 
loss reserve, which cannot truly reflect the performance of the commercial bank. The price to 
earnings cannot be used as the primary valuation model for the commercial bank.  
2.2.1.2   Insurance Sector     
Insurance has been widely defined in many studies as the equitable transfer of the risk of loss, 
from one entity to another in exchange for payment. As a special type of institution in the 
financial industry, insurance companies provide economic protection against identified risks 
occurring or discovered within a specified period. In general, insurance companies offer either 
life or nonlife insurance and their income is generated by the insurance policy underwriting and 
investment. Nissim (2013) revealed the major source of profit for insurance companies as the 
spread between the return on invested assets and the claims paid to the policy holders. 
Nissim (2013) revealed that the valuation model such as discounted cash flow and price to free 
cash flow focus on the operating activities of insurance companies (insurance policy 
underwriting). Thus, they omit a part of value creation (investment activities). In addition, the 
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free cash flows from insurance operations are often subject to great uncertainty and are difficult 
to predict. Therefore, the free cash flow based models cannot be the primary valuation models 
for insurance companies. The discounted cash flow model has been ranked as the 4th valuation 
model choice for insurance companies by Imam et al. (2008) and Demirakos et al. (2004).  
The dividend based models such as discounted dividend and dividend yield have significant 
advantages in the valuation of insurance companies. Dividend is often easier to estimate than 
free cash flow, especially for the insurance company with a long term dividend policy that bears 
an understandable and consistent relationship to the company’s profitability (Pinto et al., 2010). 
In addition to the cash dividend, the share buybacks are also a common way for the mature 
insurance company to return profit to its shareholders. Damodaran (2013) argued that the share 
buyback should be treated as dividend, the author recommended adding the share buyback each 
year to the cash dividends paid, and then computing the composite dividend.  
In the valuation of mature insurance companies, Dong (2008) found that financial analysts often 
focus directly on the equity value. Similarly to a commercial bank, the book values are solid 
measures of most items on the insurance company’s balance sheet. In addition, insurance 
companies are often required by the regulators to maintain minimum equity capital, which is at 
the level commensurate with the scope and riskiness of their activities (Nissim, 2013). These 
regulations affect the intrinsic value of insurance companies, and make the book value of equity 
a useful measure of the scale of operations. Nissim (2013) examined the accuracy of a series of 
relative models in the valuation of the U.S insurance companies. The author concluded that the 
book value based models perform significantly better than earnings based models. In contrast 
with the price to book value model, the price to tangible book value model is a better measure of 
the intrinsic value for the insurance company. The price to tangible book value model strips out 
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goodwill and other intangible assets, and gives the investors a more accurate gauge of the net 
assets left over when the company goes bankrupt (Zhang et al. 2010).  
Unlike other companies in the financial industry, the earnings of insurance companies tend to be 
stable and less subject to the business cycle effect. Therefore, the earnings based model is also a 
popular valuation model choice, especially the forecasted earnings based model. Imam et al. 
(2008) and Demirakos et al. (2004) ranked the price to earnings as the second valuation model 
choice for insurance company.  
The traditional valuation models often underestimate the intrinsic value of the insurance 
company with excellent growth prospects. In the recent valuation practice of emerging insurance 
companies, an actuarial science based appraisal value model gains in popularity. The appraisal 
value model measures the intrinsic value as the sum of embedded value and the present value of 
future new business, where the embedded value equals the adjusted net worth plus the value of 
in-force business (Dong, 2008). Although the appraisal value model is complicated and has not 
been widely used in practice, it is ideal for the strongly growing insurance company. The 
appraisal value model is able to simultaneously consider the values from the net assets, existing 
business and possible new business in the future.  
2.2.1.3   Securities Sector   
Securities companies, also known as investment banks or brokerage houses not only offer 
securities brokerage, investment banking and asset management services, but also actively 
participate in proprietary stock trading. Unlike commercial banks and insurance companies, Liu 
and Zheng (2011) concluded that securities companies have large positive beta, where their 
performance is closely correlated to the movement of the stock market. Securities companies 
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often conduct valuation assignments on the target companies in events such as equity analysis, 
initial public offering, merger and acquisition. Most literature concentrate on how securities 
companies value other companies, not on how to value themselves. This section provides a better 
understanding of the specific valuation models for securities companies.    
First, for those securities companies lack adequate business diversification and concentrate on 
risky businesses such as proprietary stock trading to generate revenues, their risks are 
significantly higher. Their earnings are extremely sensitive to investment decisions and the stock 
market condition. Their volatile and uncertain earnings are not good value indicators, thus the 
earnings based valuation model is not suitable for such securities companies. Similarly to 
commercial banks and insurance companies, securities companies are required by the regulators 
to maintain minimum loss reserves in proprietary trading. This is particularly true for the 
securities companies that lack diversification and earnings protection measures, which often have 
higher levels of loss reserves (Liu and Zheng, 2011). Thus, different securities companies are 
subject to different business structures and specific regulatory requirements, and the loss reserves 
are not the same for every company. This causes the earnings to be not comparable to others and 
makes the earnings based valuation model unsuitable, since the loss reserve is recognized as an 
expense in the income statement. In the valuation of securities companies which rely heavily on 
proprietary stock trading, the price to book value model is preferred to the price to earnings 
model. Because of the uncertainty of the stock market movement, the future performances of 
securities companies are difficult to forecast. Thus, the future performance based valuation 
models such as discounted cash flow and discounted dividend models are also not suitable.      
Second, for those securities companies that focus on low risk brokerage, investment banking and 
asset management services, and their profits tend to be stable and less subject to the movement 
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of the stock market. Therefore, their earning power is the major driver of intrinsic value. Zhang 
et al. (2010) revealed that the price to earnings is the primary valuation model for the mature 
securities companies that operate in stable businesses.  
Third, the recent consolidation and diversification trend has caused many securities companies to 
gradually abandon the single business structure, and operate in multiple businesses (Liu and 
Zheng, 2011). In order to enhance earning quality and gain higher valuation premiums, Liu and 
Zheng (2011) discovered that many securities companies have begun to focus on defensive 
investment banking and securities asset management business. For securities companies that 
operate in a variety of businesses, the sum of parts is an ideal valuation method. The sum of parts 
model estimates the intrinsic values of different business units separately, and then adds them 
together to arrive at the overall intrinsic value of a company. For example, the price to book 
value model is ideal for the valuation of proprietary stock trading business, and the price to 
earnings model can be used to estimate the intrinsic value of the security underwriting business.   
In the valuation of securities companies with strong growth prospects, the value estimates 
generated by the traditional valuation models such as price to earnings model tend to be volatile. 
In addition, the historical earnings cannot adequately reflect the potential risk and investment 
gain that a company may have in the future. Therefore, the true intrinsic value of a growing 
securities company may be severely underestimated by the traditional valuation models. Imam et 
al. (2008) emphasized the importance of the earnings growth rate in the valuation of a growing 
company. The authors recommended the price/earnings to growth as an alternative valuation 
model for growing securities companies. This model is able to simultaneously take into account 
the current earnings and future earnings growth rate in the next 3 to 5 years.    
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2.2.2  Information Technology Industry  
2.2.2.1   Software and Computer Services Sector      
The software and computer services sector is a class of companies related to research, 
development and distribution of information technology-based products and services. The 
software and computer services sector contains a large number of non-listed companies with 
short operating history and limited accounting data. Thornton and Cairns (2011) revealed that the 
software and computer services companies are intangibles-rich, where many companies derive 
most of their value from intangible assets such as technology. The revenue of a software and 
computer services company is generated not only by directly exploiting the technology and 
gaining a competitive advantage through increased sales or premium prices, but also by licensing 
or selling the technology to a third party (Thornton and Cairns, 2011). Therefore, the core 
technology of a software and computer services company plays an important role in its business 
model, the “technology value” generated from the core technology often accounts for a large 
percentage of the company’s total intrinsic value.  
The software and computer services companies often specialize in the development of one 
particular group of related products and services, and their core technologies are usually unique 
and cannot be compared to other technologies. Therefore, the relative valuation models which 
compare the company with its peer do not have significant advantage over the absolute valuation 
models (Thornton and Cairns, 2011). Pinto et al. (2010) also discovered that in the valuation of a 
fast growing industry with great uncertainty, financial analysts devote little space to the 
accounting and financial analysis. The authors further argue that the accrual based relative 
valuation models are only appropriate for stable industries, where conventional accounting is 
able to better capture the intrinsic value of the company. Demirakos (2004) argued that the 
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accounting measures of performance are less relevant for the intangibles-rich companies, or for 
those companies with large portfolios of growth opportunities. Lev (2001) discovered that 
accounting is relatively strong in valuing tangible assets and relatively weak in valuing 
intangible assets. 
In fact, the valuation model should be more forward-looking, and be able to consider both high 
earnings growth and great uncertainty in the future. Cash flow is often more stable than earnings, 
and it is often less subject to the management manipulation. For the software and computer 
services company, the future cash flow based absolute valuation model has been regarded as one 
of the most appropriate choices (Demirakos et al., 2010 and Imam et al. 2008).  
In general, the characteristics of a software and computer services company are not the same in 
each life stage. Accordingly, the valuation model choice also varies greatly across the different 
life stages. Section 2.2.2.1.1 to Section 2.2.2.1.3 discuss the characteristics of the software and 
computer services companies in each life stage, and their corresponding valuation models. 
2.2.2.1.1   Start-up Stage    
In the software and computer services sector, the start-up companies account for a large 
percentage of the total companies. For those start-up companies, Thornton and Cairns (2011) 
found that most of them were in the technology R&D stage with little revenue or even ongoing 
loss. Their future earnings and growth rates are difficult to estimate due to the absence of 
adequate accounting records. In addition, Damodaran (2009) argued that the mis-categorization 
of the R&D investment as an operating expense results in underestimated earnings. Therefore, 
the historical earnings based-valuation model such as the trailing market capitalization to 
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earnings (trailing P/E), and the future earnings-based model such as the forward market 
capitalization to earnings (forward P/E) can both be meaningless.  
Since most start-up companies do not have profit, dividend payout is often impossible for them. 
The dividend-based valuation models such as discounted dividend and dividend yield models are 
both not suitable for such companies.  
In general, the software and computer services companies have great uncertainty in their early 
stages of development. Zhang et al. (2010) recommended the modified discounted cash flow 
model (MDCF), which weighs up a number of uncertain elements to arrive at the end valuation. 
Thornton and Cairns (2011) revealed that information technology is a complex series of 
possibilities, the outcomes of each possibility need to be assessed, in order to ascertain the value 
of the technology. Unlike the traditional discounted cash flow model where a single (most-likely) 
scenario is used, the MDCF model is a type of risk-adjusted net present value model. It takes into 
account several possible scenarios for the start-up company, and then assesses the probability of 
each scenario separately (Zhang et al., 2010).  
2.2.2.1.2   Growth Stage     
As the R&D process continues and the company moves into the growth stage, the certainty of 
success and of receiving the anticipated cash flows increases substantially, resulting in an 
increase in the company’s intrinsic value (Robin and Malak, 2009). At this stage, the earnings of 
many companies become positive and less volatile. Therefore, the earnings gradually becomes a 
chief and reliable value indicator.  
In the valuation of the growing software and computer services companies, Zhang et al. (2010) 
highlighted the importance of both current earnings and future earnings growth rate. The authors 
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recommended the price/earnings to growth model as a superior alternative model over the price 
to earnings model. The traditional price to earnings model is unable to consider a company’s 
growth prospects in the future, and the price/earnings to growth model provides an effective 
solution to overcome this deficiency.  
The growing software and computer services companies often require a continuing capital 
injection to advance their R&D progress. They adopt a variety of ways to finance their growth, 
and this causes their capital structures to vary significantly. Pinto et al. (2010) recommended the 
enterprise value to EBITDA model. It is more suitable than the price to earnings model for 
comparing the companies with different financial leverages, since the EBITDA is the pre-interest 
earnings. In addition, the enterprise value takes into account the total value of equity and debt, 
and disregards the capital structure differences. 
2.2.2.1.3   Mature Stage 
After the companies complete the R&D process of their core technology and products, the 
technology uncertainty and the overall business risk are reduced sharply. Therefore, there is no 
point in considering many possible scenarios in the mature stage, especially for the mature 
software and computer services companies with little uncertainty. Hence, the single scenario 
based traditional valuation models such as discounted cash flow model gains in popularity. For 
the mature software and computer services companies with stable and sustainable cash flow, 
Demirakos et al. (2004) and Imam et al. (2008) ranked the discounted cash flow model as their 
number one valuation model choice.  
For the mature software and computer services companies, most of their technology investments 
can generate only a return on invested capital that exceeds their cost of capital (Pinto et al., 2010). 
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Their earnings tend to be stable and easy to predict. Thus, the earnings based model such as price 
to earnings is a popular valuation model for the mature companies without profitable 
reinvestment projects.  
For those mature companies with enormous amounts of retained earnings, but few reinvestment 
opportunities tend to distribute their earnings through cash dividend and share buyback. Pinto et 
al. (2010) recommended the dividend based models such as discounted dividend and dividend 
yield models for mature companies. They are appropriate for the dividend-paying companies, 
which have dividend payout policies compatible with their profitability. Damodaran (2009) 
showed that the dividend based models are appropriate for the mature software and computer 
services companies with sustainable dividend policies.   
2.2.2.2   Technology Hardware Sector      
The technology hardware sector is a “traditional” but important part of the information 
technology industry, the software and computer services companies rely heavily on the 
technology hardware. In general, the technology hardware sector includes the companies which 
develop, manufacture and distribute a variety of electrical hardware. In addition, the technology 
hardware companies are spread widely along the industry chain, the products vary greatly for the 
companies located at upstream and downstream. The upstream technology hardware companies 
often specialize in business to business products such as electrical parts, integrated circuits, 
computer chips and accessories. The downstream companies manufacture a range of final 
electrical products directly for the consumers.  
The product difference causes the characteristics of these companies to vary greatly. The 
technology hardware companies can be classified into two categories. The first category contains 
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the capital-intensive companies, which include those without considerable R&D capability, such 
as electrical parts and accessories manufacturers. In the second category are the capital and 
technology-intensive companies which focus on capital and technology innovation to create high 
earnings growth, such as integrated circuits and computer chip manufacturers. Section 2.2.2.2.1 
and Section 2.2.2.2.2 discuss the characteristics of the two categories of technology hardware 
companies, and their corresponding valuation models. 
2.2.2.2.1   Capital-Intensive Companies 
The capital-intensive technology hardware companies such as manufacturers of electrical parts 
and accessories often face high threat of new entrants. Their low barrier to entry significantly 
increases the competition and reduces their overall profitability. Although these companies 
require relatively large initial investment in the manufacturing facilities, there is little need for 
higher levels of proprietary technology and patents. Therefore, this results in low entry barrier 
for such companies. In addition, in order to be compatible with the downstream electrical 
products, the electrical parts and accessories are often under strict industry standards and 
regulations. The industry standards cause little difference in products, while the threat of 
substitutes is high since there are many similar products in the market. Dong (2008) found that 
the low switching cost of electrical parts and accessories significantly increases the customers’ 
bargaining power, and further decreases the profitability of capital-intensive companies.  
In terms of suitable valuation models for capital-intensive technology hardware companies, 
Zhang et al. (2010) recommended the price to book value as an appropriate valuation model 
(after adjusting book value to fair value). This is particular true for the manufacturing companies 
with the following features, such as large amounts of fixed assets, relatively stable book value, 
low return on assets, and intensive competition with peers. Pinto et al. (2010) emphasized that 
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the book value is appropriate for mature companies with slow growth rate and less uncertainty in 
the future. Frykman and Toleryd (2003) revealed that the price to book value model is best used 
for those companies in capital-intensive industries, where tangible assets are the source of value 
generation. Since the book value records the historical invested cost of the fixed asset, the book 
value often deviates from the current market price. The fair value of fixed assets has been 
frequently used in the price to book value model to replace book value, especially in the M&A 
valuation under the accounting rule of purchase method.  
The revenues of the technology hardware manufacturing companies are often subject to less 
uncertainty, distortion and are easy to predict. The sales based models such as price to sales and 
enterprise value to sales are also suitable valuation models. The enterprise value to sales model is 
capable of distinguishing between undervalued companies and debt-burdened companies, since 
the enterprise value disregards the capital structure difference (Pinto et al., 2010).  
The enterprise value to EBITDA model is frequently used in the valuation of manufacturing 
companies with little goodwill, negative net income but positive gross profit. Most 
manufacturing companies have substantial depreciation and amortization expenses, these 
expenses cause enormous pressure on their net incomes. Pinto et al. (2010) suggest the use of 
EBITDA to control for the differences in depreciation and amortization among companies.  
2.2.2.2.2   Capital and Technology-Intensive Companies   
The capital and technology-intensive technology hardware companies exhibit significantly 
different features, where most of their products are highly complex and based on a large amount 
of intelligence and funds. In general, the capital and technology-intensive companies such as 
integrated circuits and computer chip manufacturers are high technology companies with 
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exceptionally high barriers to entry to preserve their profitability. Such companies often have 
considerable fixed assets and R&D costs in the early stages. But they have low production-
related variable expenses in the production stage as a result of economies of scale. In addition, 
the integrated circuits and computer chip manufacturers often have high possibility of failure, 
where their R&D is often subject to countless technology risks.  
In valuation practice, the cash flow based valuation models such as discounted cash flow and 
price to cash flow are the major valuation models for the fast growing companies with volatile 
earnings and large risk. The cash flow is often more stable than earnings and less subject to 
management manipulation. The cash flow is a reliable value indictor for the capital and 
technology-intensive companies. 
For the capital and technology-intensive companies such as integrated circuits and computer chip 
manufacturers, their products often have considerably high switching costs. Therefore, most 
downstream hardware companies tend to stay with their existing upstream suppliers of integrated 
circuits and computer chips. The downstream companies are less willing to pay the high 
switching costs, unless there is a large technology improvement (Wang et al., 2007). The high 
switching cost enhances the stability of demand, the sales of the integrated circuits and computer 
chip manufacturers tend to be less volatile. Thus, the sales based valuation models of price to 
sales and enterprise value to sales are appropriate for the companies with stable revenues.  
In addition to the huge amount of tangible assets such as PPE, the capital and technology-
intensive hardware companies also have large amounts of intangible assets such as goodwill and 
intelligence properties. Zhang et al. (2010) argued that the price to book value model is not a 
good valuation model for companies with a large proportion of intangible assets, since the book 
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value often is unable to fully disclose the true value of intangible assets. The price to book value 
model also cannot take into account the large amount of value generated from the future stages 
of fast growing companies.  
When the capital and technology-intensive companies complete their R&D process and move 
into the production stage, their profits increase sharply until the mature stage when the earnings 
tend to be relatively more stable. Dong (2008) recommends the earnings based model of price to 
earnings as the major valuation model choice for those companies with mature stable earnings. 
Since there are no longer many profitable reinvestment opportunities in the mature stage and the 
companies start to distribute their earnings, the suitability of the dividend yield and discounted 
dividend model becomes more apparent. 
  2.2.3 Health Care Industry 
2.2.3.1   Pharmaceutical Sector    
The pharmaceutical sector is the biggest player in the health care industry in terms of market 
capitalization and revenue. It consists of a large number of capital intensive companies with huge 
amounts of tangible and intangible assets. In the developed economies, Trottier (2010) 
discovered that the pharmaceutical sector is often highly monopolized by a small number of 
R&D oriented large pharmaceutical companies. However, the 2011 Good Manufacturing 
Practice (GMP) significantly increased the initial capital investment and operating expenses of 
pharmaceutical companies. The degree of industry concentration is expected to increase as a 
result of the GMP (Wang et al., 2007). In addition, the products among the pharmaceutical 
companies often vary greatly. The pharmaceutical companies can be classified into two 
categories based on their major products: chemical raw medicines and chemical pharmaceuticals. 
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Section 2.2.3.1.1 and Section 2.2.3.1.2 discuss the two categories of pharmaceutical companies 
and their appropriate valuation models. 
2.2.3.1.1   Chemical Raw Medicine Manufacturers    
As the major raw material used in the production of chemical pharmaceuticals, the chemical raw 
medicines are located at the upstream of the industry chain. Trottier (2010) suggested that 
chemical raw medicine manufacturers are capital and labor intensive companies with more 
tangible assets than intangible assets. In addition, Zhang et al. (2010) revealed that the chemical 
raw medicine manufacturers often require relatively large initial investment in the chemical 
manufacturing facilities, but there is little need for a higher level of proprietary technology. 
Therefore, the chemical raw medicines manufacturers often suffer high threat of new entrants, 
which significantly increases the competition and reduces their overall profitability. Further, the 
chemical raw medicine is highly regulated by industry standards and the difference in products is 
not huge. The threat of substitutes is high, since there are many similar chemical raw medicines 
available for the downstream chemical pharmaceutical companies. The low switching cost 
significantly increases the customer’s bargaining power, and further decreases the profitability of 
chemical raw medicine manufacturers.  
In the valuation of chemical raw medicine manufacturers, Zhang et al. (2010) recommended the 
price to book value model as an appropriate valuation model. The price to book value model is 
particular useful for the chemical raw medicine manufacturers with the following features: large 
amounts of fixed assets, relatively stable book value, low return on assets and poor growth 
prospects in the future. 
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In addition, the revenues of chemical raw medicine manufacturers are often subject to less 
uncertainty, distortion and are easy to predict. Pinto et al. (2010) highlighted that the sales based 
models such as price to sales and enterprise value to sales are appropriate valuation models for 
the chemical raw medicine manufacturers.  
The chemical raw medicine manufacturers generally have substantial amounts of depreciation 
and amortization expenses. Pinto et al. (2010) argued that the EBITDA controls for the 
differences in depreciation and amortization among the different companies by adding 
depreciation and amortization back into earnings. The enterprise value to EBITDA model is 
frequently used in the valuation of chemical raw medicine manufacturers, which have a large 
amount of depreciation and amortization, negative net income but positive gross profit.  
2.2.3.1.2   Chemical Pharmaceutical Companies   
The chemical pharmaceutical companies specialize in the development, manufacturing and 
marketing of prescription and over-the counter chemical pharmaceuticals. In recent years, there 
has been an increase in competitions from the bio-pharmaceuticals and natural medicines. 
However, the chemical pharmaceuticals are still the dominant medicines in clinical treatment, 
and account for a large percentage of the total market share. Trottier (2010) concluded that the 
chemical pharmaceutical companies are capital-intensive companies, which focus on the R&D of 
chemical drugs and have relatively high levels of pharmaceutical technology. The author further 
revealed three major value-driving investments of the chemical pharmaceutical companies: 
investments in R&D, PPE and advertising. Specifically, the chemical pharmaceutical companies 
have considerable fixed costs for drug production facilities during the start-up stage, high R&D 
expenses in the early drug development phases, and huge costs in the clinical trial phases. In the 
marketing phases, the chemical pharmaceutical companies often encounter high sales expenses 
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such as advertising and salesperson commissions, but low drug production-related variable 
expenses as a result of economies of scale (Trottier, 2010). In fact, the investments in R&D, PPE 
and advertising are important for the value creation of pharmaceutical companies. Hirschey 
(1982) and Chauvin and Hirschey (1993) regressed between the market values of pharmaceutical 
companies, R&D and advertising investments, and found significant positive coefficients on both 
types of investments. Sougiannis (1994) found that a one dollar increase in R&D investment 
often produced a five-dollar increase in market value. 
After a long period of development, traditional chemical pharmaceutical technology becomes 
mature. There is little technical uncertainty and less demand for further technology development. 
For the mature chemical pharmaceutical companies that lack innovative new products or 
technology, their sales and earnings are often stable and easier to predict. In the valuation of such 
companies, Demirakos et al. (2004) ranked the price to earnings and price to sales as the first and 
second valuation model preferences. These models are particularly useful when the companies 
rely on low margin generic drugs to generate revenues. Pinto et al. (2010) found that sales are 
generally less subject to distortion or manipulation than other accounting data such as earnings. 
The price to sales model is more meaningful than the price to earnings model when the earnings 
are abnormally high or low.  
The chemical pharmaceutical companies often have large amounts of drug production facilities, 
and substantial depreciation and amortization expenses. Pinto et al. (2010) recommended the 
enterprise value to EBITDA model as a good valuation model to control for the differences in 
depreciation and amortization among companies.  
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2.2.3.2   Biotechnology Sector   
According to the 2008 UN Convention on Biological Diversity, biotechnology is any 
technological application that uses biological systems, living organisms or derivatives thereof, to 
make or modify products or processes for specific use. In today’s world, the fast growing 
biotechnology sector is attracting great amounts of investors’ attention and the emerging 
biotechnology has been widely adopted into many fields. Modern biotechnology consists of three 
branches: medical biotechnology, industrial/environmental biotechnology and plant 
biotechnology. Ranade (2008) reported that the medical biotechnology has been by far the most 
influential, beneficial, and controversial field in biotechnology and has generated many 
superlative discoveries to improve the lifespan and quality of human life.  
In general, the medical biotechnology companies are intangibles-rich, where many companies 
derive most of their value from intangible assets such as technology, patents and licenses. The 
medical biotechnology companies typically rely on patents to protect their discoveries and 
revenues. In addition, the research intensive medical biotechnology companies have fewer 
tangible assets, but rich intangible assets such as patents and licenses. The intangibles-rich 
companies often have more R&D expenditures. Zhang et al. (2010) found that on average, the 
biotechnology R&D expenses accounted for as high as 60% of the overall cost of the bio-
pharmaceuticals. Trottier (2010) highlighted the importance of R&D investment in the value 
creation of medical biotechnology companies. The intangible assets developed by the internal 
R&D are often used by the medical biotechnology companies to secure cash flows.  
The book value based valuation models often have worse performances in the valuation of 
biotechnology companies. First, the current accounting standards have limitations such as non-
recognition of self-generated intangibles assets, where all R&D investments have to be expensed 
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in the period where they occur. Damodaran (2009) criticized the current accounting standards for 
mistreating the R&D investment and causing the book value of the biotechnology company to be 
understated. In fact, the investment in R&D should be capitalized and recorded as an asset rather 
than an expense. Bublitz and Ettredge (1989) examined whether R&D is valued as a long-term 
asset via regression analysis. The authors discovered a positive coefficient on R&D, and 
suggested that R&D investment has future benefits, hence meeting the definition of an asset. 
Second, the biotechnology companies are intangibles-rich, but the value of intangible assets is 
often difficult to fully measure by the book value, and this reduces the effectiveness of book 
value as a reliable value indicator. Third, the book value focuses on the current balance sheet, it 
does not account for the future growth prospect of the R&D oriented medical biotechnology 
companies. Therefore, the book value based valuation models such as price to book value and 
enterprise value to book value models are not appropriate for the biotechnology companies. 
In the valuation of fast growing medical biotechnology companies which specialize in the R&D 
of profitable brand name bio-pharmaceuticals, Demirakos (2004) found that the financial 
analysts devoted little space to accounting and financial analysis. The reason is that the 
accounting measures of performance are less relevant for the intangibles-rich companies or for 
the companies with large portfolios of growth opportunities. Zhang et al. (2010) recommended 
the price/earnings to growth model for the biotechnology companies, which is a superior 
valuation model that takes into account the growth prospects.  
The future cash flows such as the revenues of medical biotechnology companies are often 
difficult to forecast, especially the inability to predict the shifts in the factors influencing a new 
drug’s ability to gain market share (Bird, 2009). Banerjee (2003) argued that the traditional 
discounted cash flow method fails to capture the future value of biotechnology R&D, since most 
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of their values are embedded in the unexercised real options with uncertain future values. Bird 
(2009) recommended the risk-adjusted net present value, real option, Monte Carlo Simulation 
and decision-tree valuation approaches. The four approaches can effectively address the impact 
of economic uncertainty in the drug development, regulatory approval and marketing. 
Specifically, the risk-adjusted net present value model, also known as the modified discounted 
cash flow model is one of the most commonly used valuation models for the medical 
biotechnology companies with great uncertainties. The risk-adjusted net present value model 
considers the probabilities of several possible scenarios for the unpredictable economic 
developments. It adjusts each cash flow by the corresponding success rates. In addition, Banerjee 
(2003) and Boer (2000) also recommend the concept of real options be applied to capture the 
value of biotechnology R&D. 
Ranade (2008) emphasized that one of the principal determinants of a medical biotechnology 
company’s success is the ability to maintain a reasonable capital ratio and raise funds at a 
reasonable cost. In general, the medical biotechnology companies have relatively low debt ratios 
and prefer equity financing sources, such as funds from venture capital, private equity, joint 
ventures and IPO (Ranade, 2008). As the importance of capital to support the costly ongoing 
R&D process, the medical biotechnology companies tend to retain their earnings rather than 
distribute them. Therefore, the dividend based models such as dividend yield and discounted 
dividend are both inappropriate valuation models for the biotechnology companies. 
2.3   Chapter Summary   
This chapter reviewed the relevant literatures on the industry characteristics and the industry-
based valuation models. Specifically, the chapter divided the companies in each of the sample 
industries into several sectors based on their characteristics, and then discussed their 
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corresponding valuation models according to previous studies. Table 2.1 summarizes the key 
findings of relevant literatures, which focus on the suitability of valuation models at the firm or 
industry level. 
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Table 2.1   Literature Summary – Suitability of Valuation Models 
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Table 2.1   (continued) 
 
Note: “Firm Level” stands for the study discusses the suitability of the valuation model without considering the industry characteristics; “Industry Level” means that the 
study simultaneously takes into account the valuation model suitability and industry characteristics. 
Source: Author’s summary 
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Chapter 3 
                                     Data and Methods 
3.1   Introduction   
This chapter discusses the data and research methods used in the current study. In general, the 
study focuses on the innovation of company valuation concepts and methods, and attempts to 
improve the reliability of listed companies’ value estimates and target prices. The rest of the 
chapter is organized as follows: Section 3.2 describes the study sample companies and the data 
sources. Section 3.3 presents the details of research methods such as the discount rate estimation 
method, valuation model, target price setting method, reliability testing method and out-of-
sample test. Section 3.4 concludes the chapter.  
3.2   Sample and Data     
The current study is based on 35 listed companies from the New York Stock Exchange and 
NASDAQ Stock Market (see Table 3.1). According to the 2010 Industry Classification 
Benchmark, the current study sample consists of 15 companies from the financial industry, 10 
companies from the information technology industry, and 10 companies from the health care 
industry. Research objective three of the current study is to identify the most suitable individual 
and combined valuation models for the sample industries, and this requires the sample 
companies to be capable of fully reflecting the general characteristics of their industries. The 
current study selects a range of ratios to present and measure the characteristics of the study 
sample companies and sample industries (see Appendix A). According to Appendix A, the ratios 
of sample companies are generally in line with their industry average levels, which means the 
sample companies are good representatives to reflect the characteristics of their industries.    
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Timeliness is one of the most significant characteristics of individual and combined valuation 
models. In general, the suitability of an individual or combined valuation model tends to change 
over time, especially during the different stages of the business cycle. For example, the earnings-
based valuation models have significant valuation advantages during the economic expansion 
stage, but their suitability declines sharply during a recession. According to the National Bureau 
of Economic Research (NBER), the most recent business cycle starts from June 2009 and is still 
in its expansion stage. The current study takes into account the timeliness of individual and 
combined valuation models, and limits the sample period (years 2010-2012) to within the 
expansion stage of the current business cycle. This means that the current study results are most 
suitable for the company valuation practice conducted within the economic expansion stage. In 
terms of data frequency, the quarterly accounting data is the most common type of data in many 
financial databases. Thus, quarterly data of the sample company is used in the current study. 
Table 3.2 describes the details of data used in the current study.  
The relevant data and information of the sample companies are obtained from different 
databases. These include the company historical accounting information which is available from 
Datastream and EDGAR. The historical market prices are from the CRSP database. The 
quarterly financial analysts’ consensus target prices and company performance forecast data are 
obtained from Zacks Investment Research. In addition, the data required to estimate the weighted 
average cost of capital (WACC) are obtained from Moody's, TRACE and the SBBI Yearbook.  
Thomson Reuters Datastream is a comprehensive database of company, financial and economic 
data from around the world, which integrates economic research and strategy development with 
asset analysis and has been widely used by many professionals and academics. The Electronic 
Data Gathering, Analysis, and Retrieval system (EDGAR) is operated by the U.S. Securities and 
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Exchange Commission. The EDGAR collects electronic documents, especially SEC filings to 
help investors with information about listed companies. The Center for Research in Security 
Prices (CRSP) at the University of Chicago Graduate School of Business is a provider of 
historical time series data on securities. Many professionals and academics rely on CRSP, since 
it maintains some of the largest and most comprehensive proprietary historical databases in stock 
market research. Zacks Investment Research is a well-known institutional research and financial 
data provider, which provides institutional and individual investors with analytical tools and 
financial information. As one of the major providers of company data in the US, it is best known 
for providing an extensive array of consensus forecasts for listed companies, such as target price, 
earnings and sales forecast. Zacks Investment Research has been widely used by many 
professionals and academics in their researches into American listed companies. Moody's 
Investors Service provides ratings on the bonds issued by commercial and government entities, 
and is one of the Big Three credit rating agencies in the world. Moody’s open-access database 
offers free company credit rating information to the public. The Trade Reporting and 
Compliance Engine (TRACE) is developed by the National Association of Securities Dealers, a 
vehicle that facilitates the mandatory reporting of over the counter secondary market transactions 
in fixed income securities. TRACE offers free information on yield-to-maturity rates on 
corporate bonds to the public. The Stocks, Bonds, Bills and Inflation Yearbook (SBBI) is 
published by Morningstar Ibbotson, which provides data on the long-term returns of the principal 
asset classes in the U.S economy.  
3.3   Research Method    
The general steps of the current study are presented as follows. First, the current study estimates 
the discount rates for the sample companies. Second, the current study applies the sample   
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Table 3.1   Sample Industries, Sectors and Listed Companies 
 
Source: Thomson Reuters Datastream  
Table 3.2   Characteristics of Data 
 
Source: Author’s Conclusion 
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individual valuation models to estimate the intrinsic values of the sample companies. Third, the 
current study ranks the sample individual valuation models in the sample industries. Fourth, the 
current study constructs sample combined valuation models, combines individual value estimates, 
and ranks the sample combined valuation models in the sample industries. Fifth, the current 
study applies the best industry-based individual and combined valuation models to determine the 
target prices for the sample companies. Sixth, the current study tests the target prices produced 
by the best industry-based individual and combined valuation models, and compares them with 
the financial analysts’ target prices. Last, the current study applies the out-of-sample test to 
verify the robustness of the research results. 
3.3.1   Discount Rate Estimation    
The first step is to estimate the appropriate discount rates (WACC or cost of equity) for the 
sample companies. In general, the cost of equity is an important component of WACC, and is 
often more difficult to estimate than the cost of debt. The study focuses on the cost of equity, and 
estimates it by using the expanded capital asset pricing model (Expanded CAPM). The expanded 
CAPM is based on the framework of Pratt (2002) and Pinto et al. (2010), which aims to provide 
a more accurate estimation of the cost of equity. The expanded CAPM follows the top-down 
approach, which estimates the cost of equity through three levels. The three levels are specific 
industry, a specific peer group within the industry and a specific company within the peer group. 
The model is given as follows:  
Cost of Equity = Risk-free rate + Industry-adjusted beta *Market premium + BSP + CRP     (1) 
Where: 
■ BSP = Beta-adjusted size premium  
■ CRP = Company-specific risk premium   
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Pratt (2002) revealed that the traditional CAPM is based on the assumption that the unsystematic 
risk can be diversified away in a well-diversified portfolio, thus the traditional CAPM only 
considers the systemic risk of a company. In fact, the unsystematic risk cannot be fully 
diversified away. Pratt (2002), Banz (1981) and Keim (1983) discovered that the total realized 
returns on small companies have been substantially greater than the traditional CAPM would 
have predicted. Thus, the current study introduces the multifactor expanded CAPM model to 
simultaneously consider the systematic and unsystematic risks. The main features of the 
expanded CAPM are discussed below. 
First, Pinto et al. (2010) revealed that the sum of the risk-free rate and the industry risk premium 
is the average required return on equity for all the companies in a particular industry. The 
industry risk premium reflects the unsystematic risk at the industry level, which is calculated as 
an industry-adjusted beta multiplied by market premium. The detailed estimation method for the 
industry-adjusted beta is presented at the end of this section.  
Second, equation (1) further adds a beta-adjusted size premium to reflect the average required 
equity return for a specific peer group within the industry. The beta-adjusted size premium is 
used to capture the unsystematic risk at the peer level. Based on market capitalization, the 
Morningstar Ibbotson calculates the beta-adjusted size premium by dividing NYSE listed 
companies into 10 size groups (with 1 as the largest to 10 as the smallest). Each group has its 
own average beta, the realized return in excess of what traditional CAPM estimates is the beta-
adjusted size premium.  
Third, the company-specific risk premium is added into equation (1) to derive the cost of equity 
for a particular company within the peer group. The company-specific risk premium can be 
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positive or negative (more or less risky than the peer average level), which captures the 
unsystematic risk at the company level. The estimation of company-specific risk premium often 
depends on subjective judgment, which ranges from -2% to +2% for the listed companies in 
America (Pinto et al., 2010). 
The industry-adjusted beta has been widely used in practice to replace the raw beta, which can be 
used to measure the systematic and unsystematic risks for a specific industry. In estimating the 
industry-adjusted beta, the first step is to identify a series of companies within the same industry 
of the company being valued. The selected companies should be able to fully reflect the major 
characteristics of the industry. The second step involves estimating each company’s raw beta by 
using the ordinary least squared regression. Since the raw beta reflects the capital structure and 
leverage of a company, the third step removes the effect of leverage from each company to 
obtain the unlevered beta (equation 2). Step three is important, especially for the company with a 
debt level that is significantly different from its peer average or its own historical mean value 
(Pratt, 2002). The fourth step determines the median value of unlevered beta for the selected 
companies. The last step re-levers the median unlevered beta with the industry-average capital 
structure to obtain the industry-adjusted beta. 
 
Where: 
■ Bu is the unlevered beta 
■ BL is the levered or raw beta 
■ t is the average effective tax rate of the company during the beta measurement period 
■ D is the average market value of the company’s long term debt (includes the current portion 
of long-term debt) during the beta measurement period 
■ E is the average market value of the company’s equity during the beta measurement period 
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3.3.2    Company Valuation by Sample Individual Valuation Models     
Following the estimation of the discount rates, the next step begins with the quarterly valuation 
of the sample companies by using the sample individual valuation models. The valuation models 
of listed companies can be classified into two categories. The first category is the time value of 
money theory based absolute valuation model, and the second is the law of one price based 
relative valuation model. Pinto et al. (2010) introduced 12 types of the most commonly used 
absolute and relative valuation models in practice, and the current study chooses them as the 
sample valuation models. The details of the sample valuation models and their corresponding 
value indictors are presented in Table 3.3. Specifically, the value indictor is the core element and 
“engine” of a valuation model, where the valuation model relies on its own value indictor to 
estimate the intrinsic value of a company. 
Table 3.3   Sample Individual Valuation Models and Corresponding Value Indictors 
 
Source: Pinto et al. (2010) 
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3.3.3    Sample Individual Valuation Model Ranking     
Following the application of the sample individual valuation models and a range of value 
estimates produced, the next step begins with the suitability ranking of the sample individual 
valuation models in the sample industries. The ranking is based on the suitability test results, 
where the details of the suitability test method are shown below.   
Based on the approaches suggested by Kaplan and Ruback (1995), Francis et al. (2000), Cheng 
and McNamara (2000) and Liu et al. (2007), the current study constructs an improved suitability 
test as follows. This suitability test method can be used to measure the degree of suitability of an 
individual or combined valuation model in a specific industry. This suitability test method first 
applies the individual or combined valuation model being examined to estimate the intrinsic 
value of a company at the current valuation date. The test method then compares the current 
market price with the value estimate produced by the individual or combined valuation model. 
Then the test can clearly reveal the capability of the individual or combined valuation model to 
estimate the intrinsic value of a company at the current valuation date. 
In general, the suitability test method contains three key points. First, the method emphasizes 
that the test of the individual or combined valuation model should be based on its value estimate. 
Second, this method highlights that the reliability of a value estimate depends on two equally 
important factors, namely, accuracy and explanatory power. Specifically, the accuracy reflects 
how well the value estimate can disclose the intrinsic value, and the explanatory power indicates 
how well the value estimate can explain the variation of intrinsic value.  Kaplan and Ruback 
(1995) revealed that it is possible that a value estimate could successfully estimate the intrinsic 
value on average, yet perform poorly in explaining the variation in intrinsic value and the 
converse is also possible (see Figure 3.1). Therefore, it is common to see a possible contradiction 
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between accuracy and explanatory power. In general, the accuracy and explanatory power are 
equally important: a good individual or combined valuation model is expected to have both high 
degrees of accuracy and explanatory power at the same time. Third, the test is based on the 
assumption that the market price is efficient, where the current market price is used as a proxy of 
the intrinsic value per share of the company at the current valuation date.  
The first part of the suitability test is to measure the accuracy of the value estimate. The accuracy 
emphasizes the valuation error, which is the deviation between intrinsic value and value estimate. 
The accuracy test consists of the following metrics (Francis et al., 2000):  
■      Valuation error: the signed and absolute deviation between the value estimate and the 
market price of a company at valuation date  
■          Adjusted valuation error: the average value of (1), (2), (3) and (4) 
(1) Valuation error scaled by the market price of a company at valuation date  
(2) Valuation error scaled by the value estimate of a company at valuation date 
(3) Valuation error scaled by the sum of market price and valuation error 
(4) Valuation error scaled by the sum of value estimate and valuation error  
■      Statistics distribution of the above metrics: include mean, median, average percentage 
difference between value estimate and market price, standard deviation, coefficient of 
variation and central tendency 
Specifically, the absolute valuation error reflects the size of the error, and the sign (negative or 
positive) of the valuation error indicates underpricing or overpricing of the market price. The 
valuation error is scaled by the sum of the market price and the valuation error, or by the sum of 
the value estimate and valuation error, which can be used to regulate the error between 0 and 1. 
Since an extremely large market price or value estimate may cause its distribution to be right-
skewed, the square root is required to solve the skewness issue. In addition, the coefficient of 
variation is calculated as the standard deviation divided by the mean value. The central tendency 
is the percentage of the value estimates within ±15% of market prices at valuation dates. 
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The second part of the suitability test is to measure the explanatory power of value estimate. The 
explanatory power is aimed at testing whether, and to what extent the movement of the value 
estimate is similar to the intrinsic value movement. The explanatory power test is based on the 
univariate regression given in equation (3). The explanatory power of the value estimate can be 
measured by the adjusted R2 of the regression. If the value estimate is an unbiased predictor of 
the intrinsic value, the regression intercept and coefficient are not significantly different from 0 
and 1, respectively. 
          
Where: 
■        MP t,s = market price of company s at valuation date t 
■     At = intercept term is expected to become zero if the value estimate s is the unbiased 
estimator of the intrinsic value s 
■      Bt,s = coefficient should equal to one if the value estimate s is the unbiased estimator of the 
intrinsic value s 
■       VEt,s = value estimate s for company s  
■       Ut = valuation error.  
Figure 3.1   Accuracy and Explanatory Power 
 
Source: Kaplan and Ruback (1995) 
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3.3.4   Sample Combined Valuation Model Construction, Combination and Ranking   
Following the ranking of the sample individual valuation models, the next step begins with the 
construction of the sample combined valuation models. First, according to the ranking, the 
current study randomly selects three individual valuation models from the top six individual 
valuation models in the ranking list of each sample sector. Thus, there are twenty different 
combined valuation models constructed for each sample sector. Although each combined 
valuation model only contains three individual valuation models, it is a good starting point for 
further extension by adding more suitable individual valuation models to satisfy any specific 
valuation objective. Second, since each combined valuation model produce three individual 
value estimates, the current study applies the partial least square regression approach (PLSR) to 
combine three individual value estimates into one combined value estimate. Third, the current 
study ranks the suitability of the sample combined valuation models in each sample industry by 
using the suitability test method shown in Section 3.3.3. The ranking is based on the suitability 
test on the combined value estimates produced by the sample combined valuation models.  
Based on the methods suggested by Hoogerheide et al. (2010), Thordarson (2007), Yee (2004) 
and Yoo (2006), the current study uses the PLSR approach to objectively combine several 
individual value estimates into one combined value estimate without any subjective pricing error. 
The PLSR approach is flexible, which allows the users to customize it by adding or removing 
any individual valuation model to satisfy any specific valuation needs. Similarly to Francis et al. 
(2000), the PLSR approach is based on the assumption that the market prices are efficient at all 
the valuation dates, where the market prices are used as the proxies of the intrinsic value per 
share. The general expression of the PLSR approach is given in equation (4).  
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Where:    
■ t = valuation date   
■ MPt,s = market price for company s at valuation date t 
■  = combined value estimate of company s produced by a combined valuation model   
■ At = constant term at valuation date t   
■ Wt,i = weight of individual valuation model i at valuation date t  
■ VEt,i = individual value estimate at valuation date t produced by individual valuation model i 
■ Ut = valuation error which is the remaining part of the intrinsic value that is not captured by 
the combined valuation model. It is the difference between the intrinsic value and the 
combined value estimate at valuation date t  
The rationale for the PLSR approach is straightforward. Every individual value estimate is an 
incremental piece of information, so relying on only one individual value estimate may ignore 
some valuable information. Therefore, the intrinsic value of a company is the aggregate value 
estimate equal to the weighted average sum of several individual value estimates (Yee, 2004).  
The PLSR approach is based on the partial least square regression to eliminate the possible effect 
of multi-collinearity between the independent variables (VEt,i). Francis et al. (2000) indicated 
that many valuation models are theoretically equivalent, such as discount cash flow model and 
the discount dividend model which have a strong correlation with each other. The issue of multi-
collinearity is a serious problem, which has to be resolved to ensure the validity of the regression 
results. This is particularly true when some individual valuation models in the combined 
valuation model are closely linked in some way. The common approaches to overcome the 
multi-collinearity effect are ridge, partial least square and principal component regression. The 
partial least square is preferred in the current study based on its superior capability to deal with 
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the multiple independent variables and more accurate prediction of the dependent variable 
(Garthwaite, 1994). 
The PLSR approach is under the time varying weighting scheme (TVW) proposed by 
Hoogerheide et al. (2010), Thordarson (2007) and Diebold and Pauly (1987). Since the 
importance and suitability of a valuation model tend to change over time, the constant weights 
may no longer apply in the future. For example, Demirakos et al. (2010) revealed that the price 
to earnings model is regarded as the one of the most important valuation models in boom time, 
but its suitability declines significantly during recession as the companies continue to make 
losses. Therefore, the time-varying weights are important, in which the PLSR approach generates 
different weights at different valuation dates by using certain ranges of time series data of value 
estimates. Alternatively, the PLSR approach can also estimate the time varying weights through 
peer groups. This requires the identification of the company’s peers, and then uses the cross-
sectional data of peers’ value estimates at the same valuation date to estimate the weights. 
Unlike the previous regression methods with restrictions that no constant term is added, and all 
weights must be non-negative and sum to one (Hoogerheide et al. 2010), the PLSR approach 
includes the constant term to avoid biases. Granger and Ramanathan (1984) revealed that the 
methods with constant terms are often more accurate than those using the restricted least squares 
weighting scheme. The PLSR approach further removes the restriction that the weights of 
different individual valuation models have to sum up to unity.  
3.3.5   Target Price Setting      
Following the ranking of the sample individual and combined valuation models, the current 
study selects the best individual and combined valuation models from the ranking list of each 
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sample industry, and uses them to determine the target prices for the sample companies. First, the 
target price setting process begins with the application of the best industry-based individual and 
combined valuation models to estimate the intrinsic value of the sample companies. Second, 
each best industry-based combined valuation model consists of three individual valuation models 
and produces three individual value estimates. The current study combines the three individual 
value estimates into one combined value estimate by an improved combining method (the details 
are shown in Section 3.3.4). Third, the current study sets the target price based on the value 
estimate. The target price reflects the future intrinsic value, but the value estimate is the 
estimated intrinsic value at the current valuation date. Therefore, the “current” value estimate 
needs to be adjusted to better reflect the future intrinsic value. The current study predicts the 
future intrinsic value of a company based on the value estimate, and then sets the target price 
around the estimated future intrinsic value.  
3.3.6   Reliability Test of the Target Price     
Following the target price setting process, the next step begins with the reliability test of the 
target prices produced by the best industry-based individual and combined valuation models. The 
current study also tests the target prices produced by financial analysts, and judges whether the 
best industry-based individual and combined valuation models are able to produce more reliable 
target prices than financial analysts. The detailed test method on target price is presented below. 
The reliability test method on target price used in the current study does not consider the effect 
of target price revisions. In order to avoid the influence of target price announcements on the 
market prices, the first step of the reliability test is to contrast the target prices (TP) with the 
market prices three trading days prior to the announcement or valuation dates (MPTTD). The 
current study then classifies the target prices into the following five groups (see Figure 3.2), thus 
 68 
 
that their reliability can be separately and accurately measured. The detailed classification 
methods are shown below:  
Figure 3.2   Target Price Classification Method 
  
Group 1      Group 2                  Group 3                      Group 4          Group 5                                          
     ≤75%       75%-90%                    1±10%            110%-125%      ≥125% 
                                                           MPTTD  
■   Group 1: The TPs are set equal to or less than 75% of the MPTTDs 
■   Group 2: The TPs are set within 75% to 90% of the MPTTDs  
■   Group 3: The TPs are set equal to or within (1±10%) of the MPTTDs 
■   Group 4: The TPs are set within 110% to 125% of the MPTTDs 
■   Group 5: The TPs are set equal to or more than 125% of the MPTTDs   
Source:  Examiners’ comments 
The second step tests whether the different groups of target prices have been achieved by using 
the following method, and labels them as “Realized” or “Unrealized”. Based on the metrics 
recommended by Imam et al. (2013), the current study uses the following metrics to test the 
target price. For Groups 4 and 5, the target prices are met or realized if the maximum prices of 
the companies’ shares during the next 12-month forecast horizon are greater than or equal to the 
target prices. For Groups 1 and 2, the target prices are met if the minimum prices during the 12-
month forecast horizon are less than or equal to the target price. Similarly, for Group 3, the target 
prices are achieved if the maximum and minimum market prices during the 12-month forecast 
horizon are within approximately 1±15% of the target prices. 
The third step measures the target prices in different groups labelled as “Realized”. The first 
metric (%REALIZED) is the percentage of realized target prices in each group. Previous studies 
 69 
 
examined the percentage of targets met in and met at the end of forecast horizons. Based on Kerl 
(2011) study, the current study introduces a more logical metric (%DISTRIBUTION), which 
analyzes the distribution of target price achievement within the different time frames (e.g. 
quarter) in a year. The third metric is (%FREQUENCY). For Groups 4 and 5, it is the frequency 
or percentage of market prices equal to or above the target prices in the next 12 months. For 
Groups 1 and 2, the frequency of market prices is equal to or smaller than the target prices in the 
one year forecast horizon. For Group 3, their degrees of reliability are measured by the standard 
deviation of market prices within the next 12 months.  
The last step examines the “Unrealized” target prices in the five groups. The first metric 
(%UNREALIZED) is the percentage of total unrealized target prices in each group. The second 
metric (%FORECAST_ERROR) reflects the level of forecast error for the unrealized target 
prices. Kerl (2011) and Demirakos et al. (2010) measured the forecast error by calculating the 
absolute difference between the closing price at the end of 12 months and the target price, then 
scaled it by the market price at the announcement date. The current study presents a more 
reasonable measurement as follows. Specifically, for Groups 4 and 5, it is the absolute difference 
between the maximum price during the next 12-month and the target price, then scaled by the 
target price or MPTTD. For Groups 1 and 2, it is the absolute difference between the minimum 
price and the target price, then scaled by the MPTTD. The measurement of forecast error for 
Group 3 is different. It is the absolute difference between the maximum (minimum) price and 
1+15% (1-15%) of the target price, scaled it by the target price or MPTTD. The percentage of 
market prices within the range of 1±15% of the target prices can be another metric of error. 
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3.3.7   Out-of-Sample Test 
Following the reliability test of the target price, the next step applies the out-of-sample test to 
verify the robustness of the research results. In the out-of-sample test, there are 35 new sample 
companies (see Table 3.4) and the out-of-sample period is from year 2013 to 2015.  
Table 3.4   Out of Sample Test: Sample Companies 
 
Source: Thomson Reuters Datastream  
3.4   Chapter Summary 
This chapter presented the data and research methods used in the current study. Specifically, this 
chapter discussed the details of the study sample companies, sample period and data sources. In 
addition, this chapter presented the detailed research steps of the current study. These are: first, 
how to estimate the discount rates for the sample companies. Second, what are the individual 
valuation models used in the current study to estimate the intrinsic values of sample companies. 
Third, how to test the suitability of individual valuation models. Fourth, how to construct the 
combined valuation models, combine individual value estimates, and test the suitability of 
combined valuation models. Fifth, how to set the target price. Sixth, how to test the financial 
analyst’s target price and the target prices produced by the best industry-based individual and 
combined valuation models. Last, how to verify the robustness of the research results by using 
the out-of-sample test. 
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Chapter 4 
 Research Results: Individual Value Estimates 
4.1   Introduction    
This chapter discusses the study sample companies’ individual value estimates produced by the 
sample industry-based individual valuation models. It then identifies the appropriate industry-
based individual valuation models according to the reliability of their individual value estimates. 
The chapter uses the individual value estimates to judge the suitability of individual valuation 
models in the study sample industries, where the individual value estimate is the direct product 
of the individual valuation model. The following discussion is based on the quarterly individual 
value estimates produced by the sample industry-based individual valuation models, for a sample 
of 35 companies between the years 2010 and 2012. The rest of the chapter is organized as 
follows: Section 4.2 presents the suitability ranking of the study sample industry-based 
individual valuation models. Section 4.3 compares the suitability of absolute with relative 
valuation models in the study sample industries. Section 4.4 compares the suitability of forward 
with trailing valuation models in the study sample industries. Section 4.5 compares the suitability 
of enterprise value with price valuation models in the study sample industries. The last section 
concludes the chapter.  
4.2   Industry-based Individual Valuation Models    
This section identifies the appropriate individual valuation models for the study sample 
industries. The valuation models often perform differently across different industries. The 
selection of an appropriate valuation model consistent with the general characteristics of the 
company/industry being valued is already a common practice in company valuation. Tables 4.1, 
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4.2 and 4.3 present the suitability rankings of the sample industry-based individual valuation 
models. The ranking lists provide effective practical guidance for financial analysts to properly 
select the valuation model. The ranking lists are for indicative purposes only and financial 
analysts should make appropriate choice based on the specific valuation need or objective. Stowe 
et al. (2002) revealed that one of the criteria for selecting valuation models is that it has to be 
consistent with the financial analyst's valuation purpose and perspective.  
The suitability rankings of the sample industry-based individual valuation models are based on 
the reliability test of their individual value estimates. The reliability test consists of two parts: the 
accuracy is measured by using the absolute value of adjusted valuation error (Adj Valuation 
Error), and the explanatory power is measured by the adjusted R-square of the regression model 
(R-Sq). Specifically, the smaller the valuation error, the higher the degree of accuracy. Similarly, 
the larger the R-square, the higher the degree of explanatory power. A good industry-based 
individual valuation model is expected to have higher degrees of accuracy and explanatory 
power at the same time. Thus, the accuracy and explanatory power tests are two equally 
important parts of the reliability test, where each accounts for 50% weight of the “Overall Rank” 
in the tables. The details of the reliability test method are presented in Chapter 3. Sections 4.2.1 
to Section 4.2.3 discuss the appropriate individual valuation models for the financial, information 
technology and health care industries based on the suitability rankings.  
4.2.1   Financial Industry 
Table 4.1 indicates that the forward dividend yield model (FDY) is the number one valuation 
model choice for commercial banks. The FDY model produces value estimates with the lowest 
adjusted valuation error (18.94%), and the third highest explanatory power (20.34%). In general, 
dividend is the residual income that belongs to the shareholders. Pinto et al. (2010) revealed that 
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dividend is an effective value indictor for the mature commercial banks, especially for those with 
stable earnings history and well-established long term dividend payout policy. During the 
economic recovery stage following the 2008 global financial crisis, the enormous interest and fee 
income provided strong support for the ongoing and stable dividend payout plan. Thus, the future 
short term dividend is easy to forecast, and the future forecasted dividend based FDY model has 
been ranked as the number one valuation model choice for commercial banks. Similarly, the 
price to book value model (PBV) is also a suitable valuation model for them. The book value 
focuses on important equity capital. Fink (2012) and Wild et al. (2001) found that the book value 
is appropriate for the commercial banks with enormous marketable assets and “mark-to-market” 
accounting standards. Since the book values of commercial banks’ assets may approximate their 
current market values, the book value is a reliable and exact value indicator of the intrinsic value 
(Pinto et al. 2010). In addition, Table 4.1 also presents the valuation advantage of the forward 
price to earnings model (FPE) in the commercial bank sector. The FPE model has a small 
adjusted valuation error of 24.87%, and a relatively higher explanatory power of 20.34%. The 
FPE model relies on the estimated future earnings to estimate the intrinsic value of commercial 
banks. However, Damodara (2009) found that the earnings of commercial banks are often overly 
sensitive to changes in interest rate and level of loan loss reserves. The volatile earnings increase 
the difficulty in forecasting the future earnings and reduce the effectiveness of earnings as a 
reliable value indictor, thus the FPE model is ranked as the third valuation model choice for 
commercial banks. 
In general, the premium earned from the insurance policy underwriting, and the returns from 
investment are two major sources of income for the insurance companies. Hence, in the valuation 
of insurance companies, the selected valuation model should be able to simultaneously consider 
 74 
 
the operating and investment activities. For the cash flow based valuation models such as the 
DCF model and price to free cash flow model (PFCF), Nissim (2013) revealed that both models 
focus only on the operating activities of insurance companies, but omit another part of value 
creation (investment activities). Table 4.1 confirms the weakness of DCF and PFCF models in 
the valuation of insurance companies, where the value estimates produced by the DCF and PFCF 
models have considerably large valuation errors and significantly low explanatory power. In 
addition, unlike the high-technology companies with remarkable earnings growth driven by the 
commercialization of core technology, the insurance companies do not have significant growth 
prospects. They derive their earnings from the spread between the returns on invested assets and 
the claims paid to their policy holders (Damodaran, 2013). The slow earnings growth rate 
reduces the effectiveness of the price/earnings to growth model (PEG). The PEG model is 
designed for the fast growing companies, which focuses on the future long term growth 
prospects and relies on the forecasted future five year earnings growth rate to estimate the 
intrinsic value. Table 4.1 confirms that the PEG model is not a suitable valuation model for 
insurance companies, especially as the trailing PEG model has large valuation error (133.43%) 
and small explanatory power (30.90%). On the other hand, since the book values are good 
measures of most items on the insurance companies’ balance sheets, the PBV model has been 
ranked as the first valuation model choice in Table 4.1. In addition, the earnings of insurance 
companies tend to be stable and less subject to the business cycle effect. Nissim (2013) found 
that the forecasted earnings based model of FPE can effectively estimate the intrinsic value of 
the insurance companies with sustainable earnings. Thus, the FPE model is also a good valuation 
model choice for insurance companies. 
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Table 4.1 shows that the FPE model is an effective valuation model for securities companies, 
which exhibit lower valuation error (31.55%) and higher explanatory power (28.20%). The FPE 
model is based on the forecasted future short term earnings and is suitable for the mature 
securities companies that focus on low risk brokerage, investment banking and asset 
management services. The stable profits of these mature securities companies are often easy to 
forecast, and subject less to the movement of the stock market. Zhang et al. (2010) found that the 
earnings are the chief value indictor for the matured securities companies operating in stable 
businesses, and the earnings based FPE model is the primary valuation model. On the other hand, 
the earnings cannot adequately reflect the value of young and less diversified securities 
companies, especially for the securities companies which concentrate on risky businesses such as 
proprietary stock trading. Liu and Zheng (2011) revealed that the risk of proprietary stock 
trading is significantly high, and its revenue is extremely sensitive to the investment decisions 
and the stock market condition. Therefore, the volatile and uncertain earnings are not good value 
indicators and the earning based valuation model is not suitable for the young and less 
diversified securities companies with unstable earnings. In fact, the book value provides a better 
intrinsic value measurement for the securities companies which concentrate on proprietary stock 
trading business. The book value focuses on the stable balance sheet rather than the volatile 
income statement. The PBV model is ideal for the young and less diversified securities 
companies with high operating and investment risks. In addition, Table 4.1 suggests that the RI 
model has superior performance in the valuation of securities companies, where it has the lowest 
valuation error (18.28%) and relatively higher explanatory power (27.60%). The RI model relies 
on the current book value and the forecasted future long term residual income to estimate 
intrinsic value, where the residual income has many more special advantages than the traditional 
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value indictors. For example, Pinto et al. (2010) found that the residual income had excellent 
performance in the valuation of companies with negative earnings, negative cash flow or no 
dividend payment in the future. Thus, the RI model is an effective valuation model for the less 
diversified securities companies with high possibility of losses in the future. Copeland et al. 
(2000) highlighted that an important conceptual advantage of residual income is that it focuses 
on whether the company is generating a return in excess of the cost of capital, it is often a more 
meaningful company performance metric than earnings. 
Table 4.1   Suitability Ranking of Individual Valuation Models - Financial Industry 
 
 
 77 
 
 
Note: “Accuracy” is measured by using the absolute value of adjusted valuation error (Adj Valuation Error); 
“Explanatory Power” is measured by the adjusted R-square of OLS regression (R-Sq); “Overall Rank” = rank 
of accuracy * 0.5 + rank of explanatory power * 0.5. 
Source:  Author’s calculation 
4.2.2   Information Technology Industry    
Table 4.2 presents the suitability rankings of the sample individual valuation models, based on 
their performances in the valuation of companies from the software and computer services sector. 
Table 4.2 shows that the forward price/earnings to growth model (FPEG) is the number one 
valuation model choice with the largest valuation accuracy (25.06%), and the second highest 
explanatory power (66.74%). In fact, the FPEG model is the most suitable valuation model for 
the software and computer services companies in the growth stage. As the R&D process 
continues and the companies move into the growth stage, Robin and Malak (2009) revealed that 
as the certainty of success and receiving the anticipated cash flows rises substantially, the 
earnings of software and computer services companies become positive and increase sharply. In 
the valuation of fast growing software and computer services companies, Zhang et al. (2010) 
discovered that it is important to take into account the considerable growth prospects. The FPEG 
model is able to simultaneously consider both recent years’ earnings and future long term 
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earnings growth rate, it significantly outperforms the FPE model in the valuation of companies in 
the growth stage. In fact, the FPE model is more suitable for the mature software and computer 
services companies. Pinto et al. (2010) find that these companies often do not have too many 
reinvestment opportunities and their earnings tend to be stable and easy to predict. In addition, 
Table 4.2 shows that the DCF model is also a popular valuation model choice for the software 
and computer services companies, especially for those in the mature stage. Demirakos et al. 
(2004) and Imam et al. (2008) also recommend the DCF model as their preferred valuation 
model choice for the mature software and computer services companies with stable and 
sustainable cash flows. Since most of these companies have completed their R&D process of 
their core technologies and products, the technology uncertainty and overall business risk have 
reduced sharply. The current and future cash flows tend to be less volatile and more sustainable, 
and the difficulty in forecasting future cash flow declines. Therefore, this enables the forecasted 
cash flow based DCF model to estimate the intrinsic values better.     
In the information technology industry, the technology hardware sector has apparent different 
characteristics in contrast with the software and computer services sector. The differences in 
characteristics cause the suitable valuation models to vary greatly across the two sectors. Table 
4.2 shows that the FPE model is the most suitable valuation model for the technology hardware 
sector, with the highest level of accuracy (28.48%) and explanatory power (45.54%). The 
technology hardware sector is a traditional sector, which develops, manufactures and distributes 
a variety of electrical equipment. Most of the technology hardware companies are in their mature 
stages, where low but sustainable earnings is one of their most significant characteristics. The 
sustainable earnings largely reduce the difficulty in forecasting future earnings. The forecasted 
future short term earnings based FPE model is most suitable for the mature technology hardware 
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companies with strong sustainable earnings. In the valuation of technology hardware companies, 
Table 4.2 shows that the current book value based valuation models of PBV and enterprise value 
to book value model (EVBV) also exhibit superior performance. Robin and Malak (2009) 
revealed that the book value is a reliable value indictor for the capital intensive-companies with 
the following features: large amounts of fixed assets, relatively stable book value, low return on 
assets, slow earnings growth rate and rampant rivalry with peers. However, the book value is not 
a good value indicator for the technology intensive-hardware producers such as the integrated 
circuits and computer chip manufacturers. These hardware companies require considerable 
capital and knowledge investment. The intangible assets such as technology and patents often 
account for a large percentage of the total assets of such companies. The book value has an 
inherent weakness in measuring the true value of intangible assets and thus it cannot estimate the 
intrinsic value adequately. Demirakos (2004) also argued that accounting measures of 
performance such as book value are less relevant for the intangibles-rich companies. Pinto et al. 
(2010) found that financial analysts devote little space to the accounting data in the valuation of 
companies with great amounts of intangible assets, since conventional accounting is often unable 
to fully capture the intrinsic value of such companies. 
Table 4.2   Suitability Ranking of Individual Valuation Models - Information Technology Industry 
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Source:  Author’s calculation 
4.2.3   Health Care Industry    
Table 4.3 presents the overall suitability ranking of the sample individual valuation models in the 
pharmaceutical sector. Specifically, the historical dividend based trailing dividend yield model 
(TDY) is the number one valuation model choice with the smallest valuation error (25.40%) and 
highest explanatory power (72.80%). In general, the dividend is an exact value indictor for the 
mature companies, especially for the companies with long term dividend payout ratios consistent 
with their profitability (Pinto et al., 2010). In fact, the dividend based valuation models are 
particularly suitable for chemical pharmaceutical companies in the pharmaceutical sector without 
considerable growth prospects. In the developed economies, Trottier (2010) found that the 
pharmaceutical sector is often dominated by a small number of large chemical pharmaceutical 
companies. After a long period of development, the traditional chemical pharmaceutical 
technology becomes matured. There is little technical uncertainty and less demand for further 
technology development. Most chemical pharmaceutical companies prefer to distribute their 
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earnings rather than retain them for reinvestment. In the valuation of chemical pharmaceutical 
companies with stable dividend payout plans, the historical dividend is a good value indictor and 
the historical dividend based TDY model has significant advantages. In addition, there is often 
little growth opportunity for the mature chemical pharmaceutical companies without new 
innovative medical products or technology. The earnings and cash flow of such companies often 
tend to be stable and easier to predict, and this significantly increase the suitability of the cash 
flow and earnings based valuation models such as PFCF and FPE. Demirakos et al. (2004) found 
that the earnings and cash flow based valuation models are particularly useful for pharmaceutical 
companies, which rely on low margin generic drugs to generate revenue. Table 4.3 confirms the 
valuation advantage of the PFCF and FPE models, where they are ranked as the second and third 
valuation model choices for the chemical pharmaceutical companies with matured cash flows 
and earnings. 
In general, the intangibles rich-biotechnology companies have fewer fixed assets and derive most 
of their values from intangible assets such as technology, patents and licenses. The huge amounts 
of intangible assets largely reduce the suitability of many traditional valuation models such as the 
book value based models. Demirakos (2004) revealed that the accounting measurement is often 
unable to fully reflect the true value of intangible assets. In addition, there is great uncertainty in 
the development, regulatory approval and marketing stages of biotechnology products. These 
uncertainties largely increase the difficulty in forecasting the future long term cash flow, 
especially the inability to predict shifts in the factors influencing a new biotechnology product’s 
ability to gain market share (Bird, 2009). Banerjee (2003) also argued that the traditional 
discounted cash flow method fails to capture the future value of biotechnology companies, since 
most of their values are embedded in the unexercised real options with uncertain future values. 
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Table 4.3 confirms the weakness of the future long term cash flow in the estimating the intrinsic 
value of biotechnology companies. The long term cash flow based DCF model is the most 
unsuitable valuation model for the biotechnology companies. In fact, the valuation model should 
be able to consider the fast earnings growth while overcoming the great uncertainty in the future 
long term period. Table 4.3 shows that the FPE model has highest level of valuation accuracy 
(40.67%) and explanatory power (61.02%). The FPE model relies on the forecasted short term 
earnings to estimate the intrinsic values of biotechnology companies. The future short term 
earnings are often easier to predict than the future long term earnings, and less subject to the 
uncertainties of technology and regulation. In addition, Table 4.3 shows that the historical 
accounting data based valuation models such as the trailing price/earnings to growth model 
(TPEG) and trailing price to earnings model (TPE) are also suitable valuation models for the 
biotechnology companies. This reflects that when the future cash flows such as the long term 
earnings are subject to great uncertainty and difficult to predict, the historical accounting data are 
able to provide a better estimation of intrinsic value.      
Table 4.3   Suitability Ranking of Individual Valuation Models - Health Care Industry 
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Source:  Author’s calculation 
4.3   Absolute Valuation Models versus Relative Valuation Models    
This section investigates whether the absolute valuation models have advantages over the 
relative valuation models. The present value based absolute valuation models and the “law of 
one price” based relative valuation models are two types of listed company valuation models. 
However, whether the absolute valuation models outperform the relative valuation models 
remains unclear. Table 4.4 compares the suitability of the sample absolute and relative valuation 
models across different sample sectors, based on the reliability test of their value estimates. The 
details of sample absolute and relative valuation models are presented in Table 3.3.  
In general, Table 4.4 shows that the absolute valuation models do not have apparent valuation 
advantage. The absolute valuation models only slightly outperform the relative valuation models 
in the fast growing or risky sectors, such as pharmaceutical and software and computer services 
sectors, but their valuation advantage is not significant. Normally, the multi-stage and future 
based absolute valuation models have superior capability to deal with the volatile and uncertain 
future cash flows. Imam et al. (2008) also found that the forward-looking absolute valuation 
 84 
 
models such as DCF model are able to simultaneously consider the risk and growth faced by the 
emerging companies in the future. In general, the intrinsic value of a company consists of two 
parts: current and future parts. Specifically, the current part of intrinsic value has already been 
generated by the past and current company operating activities. On the other hand, the future part 
of intrinsic value is expected to be generated by the future operating activities. The absolute 
valuation models pay less attention to the current part of intrinsic value, but concentrate on the 
future part, especially the intrinsic value generated from the future infinite year (terminal value). 
Francis et al. (2000) concluded that the absolute valuation models often rely on the estimated 
terminal value to estimate the intrinsic value. Gode and Ohlson (2006) found that for the high 
growth companies, the terminal values estimated by absolute valuation models can account for as 
much as 80-90% of the value estimates. Therefore, the absolute valuation models are most 
suitable for the emerging sectors with little current intrinsic value, but with great potential to 
receive considerable amounts of intrinsic value from the future (especially from the future 
infinite year). The forward looking absolute valuation models focus on the future long term, they 
are able to effectively capture the large amounts of intrinsic value generated from the future 
stages of the emerging sectors. 
On the other hand, Table 4.4 shows that the single-period and accounting based relative 
valuation models significantly outperform the absolute valuation models in most of the sample 
sectors. This is particularly true in the mature and traditional sectors such as insurance and 
technology hardware, where the current part of the intrinsic value accounts for a large percentage 
of the total intrinsic value. In general, the relative valuation models estimate intrinsic value based 
on the historical, current or future short term value indictors, and place large emphasis on the 
current part of the intrinsic value. Demirakos et al. (2004) also revealed that for the traditional 
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companies with poor growth prospects but stable accounting data, the accounting based relative 
valuation models have significant valuation advantages. Thus, the relative valuation models are 
most suitable for the slow growing matured sector, where the intrinsic value generated from the 
past often accounts for a large percentage of its total intrinsic value.  
4.4   Forward Valuation Models versus Trailing Valuation Models 
This section investigates whether the forward valuation models have advantages over the trailing 
valuation models. The forward and trailing valuation models both belong to the relative valuation 
model, where the denominators of trailing valuation models are based on the last year’s actual 
accounting figures. On the contrary, the denominators of forward valuation models are based on  
Table 4.4   Suitability Comparison: Absolute vs Relative Valuation Models  
 
Note: “# of Obs” is the number of observations for the accuracy or explanatory power of the sample absolute 
or relative valuation models; “Accuracy” is measured by using the absolute value of adjusted valuation error 
(Adj Valuation Error); “Explanatory Power” is measured by the adjusted R-square of OLS regression (R-Sq); 
“Absolute” stands for the mean value of accuracy or explanatory power of the sample absolute valuation 
models; “Relative” stands for the mean value of accuracy or explanatory power of the sample relative 
valuation models; “ANOVA-P” is the p value in the one way ANOVA test (confidence level: 95%), it is used 
to judge whether the absolute valuation models have significant valuation advantage over the relative valuation 
models, in terms of accuracy or explanatory power. Similar to the t-test, the ANOVA test has been frequently 
used to compare the means of two or more groups. In fact, the t-test and ANOVA test are the same.  
Zimmerman and Zumbo (1993) reveal that the t-test is a special case of the one-way ANOVA test, the t-test 
and ANOVA test generate the same results when compare the means of two groups. 
Source:  Author’s calculation 
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Table 4.5   Suitability Comparison: Trailing vs Forward Valuation Models 
 
Note: “Trailing” stands for the mean value of the accuracy or explanatory power of the trailing valuation 
models; “Forward” stands for the mean value of the accuracy or explanatory power of the forward valuation 
models.  
Source:  Author’s calculation 
the following year’s forecasted data. Apparently, the forward valuation models are consistent 
with the forward-looking concept of company valuation. However, whether the forward 
valuation models outperform the trailing valuation models is debatable. Table 4.5 compares the 
suitability of sample trailing and forward valuation models in different sample sectors, based on 
the reliability test of their value estimates. The details of such models are discussed in Chapter 3. 
Table 4.5 shows the forward valuation models outperform the trailing valuation models in the 
relatively stable sectors such as commercial bank. These sectors often have less risk and 
uncertainty, where their future cash flows are easier to predict. The forward valuation models 
rely heavily on the forecasted future short and middle term value indictors to estimate the 
intrinsic value. The forward valuation models have significant valuation advantages in the 
matured sectors with accurate forecast data. On the other hand, the trailing valuation models 
have slightly larger valuation accuracy in the biotechnology sector, and relatively higher 
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explanatory power in the pharmaceutical and securities sectors, but their valuation advantage is 
not significant. This reflects that the actual accounting data provide a more accurate estimate of 
intrinsic value in the risky sectors with higher levels of uncertainty. The actual accounting data 
based trailing valuation models have significant valuation advantages when the forecast data are 
not available or reliable. Therefore, the forward valuation models are most suitable for the 
mature sectors with reliable forecast data. The trailing valuation models are good alternatives in 
the valuation of unstable sectors, where the future cash flows are subject to great uncertainty and 
are difficult to predict. Liu et al. (2002) and Lie and Lie (2002) also concluded that the forward 
valuation models are more accurate than trailing ones, especially when the consensus financial 
analysts’ forecasts are available. 
4.5   Enterprise Value Valuation Models versus Price Valuation Models   
This section investigates whether the enterprise value valuation models have advantages over the 
price valuation models. The enterprise value and price valuation models both belong to the 
relative valuation model, which estimate the intrinsic value of a company in two opposing ways. 
Specifically, the enterprise value valuation models concentrate on the market value of a 
company’s total capital, including equity and debt. The price valuation models only focus on the 
market price of a company’s public stock on a per share basis. However, it is unclear whether it 
is necessary to use the enterprise value in company valuation practice, since the price valuation 
models are relatively easier to use. Table 4.6 compares the suitability of the sample enterprise 
value and price valuation models across different sample sectors, based on the reliability test of 
their value estimates. The details of such valuation models are discussed in Chapter 3. 
The test result in Table 4.6 shows no significant difference between the suitability of the price 
and enterprise value valuation models in the study sample sectors. In fact, the price valuation 
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models are more convenient in practice and they are more widely used than the enterprise value 
valuation models. Lundholm and Sloan (2004) discovered that some financial analysts focused 
on shareholder value more than enterprise value. The enterprise value based valuation models 
have very limited usage, which are appropriate only under certain circumstances. For example, 
with regard to companies with different levels of leverage, Pinto et al. (2010) revealed that the 
enterprise value valuation models exhibit better performance, they disregard the capital structure 
differences by considering the total value of equity and debt. In addition, the enterprise value 
models are able to better estimate the intrinsic value of companies with enormous amounts of 
real estate. Koller et al. (2010) revealed that the enterprise value models treat the real estate as a 
non-operating asset and separately appraise the fair value of real estate, and then add it to the 
value of the business operation to get the enterprise value. However, the enterprise value 
valuation models are not suitable in the valuation of certain sectors. For example, it is not 
appropriate to consider the enterprise value in the valuation of the commercial bank sector. 
Because of the unique role of debt in a commercial bank’s capital structure, Damodaran (2013) 
argues that the debt should not be viewed as a source of capital, but as raw material for 
commercial banks to generate income. 
Table 4.6   Suitability Comparison: Enterprise Value vs Price Valuation Models 
 
Note: “Enterprise Value”- the mean value of accuracy or explanatory power of the enterprise value valuation 
models; “Price” - the mean value of the accuracy or explanatory power of the price valuation models.   
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Source:  Author’s calculation 
4.6   Chapter Summary   
Based on the reliability test results, this chapter discussed the sample companies’ individual 
value estimates produced by the sample industry-based individual valuation models. First, the 
chapter identified and ranked a series of industry-based individual valuation models based on the 
reliability of their individual value estimates. The best (number one in the suitability ranking list) 
individual valuation model for each industry and their special features are displayed in Table 4.7. 
The suitability ranking of industry-based individual valuation models has excellent practical 
relevance in company valuation, where the ranking provides effective practical guidance for the 
selection of valuation models. The reliability of valuation results is expected to improve as a 
result of more suitable valuation model selection. Second, the absolute valuation models are 
most suitable for the emerging sectors with little current intrinsic value. The relative valuation 
models have higher degrees of suitability in the valuation of traditional sectors, where their 
current parts of intrinsic values account for a large percentage of their total intrinsic values. Third, 
the forward valuation models are most suitable for the stable sectors with reliable forecasts. The 
trailing valuation models have good performance in the valuation of unstable sectors, where the 
future cash flows are subject to great uncertainty and difficult to predict. Fourth, in the study 
sample sectors, there is no significant difference between the suitability of the price and 
enterprise value valuation models. The price valuation models are more widely used in practice, 
the enterprise value valuation models have very limited usage and they are appropriate only 
under certain circumstances. 
 
 90 
 
Table 4.7   Best Industry-based Individual Valuation Models during Year 2010 – 2012 
 
 Best Individual 
Valuation Model  
                              Special Features   
Financial Industry         
      Commercial Bank FDY  Captures the intrinsic value of commercial bank via the effective future short term value indictor 
      Insurance PBV  Consistent with the stable nature of insurance company    
      Securities FPE  Takes into account the expected fast earnings growth rate of securities company in the future short term 
Information Technology Industry        
      Software & Computer Services FPEG  Simultaneously considers the fast earnings growth rate of S&C services company in the future short and middle term 
      Technology Hardware FPE  Consistent with the low but sustainable earnings of technology hardware company  
Health Care Industry         
      Pharmaceuticals TDY  Historical dividend is an ideal value indictor for the matured pharmaceutical company with stable dividend plan  
      Biotechnology FPE  Complies with the forward looking concept and compatible with the fast growth nature of biotechnology company  
 
Source:  Author’s summary 
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Chapter 5 
 Research Results: Combined Value Estimates 
5.1   Introduction   
This chapter discusses the sample companies’ combined value estimates produced by the sample 
industry-based combined valuation models. It then identifies the suitable industry-based 
combined valuation models based on the reliability of their combined value estimates. In other 
words, this chapter uses the combined value estimates to judge the suitability of combined 
valuation models in the sample industries, where combined value estimate is the direct product 
of a combined valuation model. The following discussion is based on the quarterly combined 
value estimates produced by the sample industry-based combined valuation models, for a sample 
of 35 companies between the years 2010 and 2012. The rest of the chapter is organized as 
follows: Section 5.2 presents the suitability ranking of the study sample industry-based combined 
valuation models. Section 5.3 compares the suitability of combined with individual valuation 
models in the study sample industries. Section 5.4 compares the suitability of mixed with pure 
combined valuation models in the study sample industries. The last section concludes the chapter.  
5.2   Industry-based Combined Valuation Models   
This section identifies the appropriate combined valuation models for the study sample industries. 
The industry-based combined valuation models can largely improve the valuation methodology. 
Such valuation models benefit from not only the valuation advantage of considering the industry 
characteristics, but also from the synergy generated by the combination of individual valuation 
models. Tables 5.1, 5.2 and 5.3 present the suitability rankings of the sample industry-based 
combined valuation models, based on the reliability test of their combined value estimates. The 
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details of the reliability test method are presented in Chapter 3. The ranking lists provide 
effective practical guidance for financial analysts to appropriately construct combined valuation 
models. The ranking lists are for indicative purposes only, financial analysts should make 
necessary adjustments based on the specific valuation need or objective.  
The industry-based combined valuation models are constructed based on the suitability ranking 
of industry-based individual valuation models in Chapter 4 (see Tables 4.1, 4.2 and 4.3). 
According to the rankings, the study randomly selects three individual valuation models from the 
top six individual valuation models in the ranking list of each sample sector. Therefore, there are 
20 different combined valuation models constructed for each sample sector, and each combined 
valuation model consists of three individual valuation models. With regard to the weights to 
combine three individual value estimates, the detailed weights estimation method is presented in 
Section 3.3.4 of Chapter 3, Appendix B shows the weights for the best combined valuation 
model for each sample sector. Sections 5.2.1 to Section 5.2.3 discuss the appropriate combined 
valuation models for the information technology, financial, and health care industries based on 
the suitability rankings. 
5.2.1   Financial Industry    
Table 5.1 shows the combined model of PBV, discounted dividend (DD) and FPEG is the 
number one combined valuation model for the commercial bank sector, which exhibits the 
highest level of accuracy (12.18%) and the third largest explanatory power (70.30%). The 
combined model of PBV, DD and FPEG estimates the intrinsic value of a bank by 
simultaneously considering four important value indictors. They are the current book value, 
future forecasted dividend, next year’s forecasted earnings and forecasted future five years’ 
earnings growth rate. Thus the combined model provides a comprehensive estimation of the 
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bank’s intrinsic value via multi-value indictors and multi-valuation periods. Wild et al. (2001) 
revealed the book value is appropriate for the marketable asset rich commercial banks with 
“mark-to-market” accounting standards. In addition, the considerable interest and fee income 
generated during the economic recovery period after the 2008 global financial crisis not only 
accelerated the earnings growth speed, but also provided strong support to the ongoing and stable 
dividend payout plans. Therefore, it is important to simultaneously take into account the book 
value, dividends, earnings and earnings growth in the valuation of banks. On the other hand, 
Table 5.1 also shows that the combined model of FDY, FPE and FPEG has the worst valuation 
performance in the commercial bank sector with significantly low level of accuracy (16%) and 
explanatory power (32.84%). This combined model only looks at the future, and focuses on the 
volatile value indictors such as earnings and earnings growth rate. Damodaran (2013) revealed 
that the earnings of commercial banks are often sensitive to the changes in interest rate and the 
level of loan loss reserves, since the major source of earnings for commercial bank is the spread 
between the interests it pays and the interest it charges (Dong, 2008). The volatile earnings 
reduce the effectiveness of earnings based valuation models, such as the FPE and FPEG models.  
Table 5.1 shows that the combined model of PBV, DD and FDY is the number one combined 
valuation model for the insurance companies and has the highest level of accuracy (7.33%) and 
explanatory power (94.98%). The superior valuation performance of this combined model 
reflects the strong stability of the insurance companies, regardless of the business cycle effect. 
Nissim (2013) reveals that the insurance companies derive their earnings from the spread 
between the return on invested assets and the claims paid to their policy holders. The mature 
insurance companies often do not have significant fast growth prospects. They prefer to 
distribute their earnings since there is little reinvestment opportunity, and this causes the 
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dividends to become a reliable value indictor. Pinto et al. (2010) revealed that dividend is an 
effective value indictor for the mature insurance companies with stable earnings history and 
well-established long term dividend payout policy. In addition, Nissim (2013) examined the 
accuracy of a series of relative models in the valuation of U.S. insurance companies, and 
concluded that the book value based models have significantly valuation advantages. Therefore, 
the combined model of PBV, DD and FDY identifies the intrinsic value of insurance companies 
by estimating the current part of intrinsic value via historical book value, and the future part of 
intrinsic value via forecasted dividends. On the other hand, Table 5.1 shows that the combined 
model of TDY, FPE and FPEG has the worst performance in the valuation of insurance 
companies with the lowest levels of accuracy (11.82%) and explanatory power (77.06%). The 
combination of several unsuitable value indictors is the major reason for its underperformance, 
these unsuitable value indictors include the historical dividend and forecasted earnings growth 
rate. Specifically, the historical dividend based model of TDY is not appropriate for the 
insurance company. Damodaran (2013) revealed that the historical accounting figures only 
reflect the past information. For the matured insurance companies, the future dividend is 
preferred since it is often easy to predict. As the slow growth nature of insurance companies, the 
earnings growth speed based valuation model such as the FPEG model is also not a suitable 
valuation model. 
In the financial industry, the securities companies often have higher levels of risk and uncertainty 
than the commercial banks and insurance companies. Liu and Zheng (2011) showed that 
securities companies often exhibit large positive beta, and their performance is closely correlated 
to the movement of the stock market. According to Table 5.1, the combined model of PBV, TDY 
and RI is the number one combined model for the securities companies. This combined model 
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has the lowest level of valuation error (13.82%) and the highest explanatory power (82.93%). In 
general, the proprietary stock trading, brokerage, investment banking and asset management 
services are the top four common businesses of the securities companies. These businesses are 
very risky especially the proprietary stock trading and securities brokerage, which are positively 
and closely correlated to the movement of the stock markets. Liu and Zheng (2011) revealed that 
the risk of proprietary stock trading is significantly high, and its revenue is extremely sensitive to 
the investment decisions and the stock market condition. Therefore, the future performance of 
securities companies is often subject to great uncertainty and risk. In the valuation of uncertain 
companies such as the securities companies, the trailing value indictors outperform the forward 
value indictors. The historical accounting figures based models, such as the TDY is more 
accurate and reliable than the forecasted data based models. In addition, the book value focuses  
Table 5.1   Suitability Ranking of Combined Valuation Models - Financial Industry 
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Source:  Author’s calculation 
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on the stable balance sheet rather than the volatile income statement. The book value is ideal for  
the young securities companies with great operating and investment risks. In the estimation of 
securities companies’ current part of intrinsic values, the PBV and TDY models exhibit great 
valuation advantages. In addition, Pinto et al. (2010) argued that the RI model is good at valuing 
companies with high possibility of negative earnings, negative cash flow or no dividend payment 
in the future. Thus, for the securities companies that concentrate on risky proprietary stock 
trading, the RI model is ideal to estimate their future part of intrinsic values. 
5.2.2   Information Technology Industry     
Based on the suitability ranking in Table 5.2, the combined model of TPE, FPEG and DCF has 
the best performance in the valuation of software and computer services companies. This 
combined model has considerably high levels of accuracy and explanatory power (12.10% and 
88.32%, respectively). In general, the combined model of TPE, FPEG and DCF not only 
provides a comprehensive examination of a company’s entire life, but also focuses on the 
corresponding and appropriate value indictors in each lifecycle stage. Since the software and 
computer services companies are often unstable companies with significant operating and 
technology uncertainty, it is important to take into account the actual earnings rather than the 
forecasted earnings. In general, when the future performance of a company is subject to great 
uncertainty and difficult to predict, the actual earnings based model of TPE is particularly 
reliable and useful. In addition to the high risk and uncertainty, the fast growth speed is another 
apparent characteristic of the software and computer services companies. In the valuation of 
emerging companies with optimistic prospects, Pinto et al. (2010) revealed that it is essential to 
consider the future long term earnings growth rate, and the FPEG model is the most suitable 
valuation model that takes into account the future earnings growth rate. In addition to the TPE 
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and FPEG models which concentrate on the intrinsic value from the recent years and predictable 
future, the valuation advantage of this combined model is further strengthened by the DCF 
model. This model focuses on the intrinsic value delivered by the free cash flow from the infinite 
future (steady-state stage). In the mature stage, most software and computer services companies 
have completed the R&D process of their core technology and products, where the technology 
uncertainty and overall business risks are reduced sharply. Their cash flows tend to be more 
sustainable and the difficulty in forecasting future cash flow declines significantly. Hence, the 
free cash flow becomes an extremely reliable value indictor to reflect the intrinsic value from the 
mature and steady-state stages of a company. Demirakos et al. (2004) and Imam et al. (2008) 
also recommended the DCF model as their preferred valuation model choice for the mature 
software and computer services companies with stable and sustainable cash flows. 
In contrast with the emerging software and computer services companies, Table 5.2 reveals that 
the traditional technology hardware companies have significantly different choices of combined 
valuation models. The suitability ranking in Table 5.2 shows that the combined model of FPE, 
FPEG and price to sales (PS) has the best performance in the valuation of technology hardware 
companies (12.98% of accuracy and 75.72% of explanatory power). The valuation advantage of 
this combined model is due to the synergy generated by a well-established combination of 
several suitable individual models. Although the intrinsic value generated from the future of a 
technology hardware company only contributes to a relatively small percentage of its total 
intrinsic value, the combined model takes into account the intrinsic value from both current and 
future periods at the same time. In general, the combined model of FPE, FPEG and PS estimates 
the intrinsic value of a technology hardware company by simultaneously considering the 
following three value indictors: the actual current year sales, forecasted next year earnings and 
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forecasted long term earnings growth rate. The three value indictors are fully consistent with the 
characteristics of the technology hardware companies. Dong (2008) revealed that the tangible-
rich technology hardware sector is a traditional sector with a large number of mature companies. 
Since their revenues are often subject to less uncertainty, distortion and are easy to predict, the 
sales based models such as the PS is particularly suitable. In addition to the stable revenues, the 
low but sustainable profit is another significant characteristic for the slow growing technology 
hardware companies. Their high sustainability largely reduces the difficulty in the forecast of 
future earnings and earnings growth rate, thus the forward models of FPE and FPEG are also 
suitable valuation models. Dong (2008) also recommended the forecasted earnings based model 
of FPE as the major valuation model for the companies with mature and stable earnings. 
Table 5.2   Suitability Ranking of Combined Valuation Models - Information Technology Industry 
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Source:  Author’s calculation 
5.2.3   Health Care Industry    
Table 5.3 presents the suitability rankings of the sample combined valuation models in the 
pharmaceutical sector. Specifically, the combined model of DCF, DD and TDY has the best 
performance in the valuation of pharmaceutical companies. This combined model has 
considerably high levels of accuracy and explanatory power (10.10% and 82.90%, respectively). 
The superior performance of this combined model is the result of two important factors: multi-
valuation periods and multi-value indictors. Trottier (2010) revealed that the chemical science 
oriented-traditional pharmaceutical technology becomes mature after a long period of 
development, whereby most of the pharmaceutical companies turn into capital intensive 
companies with huge amounts of tangible assets but fewer intangible assets. For a traditional 
pharmaceutical company without technology innovation and growth opportunities, its current 
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part of intrinsic value often accounts for a large percentage of its total intrinsic value. Therefore, 
it is essential for the combined valuation model to fully capture the current part of intrinsic value 
via the appropriate value indictors. Pinto et al. (2010) found that the dividend is an ideal and 
reliable value indictor for mature companies, especially for the companies with long term 
dividend payout plans which are sustainable and compatible with their profitability. As there is 
little technical uncertainty and less demand for further development of the chemical 
pharmaceutical technology, most traditional pharmaceutical companies tend to distribute their 
earnings rather than retain them (Trottier, 2010). Hence, the dividend based model of TDY can 
better capture the current part of intrinsic value generated from the recent operating activities of 
the pharmaceutical company. In addition to the forecasted dividend, the combined model of DCF, 
DD and TDY estimates the future part of intrinsic value via the value indictor of forecasted free 
cash flow. Since there is little growth opportunity for the mature pharmaceutical companies 
without innovative new medical products or technology, their future free cash flows are stable 
and easier to predict. Demirakos et al. (2004) found that for the traditional pharmaceutical 
companies which rely on the low margin generic drugs to generate revenue, the free cash flow 
based valuation models were particularly useful. Thus the free cash flow based DCF model can 
largely improve the capability of the combined model to estimate the future part of intrinsic 
value, which is derived from the later life stages of pharmaceutical companies. 
Similarly to other fast growing but risky high-technology companies, the biotechnology 
companies have great amounts of intrinsic value created by their intangible assets and future 
operating activities. In the valuation of biotechnology companies, the forward-looking and non-
book value based combined models exhibit significant valuation advantages. Demirakos (2004) 
argued that the accounting measurement such as book value is often difficult to fully reflect the 
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true value of intangible assets. Table 5.3 also shows that the combined model which focuses on 
the future has better performance. Specifically, the combined model of FPE, FPEG and RI is the 
number one combined model with considerably high levels of accuracy and explanatory power 
(14.19% and 68.30%, respectively). The superior performance of this combined model is the 
result of a series of value indictors, which are fully compatible with the nature of biotechnology 
companies. These value indictors include the forecasted next year’s earnings, forecasted future 
long term earnings growth rate, last year’s book value and forecasted residual income. Banerjee 
(2003) concluded that the biotechnology companies are capital and technology intensive 
companies with little current intrinsic value, and most of their intrinsic values are embedded in 
the long and risky R&D still in progress. Once their core biotechnology products complete the 
development, regulatory approval and enter into the marketing stage, their earnings are expected 
to increase sharply. Thus, it is essential for the combined model to consider the possible and 
enormous amount of intrinsic value released from the future. The value indictor of the forecasted 
next year’s earnings, especially the forecasted future long term earnings growth rate are able to 
capture the possible intrinsic value delivered by the commercialization of biotechnology R&D in 
the future. As the biotechnology product development is often subject to great technology risk 
and regulatory uncertainty, it is also important to take into account the possible loss in the future. 
In the valuation of companies with high possibility of negative earnings, Pinto et al. (2010) 
discovered that the value indictor of residual income has a significant valuation advantage.  
5.3   Combined Valuation Models versus Individual Valuation Models    
This section investigates whether the combined valuation models outperform the individual 
valuation models in the study sample industries. In recent years, the use of more than one 
individual valuation model has become a common practice in company valuation. According to 
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Table 5.3   Suitability Ranking of Combined Valuation Models - Health Care Industry 
 
 
Source:  Author’s calculation 
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the Institutional Factor Survey conducted by Merrill Lynch in 2006, institutional investors use an 
average of nine individual valuation models and financial ratios together in equity valuation. 
However, whether several individual valuation models have significant valuation advantages 
when they work as a group, and whether it is appropriate to combine certain individual valuation 
models together remain unsolved. Table 5.4 provides a detailed suitability comparison of the 
study sample combined valuation models with the sample individual valuation models, based on 
the reliability test of their value estimates.  
Table 5.4 reflects the valuation advantage of the combined valuation models. In the study sample 
industries, the combined valuation models have higher degree of suitability than the individual 
valuation models. Vardavaki and Mylonakis (2007) confirmed that the proper use of more than 
one individual valuation model at the same time is able to produce more reliable value estimates. 
The authors also argued that the combined valuation model is more informative by providing 
better and accurate estimations of equity market values. Tiwari and Singla (2015) revealed that 
since the combined value estimate considers all bona fide information of individual valuation 
models, the combined valuation model is more reliable. Lie and Lie (2002) also discovered that 
the combination of several individual valuation models with opposite biases performed better 
than an individual valuation model.  
However, it is not appropriate to combine certain individual valuation models together. Table 5.5 
shows that certain individual valuation models perform better when they work as individuals 
rather than in a group. In general, the result reveals that the performance of a combined valuation 
model is determined by two important factors. The first is whether the individual valuation 
models in the combined valuation model are compatible with the characteristics of the company 
being valued. The second is whether the individual valuation models in the combined valuation 
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model are complementary. Specifically, the second factor is hugely important as it directly 
determines whether synergy can be generated from the combined valuation model. The current 
study introduces two important valuation concepts to ensure that the individual valuation models 
in the combined valuation model are complementary and the synergy can be generated. First, a 
superior combined valuation model should be able to cover all the important life stages of a 
company (multi-valuation periods), especially the life stage with a large amount of intrinsic 
value generated. Any combined valuation model that focuses only on a single period often 
results in incomplete valuation results. Second, a superior combined valuation model should also 
fully disclose the intrinsic value generated in all the important life stages. In each important life 
stage, there should be at least one effective value indictor which is able to fully capture the 
intrinsic value produced during that life stage. Thus, there should be more than one suitable 
value indictor in total to simultaneously capture the intrinsic values from different important life 
stages (multi-value indictors). Yee (2004) argued that every value indicator reflects an 
incremental piece of intrinsic value, any combined valuation model that relies on just one value 
indicator may ignore some parts of the intrinsic value. Thus, the superior performance of an 
industry-based combined valuation model is only guaranteed when it fully complies with two 
important valuation concepts introduced in the current study: multi-valuation periods and multi-
value indictors. 
5.4   Mixed Combined Models versus Pure Combined Models 
This section investigates whether the combinations of absolute and relative valuation models 
(mixed combined models) have significant valuation advantage over the combined models, 
which contain only the absolute or relative valuation model (pure combined models). In the 
construction of the combined model, whether it is necessary to include both absolute and relative   
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Table 5.4   Suitability Comparison: Combined vs Individual Valuation Models  
 
Note: “# of Obs” is the number of observations for the accuracy or explanatory power of the sample combined 
or individual valuation models; “Accuracy” is measured by using the absolute value of adjusted valuation error 
(Adj Valuation Error); “Explanatory Power” is measured by the adjusted R-square of OLS regression (R-Sq). 
“Combined” means that in each sample sector, the median value of accuracy or explanatory power for 20 
combined models (as shown in Table 5.1, 5.2 and 5.3); “Individual” is the median value of the accuracy or 
explanatory power, for the top 6 individual models in each sample sector (as shown in Tables 4.1, 4.2 and 4.3); 
“ANOVA-P” is the p value in the one way ANOVA test (confidence level: 95%), it is used to judge whether 
the sample combined valuation models have significant valuation advantage over the sample individual 
valuation models, in terms of accuracy or explanatory power.  
Source:  Author’s calculation 
Table 5.5   Work as a Group vs Work as Individuals   
 
Note: “% Outperformed” means that in each sample sector, the percentage of combined models outperform all 
their own individual models. When “% Outperformed” is 100%, it indicates that individual models perform 
better when they work as a group rather than individual. The details of the table are presented in Appendix C. 
Source:  Author’s calculation 
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valuation models remains unclear. Table 5.6 provides an answer to this question by comparing 
the suitability of the study sample mixed and pure combined models, based on the reliability test 
of their value estimates. The details of the sample mixed and pure combined models are 
illustrated in Appendix D. 
The test result in Table 5.6 indicates that in general, the mixed combined models do not 
significantly outperform the pure combined models. In fact, the overall performances of the 
mixed combined models have been largely reduced by several mixed combined models that 
contain unbalanced and non-complementary individual valuation models. For the well-
established mixed combined models, which comply with the concept of multi-valuation periods 
and multi-value indictors, they perform better than the pure combined models. Demirakos et al. 
(2004) found evidence that in valuation practice, the absolute valuation methods are frequently 
used in combination with relative valuation models. Jenkins (2006) confirmed that the effective 
combination of absolute and relative valuation models is able to focus both on the long-term 
forecasts as well as short-term forecasts. Imam et al. (2013) discovered that the use of an accrual 
based relative model alongside a cash flow based absolute model reduced valuation error, as 
accruals add value relevant information to cash flows. Therefore, it is necessary to 
simultaneously apply the absolute and relative valuation models.  
Table 5.6 shows that the mixed combined models have good valuation performance in the 
emerging sectors such as biotechnology. The mixed combined models are consistent with the 
valuation concept of multi-valuation periods, where they simultaneously take into account the 
current and future parts of intrinsic value. Therefore, the mixed combined models have superior 
capability to deal with the volatile and uncertain future cash flow, they are good at capturing the 
enormous amount of intrinsic value generated from the future operating activities. On the other 
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hand, for the companies in the traditional sectors with fewer future growth opportunities, most of 
their intrinsic values have already been generated by the past and current operating activities. 
Thus, their current parts of intrinsic values often account for large percentages of their total 
intrinsic values. For such traditional companies, there is less demand for the mixed combined 
models that focus on the future part of intrinsic value. It is necessary to adjust the mixed 
combined model by including more current intrinsic value based relative valuation models, while 
reducing the number of future intrinsic value based absolute valuation models in the combination. 
Table 5.6   Suitability Comparison: Mixed vs Pure Combined Models 
 
Note: “Mixed” stands for the sample combined valuation models which consist of both absolute and relative 
valuation models; “Pure” stands for the sample combined valuation models which contain only absolute or 
relative valuation models; The “%” is the median value of accuracy or explanatory power for the sample 
mixed or pure combined models; The Technology Hardware industry only contains pure combined models, 
thus it is removed from Table 5.6.   
Source:  Author’s calculation 
5.5   Chapter Summary   
Based on the reliability test results, this chapter discussed the sample companies’ combined 
value estimates produced by the sample industry-based combined valuation models. First, the 
chapter identified and ranked a series of industry-based combined valuation models based on the 
reliability of their combined value estimates. The best (number one in the suitability ranking list) 
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combined valuation models for each sample industry and their special features are displayed in 
Table 5.7. The suitability ranking of industry-based combined valuation models has excellent 
practical relevance in company valuation, where the ranking provides effective practical 
guidance for the construction of combined valuation models. The reliability of valuation results 
is expected to improve as a result of more suitable combined valuation model construction. 
Second, the test result clearly reflects the overwhelming valuation advantage of the industry-
based combined valuation models. These models have significantly higher degrees of reliability 
than the industry-based individual valuation models. This is particularly true for the combined 
valuation models, which are compatible with the characteristics of the company being valued, 
and comply with the concept of multi-valuation periods and multi-value indictors. Third, in the 
construction of combined valuation models, it is critical to include both absolute and relative 
valuation models. The mixed combined valuation models are able to maximize the advantage of 
absolute and relative valuation models, while minimizing their drawbacks.  
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Table 5.7   Best Industry-based Combined Valuation Models during Year 2010 - 2012 
 
 
Best Combined 
Valuation Model       Special Features   
  
    
 
Financial Industry   
          
   Commercial Bank PBV, DD and FPEG 
Fully covers all the life stages of commercial bank through the current, future short, middle, long and infinite  
value indictors 
   
   Insurance PBV, DD and FDY 
Captures the current part of insurance company's intrinsic value via historical book value, and the future part  
of intrinsic value via estimated dividend 
 
   Securities PBV, TDY and RI 
Considers the great uncertainty and possible loss of securities company via the current book value, historical  
dividend and estimated residual income   
 
Information Technology Industry   
          
   Software & Computer Services TPE, FPEG and DCF 
 Captures the intrinsic value generated from the recent years, predictable and infinite future through earnings,  
earnings growth rate and free cash flow 
 
   Technology Hardware FPE, FPEG and PS 
 Synergy generated by a combination of several suitable individual models which are consistent with the stable 
 nature of technology hardware company   
 
Health Care Industry   
          
   Pharmaceuticals DCF, DD and TDY 
 Captures the current part of intrinsic value via historical dividend, and the future part of intrinsic value via 
 estimated dividend and free cash flow 
 
   Biotechnology FPE, FPEG and RI 
 Fully compatible with the long and risky nature of biotechnology R&D, and complies with the principle of  
multi-periods and multi-value indictors   
 
Source: Author’s summary 
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Chapter 6 
 Research Results: Target Prices 
6.1   Introduction    
This chapter discusses the sample companies’ target prices produced by both financial analysts 
and the current study. First, the chapter analyzes the financial analysts’ target prices produced in 
recent years. Second, the chapter tests the best industry-based individual and combined valuation 
models identified in Chapters 4 and 5, whether they are capable of producing target prices with 
higher degrees of reliability. The rest of the chapter is organized as follows: Section 6.2 
discusses the financial analysts’ target prices. Section 6.3 discusses the target prices produced by 
the best industry-based individual and combined valuation models. The last section compares the 
two categories of target prices and concludes the major findings.    
6.2   Target Prices Produced by Financial Analysts     
This section discusses the characteristics and performance of financial analysts’ target prices. 
The discussion is based on the quarterly financial analysts’ consensus target prices obtained 
directly from Zacks Investment Research, for 35 sample companies across three industries 
between the years 2010 and 2012. The term “consensus target price” refers to the future price of 
a stock that financial analysts have agreed on.  
6.2.1   Target Price Characteristics   
Table 6.1 presents the general characteristics of the financial analysts’ target prices between the 
years 2010 and 2012. In general, there are more “positive” than “negative” target prices. The 
following sections offer detailed discussion on the characteristics of the financial analysts’ target 
prices across the financial, information technology and health care industries. 
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Table 6.1 reveals that the Groups 4 and 5 target prices account for 77.78% of the total target 
prices, while Groups 1 and 2 target prices only account for 0.56% in the financial industry. 
Specifically, the securities sector exhibits the largest number of Groups 4 and 5 target prices 
(81.67%). The underlying reason for this phenomenon is straightforward. The financial industry 
recovered rapidly from the 2008 global financial crisis, where the performance of the financial 
industry is often positively and significantly correlated to the business cycle. Following the 2008 
global financial crisis, M&A emerged and the financial intermediaries played an important role 
to assist the M&A and business reform activities, in the form of funds support and transaction 
services provision. The considerable commissions and interest incomes earned by the securities 
companies and commercial banks resulted in higher earnings forecast for themselves. Table 6.3 
presents the high short term estimated earnings growth rates of the commercial bank and 
securities sectors for the years 2010, 2011 and 2012. Specifically, the securities sector exhibits 
the highest short term estimated earnings growth rate (from 53.83% to 130.57%) and growth/risk 
ratio (from 36.99 to 99.41) during the three years. Since the target price is the most likely price 
level in the next 12 months, the financial analysts often focus on the estimated future short term 
performance to set target prices. Thus, the financial analysts produced the largest number of 
Groups 4 and 5 target prices for the securities sector. 
Table 6.1 shows that the financial analysts produced the most conservative target prices for the 
software and computer services sector, which exhibits the largest number of Group 3 target 
prices (36.67% of its total target prices). In addition, some financial analysts produced Group 1 
target prices (1.67%). The cyclical software and computer services sector is highly risky, and its 
performance is extremely sensitive to the level of technology spending. The level of technology 
spending is often affected by the business cycle effects, where companies reduce their IT budgets 
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and are less willing to spend on new IT products during difficult times. The software and 
computer services companies fall in value during the bottom and early-recovery stages of the 
business cycle. The short term earnings forecast and valuation have been depressed by the recent 
underperformance, where its earnings have been on a decline (see Table 6.3). The software and 
computer services sector had relatively low short term estimated earnings growth rates (from 
7.01% to 14.86%) and growth/risk ratios (from 6.80 to 13.34) during the study sample period. 
Thus, the financial analysts produced conservative and negative target prices for this sector. On 
the contrary, the performance of the technology hardware sector was more stable during and 
after the 2008 globe financial crisis. Most of the technology hardware companies’ products are 
electrical equipment, which is less elastic toward price changes and macroeconomic conditions. 
The financial analysts are more confident toward the future performance of the defensive 
technology hardware companies. Table 6.1 shows the technology hardware sector exhibits a 
large amount of Group 4 target prices (51.67%), and Group 5 target prices (20%).  
Table 6.1 shows the pharmaceutical sector has the second largest number of Groups 4 and 5 
target prices (81.66% of the total target price). The pharmaceutical sector is a medical science-
based sector, which specializes in the development and provision of medicines. As the rigid 
demand for medical products, the performance of the pharmaceutical sector is often less sensitive 
to the economic recession. Therefore, the pharmaceutical sector was more resistant than most 
sectors during the recession and maintained a higher past five years’ growth rate of 10.09% to 
21.89% (see Table 6.3). On the other hand, the biotechnology sector has been seriously impacted 
by the 2008 global financial crisis, in which the past five years’ growth rate of the biotechnology 
sector only ranges from -105.09% to 10.97% (see Table 6.3). Thus, Table 6.1 reflects the 
financial analysts’ negative attitude towards the biotechnology sector. The biotechnology sector 
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has the largest number of Groups 1 and 2 target prices (20%), while the smallest number of 
Groups 4 and 5 target prices (48.33%) in all the sample sectors. In general, the performance of 
biotechnology companies is highly dependent on the progress of R&D. However, the 2008 
global financial crisis largely reduced the outsourcing development orders from the downstream 
companies, and resulted in significantly fewer funds to support the ongoing R&D. Therefore, the 
biotechnology sector exhibited poor performance. 
Table 6.1   Financial Analysts’ Target Prices 
 
Note: “%” above is the number of a specific group’s target price, as a percentage of total target prices; the 
detailed target price classification method is presented in Table 6.2 
Source:  Author’s calculation 
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Table 6.2   Target Price Classification Method 
 
Note: “TP” - target price; “MPTTD” - market prices three trading days prior to the target price announcement dates or valuation dates;  
Source:  Author’s conclusion 
 
Table 6.3   Growth and Risk 
 
Note: Growth and risk are two important elements in company valuation. They directly determine the level of a company’s intrinsic value. In general, the 
less risky and faster growth the sector, the more bullish the target price. 
“-5yr” - the actual past five years earnings average growth rate; “-1yr” - the actual past one year earnings growth rate; “+1yr” - the forecasted future one 
year earnings growth rate; “+5yr” - the forecasted future five years earnings average growth rate; “Risk” - the current raw beta; “Growth/Risk” - the 
forecasted future one year earnings growth rate divided by the current raw beta. 
Source:  Author’s calculation 
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6.2.2   Target Price Performance   
Tables 6.4, 6.5 and 6.6 present the general performance of the financial analysts’ target prices in 
the study sample sectors between the years 2010 and 2012. In general, the percentage of realized 
target prices is low, which ranges from 22.42% to 55.42% across the three sample industries. 
This reflects the low reliability of the financial analysts’ target prices, where only half of the 
target prices (55.42%) were achieved in the following 12 months after the initial target price 
announcement dates. In addition, the valuation forecast error is considerably high, ranging from 
7.35% to 32.19% across the three sample industries. This reflects that the gap between the 
financial analyst’s target price and market price in the following 12 months is huge, where the 
target price level is too high or low to reach. Sections 6.2.2.1 to Section 6.2.2.3 provide detailed 
discussion of the performance of the financial analysts’ target prices across the financial, 
information technology and health care industries. 
6.2.2.1   Financial Industry   
Table 6.4 shows that the securities sector has the largest percentage of Groups 4 and 5 target 
prices (81.67%). However, Table 6.4 also shows that the securities sector has the lowest 
percentage of realized target prices (22.42%), the lowest level of frequency (30.17%), and the 
highest level of valuation forecast error (21.76%). This reflects the low reliability of the financial 
analysts’ target prices in the securities sector. In fact, the over-optimism of financial analysts 
toward the future performance of the securities companies often results in over-aggressive target 
prices. In general, there are two major reasons for the over-optimism of the financial analysts. 
First, they often concentrate on the recent events of a company, while paying less attention to the 
long term trends. Following the 2008 global financial crisis, the financial analysts’ future short 
term earnings forecast have been irrationally pushed up by the short term outperformance of the 
 117 
 
securities companies. Table 6.3 shows the large future one year earnings growth rate estimated 
by financial analysts, which ranges from 53.83% to 130.57%. Thus, this results in higher levels 
of valuation and target prices. Second, the commission generated from the securities brokerage 
services is one of the major income sources for the financial analyst. The optimism of financial 
analysts was exacerbated by the incentives to generate more trading in the bull market after the 
2008 global financial crisis. In order to attract more orders from their clients, the financial 
analysts have been motivated to produce positive target prices.  
In fact, the over-optimism of financial analysts is harmful to the reliability of target prices and 
often causes the target price to become too high to achieve. For example, the most “aggressive” 
securities sector exhibits the worst target price performance. On the contrary, the most 
conservative insurance sector has the lowest numbers of Groups 4 and 5 target prices (75%), but 
it exhibits the best target price performance in the financial industry. Specifically, the insurance 
sector has the highest percentage of realized target prices (43.99%), the highest level of 
frequency (51.21%), and the lowest degree of valuation forecast error (7.35%).  
Table 6.4 also presents the duration of the market prices reaching their target levels (as measured 
by % DISTRIBUTION). In general, the duration is simultaneously determined by the short term 
earnings growth rate and target price level. For the positive target prices, the less aggressive the 
target level and the faster the growth in the sector, the shorter the duration. Although the 
securities sector has the most aggressive target prices, Table 6.3 shows it also has the largest 
short term growth rate (53.83% to 130.57%). Thus, the securities sector has the second shortest 
duration in the financial industry, where 17.74% of the target prices have been achieved within 
six months. On the contrary, the insurance sector has the most conservative target prices, but also 
has the lowest growth rate (-5.58% to 16.32%). Thus, the insurance sector has the longest 
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duration with only 14.7% of target prices achieved within six months and most target prices 
(19.52%) have been achieved in the fourth quarter after the initial target price announcement 
date. Hence, the target price setting process should fully consider the nature of the company 
being valued, and the target level must be consistent with the growth potential of the company.  
Table 6.4   Performance of Financial Analysts’ Target Prices: Financial Industry  
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Note: The study classifies the target prices estimated by financial analysts into two groups (Realized and 
Unrealized) and tests them differently. Details of the reliability test method including how to judge “Realized” 
and “Unrealized” are discussed in Chapter 3. A reliable target price is expected to have high degrees of “% 
REALIZED”, short duration (measured by “% DISTRIBUTION”), high level of “% FREQUENCY”, small 
“%UNREALIZED” and “% FORECAST_ERROR”.  
“% of Total Target Price”- the number of a specific group’s target price, as a percentage of the total target 
price; “Overall” - the average value of the five groups, except “% of Total Target Price”, which is the sum of 
the five groups. 
“% REALIZED” - in a specific group, the realized target prices as a percentage of the total target prices in this 
group; “% DISTRIBUTION” - in a specific group, the percentage of target prices realized within a certain time 
period after the target price announcement date; “% FREQUENCY” - in a specific group, the frequency of 
market price reach or beyond the target level in the following 12 months; “%UNREALIZED” - in a specific 
group, the unrealized target prices as a percentage of the total target prices in this group; “% 
FORECAST_ERROR” - in a specific group, the valuation forecast errors of the unrealized target prices;  
Source:  Author’s calculation    
6.2.2.2   Information Technology Industry     
Table 6.5 provides a detailed performance summary of the financial analysts’ target prices in the 
information technology industry. The results show the Group 4 target prices have better 
performances than the other groups of target prices. In fact, Group 4 target prices have good 
performances in all the study sample sectors. Specifically, they have the highest percentage of 
realized target prices, the shortest duration and the lowest valuation error across all the study 
sample sectors. The underlying reason for this phenomenon is straightforward. During the 
 120 
 
economic recovery stage after the 2008 global financial crisis, the most easily achieved target 
prices are Group 4 target prices. Since their target levels are just about 10% to 25% above the 
current price levels, these target levels can be easily achieved in the bull market.  
On the other hand, Group 5 target prices exhibit significantly worse performances in all the study 
sample sectors. Table 6.5 shows that Group 5 target prices have lower percentages of realized 
target prices, longer duration and higher valuation error than Group 4 target prices. The reason is 
that Group 5 means the target level is more than 25% of above the current price levels, which 
causes the targets become too high to achieve during the economic recovery stage. The 
aggressive target price often results in poor degree of reliability, especially in the early stage of 
the bull market. 
Table 6.5 demonstrates that the software and computer services sector has the largest number of 
conservative target prices. In general, this sector outperformed the bullish technology hardware 
sector, where it has more realized target prices (55.42%) and higher levels of frequency 
(72.62%). However, in contrast with Groups 3, 4 and 5 target prices, the software and computer 
services sector did not outperform the technology hardware sector. Table 6.5 shows Groups 3, 4 
and 5 target prices have lower percentages of realized target prices and larger valuation forecast 
errors in the software and computer services sector. In contrast with the defensive technology 
hardware sector, the unstable software and computer services sector is more elastic towards the 
changes in macroeconomic condition. The cyclical software and computer services sector is 
extremely sensitive to the business cycle effect. It performed badly during the 2008 global 
financial crisis and was expected to continue its bad performance in the following economic 
early-recovery stage. Table 6.3 presents the low short term estimated earnings growth rate of the 
software and computer services sector, which ranges from 7.01% to 14.86%. Hence, their market 
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prices moved slowly toward their target levels (as measured by “% DISTRIBUTION”), 
especially for the bullish target levels.  
Table 6.5   Performance of Financial Analysts’ Target Prices: Information Technology Industry   
 
 
Source:  Author’s calculation 
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6.2.2.3   Health Care Industry    
The financial analysts have significantly different views about the future performance of the 
pharmaceutical and biotechnology sectors. The pharmaceutical sector is a traditional and stable 
sector, where the rigid demand for medical products and devices causes the earnings of the 
pharmaceutical sector to be less sensitive to cyclical effects. Table 6.6 presents the market 
confidence towards its sustainable profitability, where the pharmaceutical sector has the second 
largest percentage of Groups 4 and 5 target prices (81.66%).  
On the other hand, the R&D process of new biotechnology products was seriously delayed 
during the 2008 global financial crisis, and this resulted in a low and even negative earnings 
growth rate. Table 6.3 shows that in the year 2010, the past five year average earnings growth 
rate is -105.09%. In general, the costly R&D activities often require on-going capital investment, 
as R&D is important to the value creation of the intangibles-rich biotechnology companies. 
However, the decrease in outsourcing orders from downstream companies has put serious 
pressure on the operating incomes of the biotechnology companies. The decreased working 
capital significantly slowed down the R&D process, and resulted in lower valuation for the 
biotechnology companies. Table 6.6 reflects the low level valuation of the biotechnology sector, 
where it has the largest number of Groups 1 and 2 target prices (20%), and the smallest number 
of Groups 4 and 5 target prices (48.33%). 
Although the biotechnology sector exhibits the most “negative” target prices, its target prices 
have a higher degree of reliability than the pharmaceutical sector. Table 6.6 reveals that the 
biotechnology sector exhibits the higher percentage of realized target prices (53.33%) and 
smaller valuation error (24.64%). Specifically, all Group 1 target prices reached their target 
levels, 80% of the Group 4 target prices and 33.33% of Group 5 target prices were also achieved. 
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On the contrary, the pharmaceutical sector exhibits a lower percentage of realized target prices 
(38.17%) and larger valuation errors (26.85%). Therefore, similarly to other industries in the 
study, a less aggressive target price often results in a better degree of reliability during the 
economic recovery period. This rule also applies to the health care industry. 
Table 6.6   Performance of Financial Analysts’ Target Prices: Health Care Industry   
 
 
Source:  Author’s calculation 
 124 
 
6.3   Target Prices Produced by the Current Study     
This section discusses the quarterly target prices produced by the current study for the 35 sample 
companies between the years 2010 and 2012. The discussion is based on the target prices 
produced in the current study by using the best industry-based individual and combined 
valuation models (see Table 4.7 and Table 5.7). For simplicity, the best industry-based combined 
valuation models are abbreviated to combined models, and the best industry-based individual 
valuation models are abbreviated to individual models in this section.  
Tables 6.7 and 6.8 present the general characteristics and performance of the target prices 
produced by the current study. Specifically, Table 6.7 shows that the combined models are more 
conservative than the individual models. The combined models have significantly higher 
percentages of Group 3 target prices, which range from 70% to 100% of the total target prices 
across all the study sample sectors. On the contrary, the individual models have fewer Group 3 
target prices, which range only from 25% to 38.33%. In general, the combined model has 
apparent advantages in overcoming the outlier effect by averaging away any extremely large or 
small target prices. The target prices estimated by the combined models are often more 
reasonable and they are able to better reflect the future intrinsic values. Table 6.8 confirms the 
significant valuation advantage of the combined models over the individual models. The target 
prices produced by the combined models have higher realization ratios (from 31.25% to 77.45%), 
shorter duration (as measured by “% DISTRIBUTION”), higher frequency (from 43.09% to 
100.00%) and smaller valuation errors (from 7.83% to 28.97%). The following two sections 
provide a discussion on the target prices estimated by the individual and combined models. 
The individual models tend to be over-optimistic toward the future performance of the securities 
and pharmaceutical sectors. Table 6.7 shows that the two sectors have the largest percentage of 
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Groups 4 and 5 target prices in the financial and health care industries, respectively. In fact, it is 
impossible for the mature sectors such as pharmaceutical to have such high levels of valuations 
due to their nature, these sectors often lack significant growth opportunities in the future. Table 
6.3 shows that the future short term earnings growth rate of the pharmaceutical sector only 
ranges from -8.66% to 8.09%. In addition, it is also unreasonable for risky sectors such as 
securities to have over-optimistic target prices. The volatile securities sector is subject to great 
uncertainty since its performance is often closely related to the movement of stock markets. 
Table 6.3 reflects that the securities sector has the largest beta in all the study sample sectors. 
Thus, it is irrational to set over-optimistic target prices for a sector with great uncertainty. In fact, 
Table 6.8 shows the poor performance of target prices in the slow growing pharmaceutical sector, 
and in the volatile securities sector. Specifically, the pharmaceutical sector has the lowest 
number of realized target prices (34.34%) in the health care industry. In the financial industry, 
the securities sector has the lowest number of realized target prices (16.00%), the longest 
duration (measured by % DISTRIBUTION), the lowest frequency (35.67%) and the largest 
valuation error (43.29%). Overall, the individual models produce large target prices for the 
mature or uncertain sectors.  
In general, the target prices estimated by the combined models are more compatible with the 
nature of the sector being valued. Table 6.7 summarizes the characteristics of the combined 
models’ target prices, where the less risk and faster growth in the sector, the more bullish the 
target prices. Specifically, the commercial bank, technology hardware and biotechnology sectors 
have the largest number of Groups 4 and 5 target prices in the financial, information technology 
and health care industries, respectively. Groups 4 and 5 target prices in the commercial bank, 
technology hardware and biotechnology sectors range from 10% to 18.33% of the total target 
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prices. Table 6.3 presents the high growth/risk ratio for the commercial bank, technology 
hardware and biotechnology sectors for the years 2010, 2011 and 2012. In general, a high 
growth/risk ratio often results in high levels of valuation and target price. Thus, the bullish target 
prices in the commercial bank, technology hardware and biotechnology sectors are reasonable 
and reliable. Table 6.8 confirms the superior reliability of these target prices. Specifically, the 
commercial bank has the highest realization ratio (67.55%) and the lowest valuation forecast 
error (7.83%) in the financial industry. The technology hardware sector has the shortest duration 
(as measured by % DISTRIBUTION), the highest level of frequency (72.89%) and the lowest 
level of valuation forecast error (12.51%) in the information technology industry. The 
biotechnology sector also has the highest realization ratio (59.92%) in the health care industry. 
The reliability test results in Tables 6.7 and 6.8 conclude that the combined models produce 
more reasonable target prices with higher degrees of reliability than the individual models. 
6.4   Chapter Summary    
This chapter discusses the sample companies’ target prices produced by both financial analysts 
and the current study. The chapter summarizes the characteristics of the financial analysts’ target 
prices produced between the years 2010 and 2012. There are more positive than negative target 
prices which reflects that the financial analysts were optimistic toward the future during the 
sample period, and produced many large target prices in the economic recovery stage after the 
2008 global financial crisis. However, the reliability for these target prices is low. The reliability 
test results show the low percentage of realized target prices, long duration, low frequency, and 
large valuation forecast errors for the financial analysts’ target prices.  
The target prices produced by the current study exhibit significantly different characteristics and 
performances. Table 6.9 shows that the target prices estimated by the best industry-based 
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combined valuation models are more conservative, where Group 3 target prices account for 70% 
to 100% of the total target prices across the sample industries. On the contrary, the financial 
analysts’ target prices are more aggressive, where Group 3 target prices only account for 18.33% 
to 36.67%. However, during the economic recovery stage after the 2008 global financial crisis, 
conservative target prices exhibited higher degrees of reliability. Table 6.10 indicates that the 
best industry-based combined valuation models have overwhelming valuation advantages. The 
best industry-based combined valuation models significantly outperform the financial analysts in 
terms of target price performance. Specifically, there are more realized target prices, shorter 
duration, higher frequency and lower valuation forecast errors in all the study sample sectors. 
Thus, the best industry-based combined valuation models are able to improve the valuation 
methodology and the reliability of target prices. 
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Table 6.7   Target Prices Produced by the Current Study (2010 - 2012)   
 
Note: “Individual” - the target prices estimated by the best industry-based individual valuation models; “Combined” - the target prices estimated by the 
best industry-based combined valuation models; “%” above is the number of a specific group’s target price, as a percentage of total target prices 
Source:  Author’s calculation 
Table 6.8   Target Prices Produced by the Current Study (2010 - 2012): Performance 
 
Source:  Author’s calculation 
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Table 6.9   Target Prices Produced by Financial Analysts versus Target Prices Produced by the Current Study (2010 - 2012) 
 
Source:  Author’s calculation 
 
Table 6.10   Target Prices Produced by Financial Analysts versus Target Prices Produced by the Current Study (2010 - 2012): Performance 
 
Note: “Analyst” - the target prices estimated by financial analysts; “Combined” - the target prices estimated by the best industry-based combined 
valuation models. Since the target prices of pharmaceuticals sector estimated by the “Combined” models all belong to Group 3, “%DISTRIBUTION” is 
not applicable to Group 3. Source:  Author’s calculation 
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Chapter 7 
                                    Out-of-Sample Test 
7.1   Introduction  
This chapter applies the out-of-sample test to verify the robustness of the research results 
presented in Chapter 4, 5 and 6.  The rest of the chapter is organized as follows: Section 7.2, 7.3 
and 7.4 verify the robustness of the research results based on the out-of-sample results. Section 
7.5 concludes the chapter. 
7.2   Robustness of In-Sample Research Results: Individual Value Estimates  
7.2.1   Industry-based Individual Valuation Models  
 
In general, the suitability of a valuation model reflects its degree of applicability in the valuation 
of a specific sector. Based on the suitability rankings in Table 7.2, 7.3 and 7.4, the sample 
individual valuation models exhibit similar rankings in the sample period (2010-2012) and the 
out-of-sample period (2013-2015), the median value of rank difference is only ranges from 1 to 
3.5 among the 7 sample sectors. The in-sample ranking is generally consistent with the out-of-
sample ranking, which means that the in-sample ranking is reliable and its robustness has been 
confirmed by the out-of-sample test. 
In addition, the small rank difference reveals that the suitability of sample individual valuation 
models in the sample sectors did not have significant change during the sample and out-of-
sample period. Since the period of year 2010 to 2015 is within the current economic expansion 
stage, the characteristics of each of the sector did not have apparent changes during this period, 
especially for the traditional sectors such as technology hardware. In general, the technology 
hardware is mature sector with a large amount of tangible assets but little intangible assets such 
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as proprietary technology and patents. Demirakos et al. (2004) found that for the traditional 
sectors without innovative technology, they often have slow but stable future earnings growth. 
The characteristics of technology hardware sector had little changes due to its low growth. Thus, 
the small characteristics difference results in little change of the valuation model suitability, the 
median value of rank difference in the technology hardware is only 1 (Table 7.3).  
On the other side, the strong growth of the emerging biotechnology sector is largely driven by 
the R&D process. Banerjee (2003) concluded that most of intrinsic value of the biotechnology 
sector is embedded in the long and risky R&D still in progress. The earnings of biotechnology 
sector are expected to increase sharply once the core biotechnology products complete the 
development, regulatory approval and enter into the marketing stage. The strong growth of the 
R&D oriented biotechnology sector caused relatively larger change in characteristics during the 
period of year 2010 to 2015. Accordingly, the sample valuation models had certain degrees of 
suitability change, Table 7.4 shows that the biotechnology sector has the largest rank difference 
(median value 3.5) in all the sample sectors. 
Table 7.1   Suitability Ranking of Individual Valuation Models - Financial Industry 
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Note: “In-sample” means the research results presented in Chapter 4, 5 and 6 (sample period 2010-2012); 
“Out-of-sample” means the research results generated by the out-of-sample test; “Rank Difference” is the 
difference between the “In Sample” and “Out of Sample” rankings. Source: Author’s calculation 
Table 7.2   Suitability Ranking of Individual Valuation Models - Information Technology Industry 
 
 
 133 
 
 
Source:  Author’s calculation 
Table 7.3   Suitability Ranking of Individual Valuation Models - Health Care Industry 
 
 
 
Source:  Author’s calculation 
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7.2.2   Absolute Valuation Models versus Relative Valuation Models    
The out-of-sample results in Table 7.5 show that the relative valuation models outperform the 
absolute valuation models in most of the sample sectors, especially in the traditional sectors such 
as technology hardware. This result is consistent with the in-sample results “relative valuation 
models significantly outperform the absolute valuation models in most of the sample 
sectors…the relative valuation models are most suitable for the slow growing matured sector” 
(p.83 & p.84). Demirakos et al. (2004) also revealed that for the traditional sectors with poor 
growth prospects but stable accounting data, the accounting based relative valuation models have 
significant valuation advantages. In addition, the out-of-sample results in Table 7.5 also indicate 
that the absolute valuation models only have relatively higher degree of accuracy in the 
biotechnology sector. This finding is in line with the in-sample result “the absolute valuation 
models only slightly outperform the relative valuation models in the fast growing or risky 
sectors” (p.82).  Imam et al. (2008) found that the forward-looking absolute valuation models are 
able to simultaneously consider the risk and growth faced by the emerging companies in the 
future. In general, the in-sample and out-of-sample test results both conclude that the forward-
looking absolute valuation model concentrate on the future, thus they are most suitable for the 
high growing emerging sectors with a large amount of intrinsic value generated from the future 
stage. The current value-based relative valuation models focuses on the intrinsic value already 
generated by the companies, they are ideal valuation models for the mature sectors with less 
growth prospect.  
7.2.3   Forward Valuation Models versus Trailing Valuation Models 
Based on the out-of-sample results in Table 7.6, the forward valuation models have significant 
valuation advantage in the mature and stable sectors such as pharmaceuticals with accurate 
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forecast data. As the traditional chemical pharmaceutical technology gradually matures and there 
is little technology uncertainty and re-development opportunity. Trottier (2010) found that the 
pharmaceutical companies especially the chemical pharmaceutical companies often lack 
innovative new products and their future earnings are stable and easier to predict. Therefore, the 
future short term-based forward valuation models have significant advantage in the valuation of 
the stable pharmaceutical companies with adequate, reliable and accurate forecast financial data. 
This finding is consistent with the in-sample result “the forward valuation models are most 
suitable for the mature sectors with reliable forecast data” (p.86). Liu et al. (2002) and Lie and 
Lie (2002) also concluded that the forward valuation models are more accurate than trailing ones, 
especially when the consensus financial analysts’ forecasts are available. On the other hand, the 
out-of-sample results show that the trailing valuation models have significant higher suitability in 
the high growing but risky sector such biotechnology. The biotechnology companies often have 
great risk and uncertainity in the R&D, regulatory approval and marketing stage, their future 
financial data are subject to great uncertainty and difficult to predict (Banerjee, 2003). The 
trailing valuation models focus on the historical data thus they have apparent advantage in the 
valuation of unstable business. This finding is consistent with the in-sample result “The trailing 
valuation models are good alternatives in the valuation of unstable sectors, where the future cash 
flows are subject to great uncertainty and are difficult to predict” (p.86).  
7.2.4   Enterprise Value Valuation Models versus Price Valuation Models 
The out-of-sample results in Table 7.7 show that in the sample sectors, the suitability difference 
between the enterprise value and price valuation models is not significant. This result is in line 
with the in-sample result “no significant difference between the suitability of the price and 
enterprise value valuation models in the study sample sectors” (p.86). The in-sample and out-of-
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sample research results both implied that in the valuation of the listed companies from the 
sample sectors, it is not necessary to consider the total value of a company’s total capital 
(including equity and debt). The price valuation models focus on the market price per share of 
company and they are more convenient and easy to use in practice. Lundholm and Sloan (2004) 
also discovered that financial analysts focused on shareholder value more than enterprise value. 
The enterprise value valuation models are only appropriate under certain circumstance, such as 
in the valuation of companies with different levels of leverage (Pinto et al., 2010), or with a large 
amount real estate (Koller et al., 2010). 
Table 7.4   Suitability Comparison: Absolute vs Relative Valuation Models   
 
Note: “AC” is accuracy; “EP” is explanatory power;  
Source:  Author’s calculation 
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Table 7.5   Suitability Comparison: Trailing vs Forward Valuation Models 
 
Source:  Author’s calculation 
Table 7.6   Suitability Comparison: Enterprise Value vs Price Valuation Models 
 
Source:  Author’s calculation 
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7.3   Robustness of In-Sample Research Results: Combined Value Estimates  
7.3.1   Combined Valuation Models versus Individual Valuation Models    
Based on the out-of-sample results presented in Table 7.8, the combined valuation models 
significantly outperform the individual valuation models in all the sample sectors. In general, the 
combined valuation models contain more value-relevant information and they provide more 
comprehensive valuation of the target company (Vardavaki and Mylonakis, 2007). This result is 
consistent with the in-sample result “In the study sample industries, the combined valuation 
models have higher degree of suitability than the individual valuation models” (p.103). Tiwari 
and Singla (2015) also revealed that since the combined valuation model considers all bona fide 
information of individual valuation models, the combined valuation model is often more reliable.  
However, the out-of-sample results in Table 7.9 show that it is not appropriate to combine 
certain individual valuation models together, not all the combined valuation models are able to 
outperform all their own individual valuation models. This is in line with the in-sample research 
result “certain individual valuation models perform better when they work as individuals rather 
than in a group” (p.103). In fact, Vardavaki and Mylonakis (2007) argued that the superior 
performance of a combined valuation model is only guaranteed when the proper use of more 
than one individual valuation model at the same time. Lie and Lie (2002) also discovered that the 
combination of several individual valuation models with opposite biases has better valuation 
performance. The current study introduces the important valuation concepts of multi-valuation 
periods and multi-value indictors, these two concept can assist financial analysts to properly 
construct combined valuation model. 
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Table 7.7   Suitability Comparison: Combined vs Individual Valuation Models 
 
Source:  Author’s calculation 
 
Table 7.8   Work as a Group vs Work as Individuals   
 
Note: “%” above means that in each sample sector, the percentage of combined models outperform all their 
own individual models 
Source:  Author’s calculation 
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Table 7.9   Suitability Comparison: Mixed vs Pure Combined Models 
 
Source:  Author’s calculation 
 
7.3.2   Mixed Combined Models versus Pure Combined Models 
According to Table 7.10, the out-of-sample test results show that in most of the sample sectors, 
the mixed combined models do not have significant valuation advantage. This is consistent with 
the in-sample result “in general, the mixed combined models do not significantly outperform the 
pure combined models” (p.106). In fact, the mixed combined models only outperform the pure 
combined models in terms of explanatory power in the securities sector. The securities sector is 
an emerging sector with high future earnings growth rate and great risk, the absolute valuation 
models contained in the mixed combined model are able to simultaneously take into account the 
growth and risk faced by the emerging companies in the future long term stage (Demirakos et al., 
2004). This out-of-sample result is in line with the in-sample result “the mixed combined models 
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have good valuation performance in the emerging sectors” (p.106). Since the importance of 
future long term stage in the valuation of emerging sector, Jenkins (2006) revealed that the 
effective combination of absolute and relative valuation models is able to focus both on the long-
term forecasts as well as short-term forecasts. Demirakos et al. (2004) also found evidence that 
in the valuation practice of emerging sector, the relative valuation models are frequently used in 
combination with absolute valuation models. On the other hand, the out-of-sample test results in 
Table 7.10 also indicate that the pure combined models have significant higher degree of 
suitability in the traditional sectors such as insurance. Since the pure combined models in the 
current study only contain relative valuation models, the pure combined models concentrate on 
the current period and they are more suitable than the mixed combined models in the valuation of 
the traditional sectors without strong future growth. This is consistent with the in-sample 
research result “For such traditional companies, there is less demand for the mixed combined 
models” (p.107).+ 
 
7.4   Robustness of In-Sample Research Results: Target Prices 
7.4.1   Target Prices Produced by Financial Analysts   
In contrast with the sample period (2010-2012), Table 7.11 shows that the financial analysts 
produced less Group 4 and 5 target prices in the out-of-sample period (2013-2015) and they 
produced more Group 3 target price, which accounts for as high as 50% of the total target prices. 
This result reflects that in the out-of-sample period, the financial analysts became less optimistic 
than at the early phrase of the current economic expansion stage, the financial analysts exhibit 
more prudent investment attitude. However, the prudent attitude did not generate better target 
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price performance. Table 7.11 shows that in most of the sample sectors, the target price 
performance (e.g. % REALIZED) in the out-of-sample period is worse than in the sample period.   
 
Table 7.10   Financial Analysts’ Target Prices 
 
Note: “%” above is the number of a specific group’s target price, as a percentage of total target prices 
Source:  Author’s calculation 
 
 
Table 7.11   Performance of Financial Analysts’ Target Prices: Financial Industry  
 
Source:  Author’s calculation 
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Table 7.12   Performance of Financial Analysts’ Target Prices: Information Technology Industry 
 
Source:  Author’s calculation 
 
 
 
Table 7.13   Performance of Financial Analysts’ Target Prices: Health Care Industry  
 
Source:  Author’s calculation 
 
 
7.4.2   Target Prices Produced by the Current Study  
Similar to the in-sample result “combined models are more conservative than the individual 
models, the combined models have significantly higher percentages of Group 3 target prices” 
(p.123). The out-of-sample result in Table 7.15 also shows that in all the sample sectors, most of 
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the target prices produced by the combined models belong to Group 3. In addition, the out-of-
sample result also indicate that the combined models outperform the individual models in most 
of the sample sectors, Table 7.16 shows that the target prices produced by the combined models 
have higher degree of realization rate and frequency, and lower level of forecast error. This out-
of-sample result is consistent with the in-sample result “combined models produce more 
reasonable target prices with higher degrees of reliability than the individual models” (p.125).   
Yee (2004) argued that since every valuation model discloses an incremental piece of intrinsic 
value, any valuation practice that relies on just one valuation model may ignore some parts of the 
intrinsic value. Therefore, the in-sample and out-of-sample result both implied that combined 
models simultaneously capture and consolidate multi-value relevant information, they are more 
informative and capable to produce more reliable target prices than individual models. In fact, 
the combined models also produce more reliable target prices than the financial analysts. The 
out-of-sample test result in Table 7.18 shows that the target prices produced by the combined 
models have higher degree of reliability than the financial analysts’ target prices. This is in line 
with the in-sample result “combined valuation models significantly outperform the financial 
analysts in terms of target price performance” (p.126). 
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7.5   Chapter Summary 
This chapter applies the out-of-sample test to verify the robustness of the in-sample results 
presented in Chapter 4, 5, and 6. In general, the in-sample and out-of-sample results are similar 
to each other, which means the in-sample result is reliable and its robustness has been confirmed 
by the out of sample test.     
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Table 7.14   Target Prices Produced by the Current Study   
 
Table 7.15   Target Prices Produced by the Current Study: Performance 
          
Source:  Author’s calculation 
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Table 7.16   Target Prices Produced by Financial Analysts versus Target Prices Produced by the Current Study 
 
Table 7.17   Target Prices Produced by Financial Analysts versus Target Prices Produced by the Current Study: Performance 
      
Source:  Author’s calculation 
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Chapter 8 
                                           Conclusion 
8.1   Introduction  
This chapter concludes the study. In general, this practice-oriented study improves the reliability 
of listed companies’ value estimates and target prices via the improvement of the valuation 
methodology. A range of innovative company valuation concepts and techniques are presented in 
the study, which can be directly applied in company valuation practice. Specifically, the study 
introduces a new valuation concept of industry-based combined valuation model and further 
introduces two important valuation concepts to enhance the performance of the industry-based 
combined valuation model. They are multi-valuation periods and multi-value indictors. In 
addition, the study improves the discount rate estimation method, designs an enhanced target 
price setting approach, and presents an improved reliability test method for value estimate and 
target price. The rest of the chapter is organized as follows: Section 8.2 concludes the major 
research results. Section 8.3 discusses the implications of the research results. Section 8.4 
discusses the research limitations and future research recommendations. 
8.2   Research Results Summary    
8.2.1   Research Objective One      
Research objective one identifies the factors which influence the reliability of listed companies’ 
target prices and value estimates.   
The result in Table 8.1 shows that the reliability of the target price is largely affected by the 
value estimate. In general, a target price reflects the financial analyst’s expectation of the future 
price level that a stock is most likely to reach within a certain time horizon (Huang et al., 2009). 
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Target price is based on the future intrinsic value per share of a company, where the future 
intrinsic value is often predicted by using the value estimate. The value estimate reflects the 
intrinsic value of a company at the current valuation date, in which the financial analysts use the 
value estimate to estimate the future intrinsic value. Therefore, the value estimate is the 
foundation of the target price, the quality of the value estimate has a direct and significant 
influence on the reliability of the target price. This current research result is consistent with the 
findings of Kerl (2011) who revealed that the financial analysts do not take the outcome of 
valuation (value estimate) at face value, they adjust the value estimate qualitatively to better 
reflect the expected future price level (target price), and the target price is the “final product” of 
the value estimate. 
The result in Table 8.1 reveals that the reliability of the target price is also affected by the target 
price setting process, which is a series of adjustments that the financial analysts use to set target 
prices based on the value estimates. Specifically, these pricing adjustments involve a large 
amount of subjective assessments of the company being valued, where a number of factors 
determine the quality of adjustment. These factors include the financial analyst’s access to 
privately available information, the competency of the financial analyst in the forecasting of 
company performance, the degree of the financial analyst’s optimism, the size and reputation of 
the investment bank, etc. Therefore, the target price setting or pricing process determines the 
reliability of the target price to some extent. This current research result is consistent with the 
findings of Bradshaw et al. (2013), where the authors highlighted the importance of the target 
price setting in the determination of target price performance. 
The result also presents a number of factors which directly affect the reliability of the value 
estimate (see Table 8.1). The influential factors include the quality of the accounting information, 
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the accuracy of the company’s performance forecast, the discount rate estimation method and the 
valuation model choice. In general, the reliability of a value estimate is not only affected by its 
“raw material” such as historical accounting data and performance forecast data, but also its 
“manufacturing technique” such as discount rate estimation method and valuation model. A 
number of other studies have documented similar findings. Gleason et al. (2013) found evidence 
that the accuracy of the value estimate is strongly associated with the accuracy of the earnings 
forecast, and the authors also highlighted the importance of both forecasting ability and the 
valuation model. Demirakos et al. (2010) showed that the valuation model choice does affect 
value estimate accuracy, since the valuation model often performs differently under different 
circumstances. 
Table 8.1   Reliability of Target Price and Value Estimate: Major Influential Factors 
 
Source:  Author’s conclusion 
8.2.2   Research Objective Two     
Research objective two improves the discount rate estimation method for listed company, which 
includes cost of equity, after-tax cost of debt and capital structure estimation technique.  
The current study improves the cost of the equity estimation technique by introducing the 
expanded CAPM model. The details of the expanded CAPM model are shown in Table 8.2 and 
are based on the studies of Pratt (2002) and Pinto et al. (2010), which aimed to provide a more 
accurate estimation of the cost of equity by simultaneously considering the systematic and 
unsystematic risks. The unsystematic risk is often ignored by the traditional CAPM model, 
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which assumes that unsystematic risk can be diversified away in a well-diversified portfolio. In 
fact, the unsystematic risk cannot be fully diversified away. Therefore, the current study 
introduces the expanded CAPM model to fully take into account the unsystematic risk. The cost 
of equity estimated by the expanded CAPM model is the sum of several factors, including risk 
free rate, industry risk premium, beta-adjusted size premium and company-specific risk premium. 
Specifically, Pinto et al. (2010) revealed that the sum of the risk-free rate and the industry risk 
premium is the average required return on equity for all the companies in a particular industry. 
The expanded CAPM model then adds a beta-adjusted size premium to reflect the average 
required equity return for a specific peer group within the industry. Finally, the company-specific 
risk premium is added to arrive at the cost of equity for a particular company within the peer 
group. In general, the expanded CAPM model follows the top down approach (industry-peer-
company). The expanded CAPM model provides an accurate cost of equity estimation by 
simultaneously considering the systematic and unsystematic risks faced by a specific company. 
Thus, the expanded CAPM model is a good alternative to the traditional CAPM model.   
Based on the studies of Koller et al. (2010), Pratt (2002), Pinto et al. (2010) and Jacobs and 
Shivdasani (2012), the current study presents an improved cost of debt estimation method (see 
Table 8.2). This method considers four possible scenarios in practice, and then estimates the cost 
of debt in different ways. First, for the companies with long-term publicly traded corporate bonds, 
the yield-to-mature (YTM) on newly issued long-term bonds can be selected as a proxy of cost 
of debt. Second, for the companies with only short-term publicly traded corporate bonds (and no 
credit rating), the possible credit rating and cost of debt can be estimated by comparing their key 
financial ratios to other comparable companies with credit ratings. Third, for the companies 
without publicly traded corporate bonds but with other forms of debts such as bank loans, the 
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possible credit rating and cost of debt can be estimated by comparing their key financial ratios to 
other comparable companies with credit ratings. Lastly, for the companies without any form of 
debt or liability at any time, the cost of debt is zero. In general, this improved cost of debt 
estimation method has good practical relevance. The improved method considers four possible 
scenarios in practice, and then estimates the cost of debt separately using different techniques. 
The current study improves the capital structure estimation method by concentrating on the 
target capital structure, which is the long term sustainable capital structure of a company. In the 
company valuation, the target capital structure is more meaningful than the current capital 
structure, especially when the current capital structure misrepresents the company’s normal 
capital structure or the structure is expected to change in the future. Based on Pinto et al. (2010) 
and Koller et al. (2010), the current study presents the following estimation method for the target 
capital structure. First, for the mature companies at or near their target structures, the current 
market value of debt and equity can be directly used to estimate the target capital structure. 
Second, for the start-up or growing companies with unstable capital structure, a three-step 
approach suggested by Koller et al. (2010) is applied to find the possible target structure that the 
companies are likely to adopt in the long term period. This approach estimates a company’s 
current capital structure by using the current market value of equity and debt, then judges the 
reasonableness of the estimated capital structure according to the comparable companies and 
adjusts it if necessary. Finally, this approach examines the company’s approach to financing and 
its possible impact on the target capital structure. In general, this capital structure estimation 
method not only highlights the importance of the target capital structure in the company 
valuation practice, but also provides an effective method to estimate the target capital structure 
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for both mature and growing companies. Table 8.2 outlines the key points of the improved target 
capital structure estimation method. 
Table 8.2   Improved Discount Rate Estimation Method 
 
 
 
Source:  Author’s conclusion 
8.2.3   Research Objective Three     
Research objective three identifies the best industry-based individual and combined valuation 
models for the financial, information technology and health care industries. 
The current research result shows the best individual valuation model for each sample sector (see 
Table 8.3). In general, the valuation advantage of the best industry-based individual valuation 
model is derived from its value indictor (the value indictors of sample valuation models are 
presented in Table 3.3 of Chapter 3). Its value indictor is fully consistent with the characteristics 
of the company/sector being valued, especially the value creation process and intrinsic value 
distribution. For example, most of the intrinsic value of the traditional insurance company has 
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already been generated from the past and current life stages, thus the value indictor need to be 
good at estimating the current part of the intrinsic value. The current book value concentrates on 
the stable balance sheet of the insurance company, which is a good proxy of the current part of 
intrinsic value. Thus, the current book value based PBV model is able to better estimate the 
current part of the intrinsic value of the insurance company. The PBV model is the best 
individual valuation model for insurance companies. On the other hand, most of the intrinsic 
value of the emerging software and computer services company is expected to be generated from 
the future, so the value indictor should be able to cover the future period. The FPEG model 
contains two value indictors - estimated future one year earnings and estimated future five years 
earnings growth rates. The FPEG model covers the future short term via the estimated future one 
year earnings, and covers the future middle term via the estimated future five years earnings 
growth rate. Thus, the FPEG model is able to better estimate the intrinsic value of the software 
and computer services company. 
The current research result also shows the best combined valuation model for each sample sector 
(see Table 8.3). In general, the valuation advantage of the best industry-based combined 
valuation model is derived from two important valuation concepts introduced by the current 
study, which are multi-valuation periods and multi-value indictors. Specifically, a good 
combined valuation model should be able to cover all the important life stages of a company 
(multi-valuation periods), especially the life stage with an enormous amount of intrinsic value 
produced. For each important life stage, there should be at least one effective value indictor 
which is able to fully capture the intrinsic value produced during that life stage. Thus, there 
should be more than one value indictor in total to simultaneously capture the intrinsic values 
from the different important life stages (multi-value indictors). The best industry-based 
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combined valuation models shown in Table 8.3 should not only be able to cover all the important 
life stages of a company, but also fully capture the intrinsic value generated in each important 
life stage. Therefore, the best industry-based combined valuation models can better estimate the 
intrinsic value of a company, which are good alternatives to the best industry-based individual 
valuation models. 
Table 8.3   Best Industry-based Individual and Combined Valuation Models 
 
Source:  Author’s conclusion 
8.2.4   Research Objective Four    
Research objective four improves the target price setting method to produce reliable listed 
companies’ target prices. 
Based on the methods suggested by Imam et al. (2008), Hoogerheide et al. (2010), Thordarson 
(2007), Yee (2004) and Yoo (2006), the current study improves the target price setting method 
by introducing a four-step approach (see Table 8.4). This approach begins with the estimation of 
the company’s intrinsic value on the basis of the best industry-based combined valuation model. 
The second step applies the partial least square regression method (PLSR) to combine several 
value estimates produced from the combined valuation model. The third step predicts the future 
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intrinsic value based on the combined value estimate. The last step sets the target price for the 
company based on the estimated future intrinsic value. In general, this four-step approach 
highlights the importance of both quantitative and qualitative methods in the target price setting 
process. A reliable target price should be based on an accurate combined value estimate and 
reasonable pricing adjustments. 
The PLSR method used in step two has the following characteristics. First, it assumes that the 
market is efficient, where the market price of a company is used as the proxy of its intrinsic 
value per share. Second, the PLSR method estimates the regression equation by using the time-
series data of market price and value estimate. The coefficients of the explanatory variables are 
used as the weights to combine several value estimates into one combined value estimate. Third, 
the partial least square regression is used to minimize the possible multi-collinearity effect 
between the explanatory variables. Fourth, for a specific company, the suitability of a valuation 
model may tend to change over time and the constant weight for a valuation model may no 
longer apply in the future. The PLSR method is able to generate time-varying weights for each 
valuation model in the combined model. Lastly, in order to improve the effectiveness of a 
combined value estimate, the combined value estimate is equal to the weighted average sum of 
several value estimates plus the constant term of the regression. In general, the PLSR method is 
the core element of the four-step target price setting approach. It provides an effective solution to 
the common practical question faced by many financial analysts, that is, how to effectively 
combine several value estimates produced by a combined valuation model. The PLSR is able to 
minimize the subjective pricing error by objectively estimating the weight for each value 
estimate generated from a combined valuation model. 
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Table 8.4   Improved Target Price Setting Method 
 
Source:  Author’s conclusion 
8.2.5   Research Objective Five  
Research objective five improves the reliability test method for listed companies’ value estimates 
and target prices.  
Based on the approaches of Kaplan and Ruback (1995), Francis et al. (2000), Cheng and 
McNamara (2000) and Liu et al. (2007), the current study designs an improved reliability test 
method for value estimates as shown in Table 8.5. This method highlights that the reliability of a 
value estimate depends on its two equally important aspects: accuracy and explanatory power. 
Specifically, the accuracy reflects how well the value estimate can disclose the intrinsic value, 
and the explanatory power indicates how well the value estimate can explain the variation of 
intrinsic value. In addition, the reliability test method is based on the assumption that the market 
price is efficient, where the market price is used as a proxy of the intrinsic value per share of the 
company. In the reliability test, the metric of accuracy is used to reflect the valuation error, 
which is the distance between the intrinsic value and the value estimate. On the other hand, the 
metric of explanatory power is designed to measure the degree of co-movement between the 
intrinsic value and the value estimate. In general, the reliability test method emphasizes the 
importance of both accuracy and explanatory power. The reliability test method can accurately 
measure the degree of reliability for a value estimate.  
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The current study also designs an improved reliability test method for the target price, based on 
the studies of Bonini et al. (2010), Imam et al. (2013), Kerl (2011) and Demirakos et al. (2010). 
This target price test method has four steps and the details are presented in Table 8.5. First, it 
contrasts the target prices with the market prices three trading days prior to the target price 
announcement dates or valuation dates, and then classifies the target prices into five groups. 
Second, it tests whether the target prices in the five groups have been achieved, and then labels 
them as “Realized” or “Unrealized”. Third, it measures the degree of reliability for the target 
prices in the five groups labelled as “Realized”. Lastly, it examines the “Unrealized” target 
prices in the five groups. In general, this reliability test method is able to better measure the 
degree of reliability for the target price. It does not attempt to test the target price directly, but 
classifies the target prices into five groups at first and then measures their reliability separately. 
By doing so, the target prices in different groups can be tested by corresponding metrics and 
their degree of reliability can be better measured.   
Table 8.5   Improved Reliability Test Method for Value Estimate and Target Price 
 
 
Source:  Author’s conclusion 
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8.2.6   Out-of-Sample Test  
8.2.6.1   Individual Value Estimates 
First, the sample individual valuation models have similar suitability rankings in the sample 
period and the out-of-sample period, the median value of rank difference is only ranges from 1 to 
3.5 among the 7 sample sectors. The in-sample ranking is generally consistent with the out-of-
sample ranking. Second, the in-sample and out-of-sample test results both conclude that the 
forward-looking absolute valuation model concentrate on the future, they are most suitable for 
the high growing emerging sectors with a large amount of intrinsic value generated from the 
future stage. The current value-based relative valuation models focuses on the intrinsic value 
already generated by the companies, they are ideal valuation models for the mature sectors with 
less growth prospect. Third, the in-sample and out-of-sample test results shows that the future 
short term-based forward valuation models have significant advantage in the valuation of the 
stable sector with adequate, reliable and accurate forecast financial data. The trailing valuation 
models focus on the historical data thus they have apparent advantage in the valuation of 
unstable sector. Last, the suitability difference between the enterprise value and price valuation 
models is not significant. The in-sample and out-of-sample results implied that in the valuation 
of the listed companies from the sample sectors, it is not necessary to consider the total value of 
a company’s capital. 
8.2.6.2   Combined Value Estimates 
First, the in-sample and out-of-sample test results both conclude that the combined valuation 
models significantly outperform the individual valuation models in all the sample sectors. In 
general, the combined valuation models contain more value-relevant information and they 
provide more comprehensive valuation of the target company. Second, the in-sample and out-of-
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sample test confirm that it is not appropriate to combine certain individual valuation models 
together, not all the combined valuation models are able to outperform all their own individual 
valuation models. Third, the in-sample and out-of-sample test reveal that the mixed combined 
models have good valuation performance in the emerging sectors, the pure combined models 
concentrate on the current period and they are more suitable than the mixed combined models in 
the valuation of the traditional sectors without strong future growth. 
8.2.6.3   Target Prices 
First, the out-of-sample test result reflects that in the out-of-sample period, the financial analysts 
became less optimistic than at the early phrase of the current economic expansion stage, the 
financial analysts exhibit more prudent investment attitude. However, the prudent attitude did not 
generate better target price performance, the target price performance in the out-of-sample period 
is worse than in the sample period. Second, the in-sample and out-of-sample results both show 
that the combined models are more conservative than the individual models, the combined 
models have significantly higher percentages of Group 3 target prices. Third, the in-sample and 
out-of-sample result also indicate that the combined models outperform the individual models 
and financial analysts in most of the sample sectors, the target prices produced by the combined 
models have significant higher degree of realization rate and frequency, and lower level of 
forecast error.  
8.3   Research Implications    
The current research results have a series of important implications for academics and financial 
analysts. A good understanding of the research implications is essential for the improvement of 
the value estimate and target price reliability. 
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8.3.1   Reliability of Listed Companies’ Value Estimates and Target Prices 
The current research results show that financial analysts often set target prices on the basis of 
value estimates. This finding implies that the reliability of a target price is directly determined by 
both value estimate and target price setting process. Therefore, financial analysts should 
concentrate on the improvement of the value estimate quality and the effectiveness of the target 
price setting method, since they are two effective and direct approaches to improve the reliability 
of target prices.   
The current study found that the quality of value estimates is not only influenced by the “raw 
material” such as company historical accounting data and performance forecast data, but also by 
the “manufacturing technique” such as discount rate estimation method and valuation model. 
The implication of this finding is that the data and the valuation methodology are equally 
important in the determination of the value estimate quality. Thus, improving the quality of data 
and the effectiveness of the valuation methodology are two important tasks in the company 
valuation practice. This current study focuses on the improvement of valuation methodology, and 
introduces a series of innovative valuation techniques which can be directly applied in the 
company valuation practice. 
The current research results show that the target price setting is a pricing process which involves 
a series of subjective assessments of the company being valued. Specifically, the quality of the 
subjective assessment is influenced by several financial analyst-related factors such as the 
accessibility to privately available information, competency in the forecasting of the company 
performance, the degree of optimism, the size and reputation of the investment bank. This 
finding implies the subjective nature of the target price setting process, and the subjectivity 
causes significant reliability differences among the target prices produced by different financial 
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analysts. In fact, the subjective target price setting process is harmful to the target price, whereby 
the target price reliability is often negatively correlated to the degree of subjective factor 
contained. Thus, financial analysts should attempt to quantify the target price setting to increase 
the reliability of target prices. The current study develops a quantized target price setting method 
to largely reduce the subjective pricing error.  
8.3.2   Discount Rate Estimation Method    
In practice, most of the financial analysts use the traditional CAPM model to estimate the cost of 
equity (Jacobs and Shivdasani, 2012). However, the traditional CAPM model does not consider 
the unsystematic risk which is actually faced by many companies. This implies that the cost of 
equity estimated by financial analysts has often been underestimated, since the premium for 
unsystematic risk has been ignored. In the company valuation, the underestimated cost of equity 
often causes the value estimate to be overestimated and makes the valuation result unreliable. 
Therefore, the financial analysts should improve their cost of equity estimation methods they use 
in practice, and comprehensively assess the risk faced by a company from multi-aspects. This 
current study introduces an expanded CAPM model to fully take into account the risk faced by a 
company via simultaneously considering the systematic and unsystematic risks.  
In the estimation of a company’s capital structure, most of the financial analysts use the current 
book value or current market value based capital structure (Jacobs and Shivdasani, 2012). This 
means the financial analysts tend to use the current capital structure based discount rate to 
discount the future cash flows. In fact, the company valuation is a forward-looking process, the 
capital structure and discount rate should be able to fully reflect the possible risk that a company 
may encounter in the future. Therefore, the sustainable target capital structure should be the 
primary choice for financial analysts in the company valuation practice, especially when the 
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current capital structure misrepresents the company’s normal capital structure or the structure is 
expected to change in the future. This study highlights the importance of the target capital 
structure, and introduces an improved estimation method to effectively identify the target capital 
structure for both emerging and mature companies.  
8.3.3   Industry-based Individual and Combined Valuation Models    
The current study reveals that using more than one valuation model is a common practice in 
company valuation. However, it is also found that the existing academic research pays little 
attention to the combined valuation model, in particular there is no theoretical guidance on how 
to appropriately construct a combined valuation model based on the characteristics of the 
company being valued. The implication of this finding is that the gap between the academic 
research and company valuation practice is significant. Academic researchers should concentrate 
on the practical issues encountered in company valuation. This current study focuses on the 
construction of combined valuation models. This is also the first study to introduce an innovative 
valuation concept of industry-based combined valuation model to improve the reliability of 
valuation results. The current study also presents the reliability rankings for a series of industry-
based individual and combined valuation models. The rankings provide effective practical 
guidance to assist financial analysts to appropriately select valuation models and construct the 
combined valuation models.  
The current research result also has a number of other findings and implications. First, the result 
shows that the absolute valuation models have good valuation performance in the emerging 
industries, the relative valuation models perform better in the traditional industries. This implies 
that in the fast growing emerging industries with enormous amounts of intrinsic value generated 
from the future, the future long term value indictor based absolute valuation models have 
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significant advantages. On the other hand, the relative valuation models are often based on 
historical or current short term value indictors. This means that the relative valuation models are 
suitable for the mature and traditional industries, where their current parts of intrinsic values 
often account for a large percentage of their total intrinsic values. Thus, the financial analysts 
should apply the absolute valuation models in the emerging industries and use the relative 
valuation models in the traditional industries. Second, the current research result reveals that the 
forward valuation models have good performance in stable industries, while the trailing 
valuation models perform better in the valuation of unstable industries. This implies that in the 
volatile industries, the future cash flows are subject to great uncertainty and are difficult to 
predict. The historical value indictor based trailing valuation models have significant advantage 
by concentrating on the actual data rather than the unreliable forecasted data. Therefore, the 
financial analysts should adopt the trailing valuation models in the unstable industries with 
unreliable forecasted data. The forecasted value indictor based forward valuation models should 
be the primary choices in the stable industries, where their future cash flows are easy to predict.  
The current study also shows that the combined valuation models have significant valuation 
advantages over the individual valuation models, especially for the combined valuation models 
which contain both absolute and relative valuation models. This implies that there is no “perfect” 
individual valuation model in practice, since every individual valuation model has its own 
limitation. It is impossible for an individual valuation model to fully capture the intrinsic value of 
a company, while the effective combination of several individual valuation models is able to 
minimize their drawbacks while maximizing their advantages. Therefore, the financial analysts 
should understand the importance of simultaneously applying more than one suitable individual 
valuation model. In addition, this is the first study to introduce the innovative valuation concepts 
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of multi-valuation periods and multi-value indictors. The two valuation concepts provide 
effective practical guidance to the financial analysts about how to properly apply several 
individual valuation models at the same time, and how to construct an appropriate combined 
valuation model. Multi-valuation periods and multi-value indictors imply that a good combined 
valuation model should not only cover all the important life stages of a company, but also fully 
capture the intrinsic value generated in each important life stage. These two valuation concepts 
are the theoretical basis of a superior combined valuation model.  
8.3.4   Target Price Setting Method     
The current study reveals that in the target price setting process, the financial analysts often set 
the target price based on the value estimates produced by several valuation models. However, the 
current study finds that there is no standard method to combine several value estimates into one 
value estimate. The existing literature also offers little theoretical guidance on this practical issue. 
In practice, the financial analysts prefer to use their own methods and judgments to subjectively 
combine several value estimates. In fact, the rule of thumb based combining process may 
introduce additional pricing error, which causes the financial analysts to apply different weight 
allocations for the same combined valuation model. The implication of these findings is that the 
valuation advantage of the combined valuation model can be negatively affected by the 
subjective combining process of the value estimates. Therefore, it is important for academics to 
further explore the target price setting method, especially how to effectively combine several 
value estimates produced by the combined valuation model. The current study introduces a 
quantized combining method to objectively estimate the weight for each value estimate produced 
from a combined valuation model. This quantized combining method is able to largely reduce 
the subjective pricing error and improve the reliability of the target price. 
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8.3.5   Suitability Test Method for Valuation Models 
The current study shows that in the existing literature, most of the studies judge the suitability of 
a valuation model via purely theoretical analysis (e.g. Pinto et al, 2010, Banerjee, 2003). These 
studies concentrate on the characteristics of the valuation model and the company being valued, 
and then qualitatively assess the suitability of the valuation model from the theoretical 
perspective. In addition, some other studies have attempted to judge the suitability of valuation 
models via the financial analysts (e.g. Imam et al., 2008, Demirakos et al., 2004). These studies 
often conduct interviews with financial analysts and also on the content analysis on the valuation 
report, and then assess the suitability of the valuation model based on the observed financial 
analyst’s usage and preference. This finding means that the lack of quantized measurement 
method in the existing literature, and the theory and observation based methods cannot 
accurately measure the degree of suitability of a valuation model. Therefore, the academics 
should attempt to apply a more objective method to accurately measure the suitability of a 
valuation model. This study designs an advanced suitability test method for valuation model 
based on the accuracy and explanatory power of its value estimate. This quantized suitability test 
method is able to accurately test the suitability of the valuation model from multi-aspects. The 
suitability of a valuation model in different industries can be better measured. 
8.4   Research Limitations and Future Research Recommendations     
There are several limitations in the current study related to sample selection and methodology. 
This section discusses the study limitations and presents the directions for future research. 
 The current study results have the characteristics of timeliness and regionalism, where the 
study is based on the data of 35 American listed companies during the period of 2010 to 
2012. Thus the current study results are best suited to the American capital market in the 
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economic expansion stage, or other mature capital markets with similar characteristics. This 
is particularly true for the best industry-based individual and combined valuation models 
identified in the current study. The suitability of an individual or combined valuation model 
often tends to change in different markets and periods. Therefore, it is recommended that 
future research selects different sample periods and companies, in order to obtain the results 
that are suitable for specific capital markets and periods.  
 The current study applies the constant discount rate to estimate the present values of the 
future cash flows. However, the risks behind the future cash flows from different life stages 
of a company are not the same, and the discount rate should fully reflect the underlying risk 
of each cash flow. Therefore, it is ideal that the discount rate is time-varying and the cash 
flow from each future stage is discounted by its corresponding rate. However, the estimation 
of different discount rates for the cash flows from different future stages is highly complex. 
In practice, the financial analysts prefer to apply a constant discount rate to all the future 
cash flows for simplicity. The existing literature also provides little guidance on this issue. 
Thus, further research on the time-varying discount rate is recommended. More accurate 
discount rate and reliable valuation results can be expected as a result of more advanced 
discount rate estimation methods. 
 Each of the best industry-based combined valuation models identified in the current study 
only contains three individual valuation models. In practice, the financial analysts 
simultaneously apply an average of nine individual valuation models (Institutional Factor 
Survey, Merrill Lynch, 2006). In theory, different individual valuation models estimate the 
intrinsic value from different points of view and every individual valuation model has its 
own limitation. Thus, it is important to select more than one suitable individual valuation 
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model to minimize their drawbacks while maximizing their advantages. The best industry-
based combined valuation models identified in the current study are for indicative purposes 
only. The financial analysts are encouraged to customize them by adding more suitable 
individual valuation models to satisfy their specific valuation need or objective. Further 
research on the extension of the best industry-based combined valuation model is 
recommended (more than three individual valuation models in the combination). 
 The current study selects only three major industries in the capital market as the sample 
industries. It is recommended to include more industries into the study of industry-based 
individual and combined valuation model. The result has excellent practical relevance in 
company valuation, which can effectively assist the financial analysts in the selection of 
individual valuation models and the construction of combined valuation models. 
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Appendix A 
Characteristics of Sample Companies and Sample Industries  
Financial Industry 
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Information Technology Industry 
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Health Care Industry 
 
 
Note: All ratios above are “TTM” (Trailing twelve months) ratios.   
Source: Author’s calculation 
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Appendix B 
Estimated Weights for the Best Industry-based Combined Valuation Models 
Financial Industry 
 
 
 
Information Technology Industry 
 
 
Health Care Industry 
 
 
Source: Author’s calculation 
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Appendix C 
Individual Valuation Models: Work as a Group vs Work as Individuals 
Financial Industry 
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Information Technology Industry 
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Health Care Industry 
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Note: “Y” means that the combined valuation model outperforms all of its own individual valuation models in 
terms of accuracy (valuation error) or explanatory power (R2). The above tables reflect whether certain 
individual models perform better when they work as a group rather than individual. 
Source: Author’s calculation 
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Appendix D 
Valuation Performance Comparison: Mixed vs Pure Combined Models 
Financial Industry   
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Information Technology Industry 
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Health Care Industry    
 
 
Source: Author’s calculation 
